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Brain injury in the preterm infant is associated with death and lifelong disability. 
Cerebral hypoxia and fluctuations in cerebral blood flow (CBF), particularly in the 
first two days of life, have been implicated in the pathophysiology of haemorrhagic 
and ischaemic brain injury. Monitoring of haemodynamic changes during the early 
transitional circulation from in-utero to ex-utero life is currently based on standard 
measurements of systemic oxygenation and arterial blood pressure, with no reliable 
assessment of end-organ perfusion. Several studies have suggested the use of near-
infrared spectroscopy (NIRS) and functional echocardiography as methods to assess 
cerebral perfusion and systemic blood flow. Although thresholds of cerebral hypoxia 
and systemic hypoperfusion have been proposed, values for cerebral oxygenation and 
CBF may differ for individual patients depending on several factors, such as 
gestational age, severity of illness and postnatal age. The aim of this thesis is to assess 
methods of monitoring cerebral oxygenation, cerebral vascular reactivity and cardiac 
function within the first two days of life, using NIRS and functional echocardiography 
measurements.  
This thesis is divided in four sections: 
1) The feasibility of monitoring cerebral oxygenation and cerebrovascular 
reactivity using cotside software is demonstrated in a series of case reviews. 
The challenges of recruiting preterm infants within the first hours of life and 
the heterogeneous characteristics of this population are discussed. In addition, 
the association between the cerebral oxygenation and impaired 
cerebrovascular reactivity within the first 48 hours of life and outcome of 
brain injury and mortality is investigated.  
2) Combining measurements of systemic blood flow with end organ perfusion 
should be the uppermost goal in monitoring haemodynamic changes in 
preterm infants. The concept of optimal mean arterial blood pressure 




proposed by studies in adults with traumatic brain injury. Deviations from 
CPPOPT have been associated with poor outcome. In this thesis, MABPOPT in 
preterm infants was defined based on an index of cerebrovascular reactivity. 
Deviations below MABPOPT were associated with intraventricular 
haemorrhage and mortality.  
3) Most studies using cerebral NIRS or systemic measurements of blood flow use 
linear analysis. However, a complex biological system, such as the human 
brain, includes many complex regulatory mechanisms that interact in a non-
linear way, resulting in effects that cannot be understood wholly through the 
analysis of its individual constituents. This thesis investigated the complexity 
of brain and systemic signals by using multi-scale entropy analysis. Lower 
complexity of brain signals was observed in infants who developed 
intraventricular hemorrhage or died.  
4) Functional echocardiography has increasingly been performed by 
neonatologists to monitor circulatory changes in preterm infants. Preterm 
infants are at increased risk to develop low systemic and cerebral blood flow 
within the first two days of life.  Several studies have attempted to correlate 
static measurements of cardiac function with cerebral oxygenation. In 
addition, threshold values of systemic and cerebral blood flow have been 
described. However, most studies on thresholds of cardiac output in preterm 
infants included stable infants with different gestational and chronological 
ages. In this thesis we describe the changes in systemic and cerebral blood 
flow in a cohort of preterm infants within the first 48 hours of life who had 
invasive monitoring of arterial blood pressure for clinical reasons. The 
patterns of changes in cardiac output and cerebral oxygenation in infants who 
had and did not have intraventricular haemorrhage are discussed. Furthermore, 
the relationship between the presence of haemodynamically significant ductus 
arteriosus and brain injury is assessed.  
The final part of this thesis discusses the implications of these results and directions 
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1. MOTIVATION, AIMS & HYPOTHESES 
1 
1. MOTIVATION, AIMS AND HYPOTHESES  
1.1. MOTIVATION 
Preterm birth is a major cause of neonatal mortality and long-term disabilities. 
Approximately 14.9 million infants are born prematurely worldwide per year and the 
complications from preterm birth are the second most common cause of death in 
children under five years of age
1, 2
. Although advances in neonatal medicine over the 
last two decades have contributed to decrease the mortality rates, the number of 
preterm infants who survive with respiratory, visual or neurological sequelae remains 
high
3-5
. The emotional and financial burden of having a child affected by 
complications of prematurity is huge, especially for those who survive with poor 
neurodevelopmental outcome such as cerebral palsy and cognitive impairment
6
. Most 
of these neurological complications result from early injury to the developing brain. 
Therefore, efforts in continuing to optimise neonatal care and improve outcome for 
infants who survive the neonatal period should focus on early brain monitoring and 
neuroprotection.  
1.2. AIMS AND HYPOTHESIS 
The aim of this thesis is to investigate methods to monitor early cerebral oxygenation, 
cerebrovascular reactivity and cardiac function using near-infrared spectroscopy 
(NIRS) and functional echocardiography. The main transitional changes in systemic 
and cerebral blood flow from in-utero to ex-utero life occur within the first 48 hours 
of age. These changes are characterised by fluctuation in systemic and in cerebral 
blood flow. The degree of cerebral hypoperfusion has been associated with the 
development of brain injury and mortality in the preterm population. Therefore, early 
monitoring of systemic and cerebral blood flow may provide better understanding of 
the pathophysiology of brain injury and predict outcome.  
 
1. MOTIVATION, AIMS & HYPOTHESES 
2 
This thesis aimed to test the following hypothesis:  
Hypothesis I: Monitoring of cerebral oxygenation and cerebral vascular reactivity 
within the first 48 hours of age can provide information on cerebral hypoxia and 
impaired cerebrovascular reactivity between infants with and without 
intraventricular haemorrhage (IVH) and infants who died and survived.  
The use of sophisticated cotside software that collects NIRS and physiological signals 
and allows real-time data analysis can provide information on the pathophysiology of 
brain injury in preterm infants. The use of ICM+ software
®
 to collect and analyse data 
in preterm infants was an important part of the work presented in this thesis and will 
be discussed with the presentation of cases. In this part of the thesis, the association 
between cerebral hypoxia and impaired cerebrovascular reactivity with brain injury 
and death is explored.  
Hypothesis II: Optimal mean arterial blood pressure in preterm infants can be 
defined by monitoring cerebrovascular reactivity using NIRS.  
Defining optimal cerebral perfusion pressure and optimal mean arterial blood pressure 
by the strength of cerebrovascular reactivity has been described in adult patients. This 
part of the thesis focuses on defining optimal mean arterial blood in preterm infants 
based on an index of cerebrovascular reactivity measured using NIRS, and 
investigating the association between deviations from optimal values and outcome.  
Hypothesis III: Complexity of cerebral near-infrared signals in preterm infants less 
than 24 hours old can predict the development of IVH and mortality in this 
population.  
The use of multi-scale entropy analysis to measure complexity of physiological 
signals has been applied to distinguish healthy from pathological status. This part of 
the thesis focuses on applying multiscale entropy to cerebral NIRS signal and 
investigating the association between complexity of brain signals and outcome in 
preterm infants.  
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Hypothesis IV: Measurements of cardiac output and ductal patency combined with 
measurements of cerebral oxygenation and cerebrovascular reactivity can 
determine the significance of low systemic blood flow on development of IVH.  
Decrease in cerebral and systemic blood flow is associated with the development of 
brain injury in preterm infants. This part of the thesis describes measurements of 
cardiac output, superior vena cava and ductal patency within the first 48 hours of life. 
The pattern of the changes in systemic blood flow, and cerebral oxygenation and the 
correlation between these measurements, between infants who had and did not have 













2.1. PRETERM BRAIN INJURY 
Brain injury in the preterm infant is associated with an increased risk of death and 
poor neurodevelopmental outcome. The advances in neonatal care over the last 
twenty years have contributed to decrease the mortality rate and to reduce severe 
motor disabilities in survivors. Nevertheless, the number of preterm infants who 
survive the neonatal period with poor long term neurodevelopmental outcome 
resulting from early brain injury remains high
4, 7-9
.  
2.1.1. Intraventricular haemorrhage 
The preterm brain is particularly susceptible to germinal matrix and intraventricular 
haemorrhage (GMH-IVH) and parenchymal haemorrhagic infarct (PHI), usually 
occurring within the first three to four days of life. The overall incidence of GMH-
IVH has declined since the 1980s but the absolute number of new cases every year 
remains high. The incidence of GMH-IVH remains around 25% to 30% for all 
preterm infants born with birth weight < 1500 grams and 45% of those with birth 




The haemorrhage arises from bleeding from the vessels in the subependymal germinal 
matrix, a layer of cells surrounding the lateral ventricles that is also known as 
ganglionic eminence. The germinal matrix is a very gelatinous and vascularised area 
of high cellular proliferation in the developing fetal brain, where neuronal precursors 
arise between 10 to 20 weeks of gestation followed, in the third trimester, by glial cell 
precursors that become oligodendrocytes and astrocytes. This area involutes 
progressively, decreasing from a width of 2.5 mm at 23 to 24 weeks to 1.4 mm at 32 
weeks to nearly complete extinction by 36 weeks of gestation. The germinal matrix is 
characterised by intense angiogenesis, induced by high levels of vascular endothelial 
growth factor (VEGF) and angiopoietin (ANGPT)-2, which may contribute to its 
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vascular fragility and vulnerability to haemorrhage. In addition, the expression of 
fibronectine is reduced in the germinal matrix, which may contribute to the fragility 
of the vasculature in this area
11
.  
The development of GMH-IVH is closely related to the arterial and venous supply to 
the germinal matrix. The arterial supply to the subependymal germinal matrix is 
derived from the anterior cerebral artery (via Heubner’s artery), the middle cerebral 
artery (deep striatal branches primarily and penetrating branches from surface 
meningeal branches) and the internal carotid artery (via anterior choroidal artery). 
This rich arterial network supplies the rich capillary bed of the germinal matrix, 
which is formed by thin and irregular endothelial-lined vessels that are very sensitive 
to hypoxia and changes in cerebral perfusion pressure. This microvascular bed is 
continuous to a deep vascular system that ends in the vein of Galen. The venous 
drainage of the subependymal germinal matrix is mainly through the terminal vein 
that is also the principal terminus of the medullary, choroidal and thalamostriate veins 
that drain blood from cerebral white matter, choroid plexus, striatum and thalamus. 
The blood flow makes a U-turn in the subependymal region at the level of the 
foramen of Monro, the location where most types of haemorrhage develop (Figure 




Figure 2.1 Development of cerebral vasculature 
 
The figure on the left shows the arterial supply to subependymal germinal matrix. The figure on the 
right shows the venous drainage of subependymal matrix with the peculiar U-shape anatomy. (Adapted 






The bleeding in the germinal matrix may disrupt the ependymal lining and extend into 
the ventricles, causing different degrees of IVH (Table 2.1). The destruction of the 
germinal matrix due to haemorrhage and thus damage to its glial cells may lead to 
detrimental effects in later brain development. Severe IVH may be complicated by 
ventricular dilatation, with later development of post-haemorrhagic hydrocephalus, or 
by PHI in the periventricular white matter, or by both complications
8
 (Figure 2.2). 
The ventricular dilatation, and possible later hydrocephalus, is a consequence of an 
obstruction to the cerebrospinal fluid flow caused by excessive bleeding and clot 
formation in the basilar cisterns in the posterior fossa, in the aqueduct of Sylvius and 
in the arachnoid villi. The PHI has been described as an “extension” of the GMH-
IVH, however microscopic studies have revealed that perivascular haemorrhage 
follow the U-shaped distribution of the medullary veins in the periventricular cerebral 
white matter and tend to be concentrated near the ventricular angle where these veins 
become confluent. Therefore, the periventricular haemorrhagic necrosis is actually a 
venous infarction. The most common injury in the white matter caused by PHI is 




Figure 2.2 Germinal matrix haemorrhage (GMH) and intraventricular 
haemorrhage (IVH) with PHI 
 
In red is shown GMH that extended into the ventricle causing IVH (left). Large GHM-IVH can result 
in PHI (right). Subventricular zone (SVZ), the ventral germinative epithelium of the ganglionic 






Cranial ultrasound is the non-invasive technique of choice to diagnose GMH-IVH. 
The severity of GMH-IVH is usually described following the modified Papile 
classification (Table 2.1 and Figure 2.3)
14
. Despite suggestions that this classification 
should be replaced by a more descriptive and precise nomenclature, the Papile criteria 
remains widely used in both clinical or research settings
15, 16
. However, ‘IVH grade 
IV’ should ideally be replaced by ‘IVH grade I, II or III with or without PHI’, as PHI 
may occur in the presence of any degree of haemorrhage
13
.   




Severity Description  
Grade I Haemorrhage is confined to the germinal matrix region 
Grade II Haemorrhage occupies ≤ 50% of the lateral ventricle volume 
Grade III Haemorrhage fills > 50% of the lateral ventricle, usually causing 
distension and dilatation of the ventricles 
Grade IV Presence of an infarction in the periventricular white matter 
ipsilateral to a large GMH-IVH 
 
Most infants will have a ‘silent’ clinical presentation at the onset of GMH-IVH; 
therefore, clinical diagnosis may be a challenge. According to cranial ultrasound 
studies, 50% of the affected infants will develop GMH-IVH within the first 24 hours 
of life and 90% of the lesion can be visualised by 72 hours. Maximal extension of the 
initial lesion can be seen after three to five days of the initial insult and all lesions 
should be visible by day seven of life
17
. Some infants may present haemodynamic 
compromise such as hypotension and general hypoperfusion, which may be 
accompanied by subtle changes in the level of consciousness, movement, tone, 
respiration and in more rare cases, infants may present acute deterioration with stupor, 





All degrees of GMH-IVH have been associated with an increased risk of poor 
outcome. IVH grade I and II may be correlated with better outcome compared to IVH 
grade III and IV. However, in a recent systematic review and meta-analysis, Mukerji 
et al. (2015) have reported that even mild GMH-IVH has been associated with death 
or moderate to severe neurodevelopment impairment
7
. On the other hand, severe 
GMH-IVH has been associated with worse outcome in all domains, such as death, 
motor and cognitive impairment at both 18 to 24 months and 3 to 18 years 
neurodevelopmental follow-up
7
. Morita et al. (2015), using diffusion tension imaging 
studies, have demonstrated an association between IVH grade I and II and cerebellar 
and cerebral white matter impairment. They have also observed that these areas were 
more vulnerable to disruption due to IVH in younger preterm infants compared to 
older preterm infants
19
. Bolisetty et al. (2014) have shown that infants who developed 
GMH-IVH had increased rates of neurosensory impairment, developmental delay, 
cerebral palsy and deafness when compared to infants with no GMH-IVH
20
.  
Figure 2.3 Ultrasound image of GMH-IVH grades 
 
 








C. Grade III: coronal view on the left and sagittal view on the right 
 
 
D. Grade IV: coronal view on the left and sagittal view on the right 
 
 
E. Cystic parenchymal changes post PHI: porenchephalic cysts can be seen on the coronal and sagittal 
views 
 
All cranial ultrasound images presented here were recorded from infants recruited to the studies 




2.1.2. White matter injury  
Periventricular leukomalacia (PVL) refers to ischaemic brain injury in preterm 
infants
21, 22
. Banker & Larroche (1962) were the first to name the ischaemic changes 
observed in the histology of preterm brain’s tissue as periventricular leukomalacia. 
The term PVL was chosen because they observed white (leukos) spots and softening 
(malacia) areas in the periventricular white matter
23
. PVL can occur as an isolated 
phenomenon or in association with GMH-IVH. The pathogenesis of PVL is 
multifactorial and less well understood than the mechanisms related to GMH-IVH; 




PVL is characterised by two components: focal and diffuse. The focal component 
consists in necrosis deep in the periventricular white matter with loss of all cellular 
elements. The focal necrotic lesions may be initially macroscopic in size and then 
evolve to cystic formation after several weeks. They usually occur in areas that are 
considered arterial border zones, lying between the long penetrating branches of the 
middle, anterior and posterior cerebral arteries that terminate in the deep 
periventricular white matter. These vascular end zones may predispose the premature 
brain to injury in the presence of cerebral ischaemia. Following an acute hypoxic-
ischaemic insult, coagulation necrosis at the sites of focal periventricular lesions is 
observed. Over the subsequent days, the cellular response includes macroglia 
infiltration, proliferation of hypertrophic astrocytes, endothelial hyperplasia and 
appearance of foamy macrophages. The tissue dissolution and cavity formation are 
usually seen in about one to two weeks from the initial insult. These cavity lesions, 
that are large enough to be seen on cranial ultrasound, are usually described as ‘cystic 
PVL’ and they should not be confounded with periventricular haemorrhagic 




In developed countries, where advanced antenatal and neonatal care is broadly 
available, severe cystic lesions are currently seen in less than 5% of preterm infants 
with birth weight < 1500 grams
27, 28
. However, focal necrosis can often be 
microscopic in size and evolve over several weeks to glial scars that are not easily 
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seen on cranial ultrasound and sometimes may be even difficult to be visualised on 
brain MRI. This form of PVL accounts for the majority of the cases and is known as 
‘non-cystic PVL’ or diffuse white matter injury
13, 26
. 
Figure 2.4 Cystic and non-cystic periventricular leukomalacia  
 
The small circles on the left are the cystic PVL lesions and the small black dots on the right are the 
non-cystic PVL lesions. Dorsal cerebral subventricular zone (SVZ), ganglionic eminence (GE), 





Two decades ago, white matter infarct with axonal degeneration and loss of cortical 
neurons was the most common cause of early brain injury associated with cerebral 
palsy. More recently, studies have shown a reduction to less than 1% in white matter 
infarcts but an increase in more diffuse lesions
29-32
. This diffuse white matter injury 
seems to occur from selective vulnerability of pre-myelinating oligodendrocytes to 
cerebral hypoxia. A reactive proliferation of new oligodendrocytes occurs, however 
these cells do not have the capacity to fully differentiate into mature myelin-
producing cells, resulting in hypomylination with ventriculomegaly is a possible later 
consequence of PVL
13, 26
. Cystic PVL is associated with spastic diplegia and diffuse 
white matter injury has been correlated with cognitive deficits, usually in the absence 





Figure 2.5 Bilateral periventricular leukomalacia  
 
 
On the right the posterior coronal view shows cystic PVL and on the left side the sagittal view shows 
the equivalent cystic. Both images were recorded from an infant recruited to the studies included in this 
dissertation.  
 
2.1.3. Pathophysiology of brain injury 
The aetiology of brain injury in the preterm infant is complex and multifactorial. 
Fluctuations in cerebral blood flow and cerebral oxygenation, as well as infection and 
inflammation, have been implicated in the pathophysiology of haemorrhagic and 
ischaemic brain lesions
22, 33, 34
.   
Pathogenesis of GMH-IVH 
Cerebral ischaemia has been recognised as an important factor associated with the 
pathophysiology of GMH-IVH
35
. Hypoperfusion of the germinal matrix can cause 
impairment in the integrity of the vascular endothelium. A subsequent period of 
reperfusion in this area, which is metabolically active with limited structural support, 




The work done by Goddard-Finegold et al. (1982) and Ment et al. (1982) has 
reinforced the concept of ischaemia/reperfusion injury in the pathophysiology of 
GMH-IVH. By using the newborn beagle puppy model, they have shown that GMH-
IVH occurred in animals that became hypertensive after receiving rapid volume 
expansion with or without previous systemic hypotension
36, 37
. Perlman et al. (1983), 
using the ultrasound Doppler technique, were the first to describe a ‘fluctuating’ 
pattern in cerebral flow velocity in infants who developed GMH-IVH
38
. The presence 
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of a persistent pressure-passive circulation in sick preterm predisposes them to sudden 
increases in cerebral blood flow (CBF) in association with increases in arterial blood 
pressure
39, 40
. Moreover, elevations in venous pressure have also been considered an 
important mechanism in development of GMH-IVH
38, 41, 42
. Recent evidence has 
suggested that disturbances in arterial and venous circulation may be modulated by 
additional factors, such as inflammation (chorioamnionitis) as a negative influence or 
antenatal glucocorticoids, as a positive influence
43-46
.  
Pathophysiology of white matter injury 
Cerebral ischaemia, maternal intrauterine or neonatal infection and fetal or neonatal 
inflammation have been associated with the pathogenesis of PVL
25
.  
Severe hypotension, along with low cerebral blood flow and impaired cerebral 
autoregulation are the main contributing factors to the development of white matter 
brain injury
47-49
. The active development of the peripheral penetrating vasculature 
occurs during the last 16 weeks of gestation. This may predispose the more immature 
infants to focal white matter injury even in the presence of very low degree of 
hypoperfusion and ischaemia
50
. The immature white matter vasculature has poor 
vasoreactivity to changes in pressure; therefore preterm infants with impaired cerebral 
autoregulation are also at risk of developing PVL
51, 52
 
Severe early hypocarbia (low PaCO2) can cause potent cerebral vasoconstriction and 
it has been associated with PVL
53, 54
. Shankaran et al. (2006) have shown that 
cumulative hypocarbia during the first week of life in preterm infants born < 1250 
grams has been associated with increased likelihood to develop PVL
55
. Infection and 
inflammation can induce injury or death of pre-oligodendrocytes cells by systemic 
upregulation of pro-inflammatory cytokines and diffuse activation of microglia within 
the immature white matter
25






2.2. CEREBRAL BLOOD FLOW AND CEREBROVASCULAR REACTIVITY IN    
THE PRETERM BRAIN 
Preterm infants are at risk of developing low systemic and cerebral blood flow (CBF) 
during the first 24 hours of age due to the haemodynamic changes following birth
56
. 
However, the nadir and duration of a decreased CBF may be a determinant factor for 
the development of brain injury in some infants. In addition, abrupt increases and 
fluctuations in CBF may contribute to ‘reperfusion injury’ – possibly due to loss of 
cerebral autoregulation – which has been strongly associated with GMH-IVH
57
.  
A decrease in CBF with increased cerebral oxygen extraction fraction (COEF) occurs 
immediately after birth in newborn infants. Garfunkel et al. (1954) were the first to 
measure CBF and cerebral oxygen consumption (CMRO2) in newborn infants
57
. 









for CBF and CMRO2, respectively. The 
Kety-Schmidt method was based on the inhalation of nitric oxide (NO). CBF was 
calculated on the assumption that the rate at which the cerebral venous blood content 
of nitric oxide approaches the arterial blood content will depend on the volume of 
blood flowing through the brain
58
. Since then, several methods have been used to 
assess CBF in term and preterm infants. Meek et al. (1998) used near-infrared 
spectroscopy (NIRS) to measure CBF in preterm infants. Applying a modified Fick 
principle (Figure 2.6), where oxygen is the intravascular tracer, they reported values 




for CBF in mechanically ventilated preterm infants within 
the first day of life. These measurements were comparable with values of CBF 












Interestingly, values for CBF in preterm infants in the first 24 hours after birth may be 
lower than the minimal estimated CBF required for minimal neuronal viability and 






. In the preterm brain the minimal 














The figure shows an increase in peripheral arterial oxygen (SaO2) and a subsequent increase in the 
concentration of oxyhaemoglobin (Δ[HbO2]). CBF is calculated by dividing the change in Δ[HbO2] (b) 




CBF increases over the first days of life as a normal adaptation to postnatal 
circulation
65
. In growing preterm infants, studies have demonstrated that global CBF 




, which is about one third of values observed 







CBF is dependent on the relationship between cerebral perfusion pressure (CPP) and 
cerebrovascular resistance (CVR) (Equation 2-5). However, this relationship is not 
linear, but curvilinear as explained by Darcy’s and Poiseuille’s Laws.  
As described by the Darcy’s Law, the flow rate of liquid (Q) is directly proportional 
to the pressure difference between the inlet and outflow (Pi – Po), which is also 
known as perfusion pressure (Equation 2-1). In the Darcy’s law, K is a constant called 
the hydraulic conductance and its reciprocal is the hydraulic resistance (R) (Equation 
2-2). The Darcy’s Law is equivalent to Ohm’s Law (in the field of electricity)
67
.  
The approximately relationship between CBF and CPP could be explained by 
Poiseulle’s Law (Equation 2-3). Poiseuille observed that resistance to liquid (blood) 
through a straight rigid tube is directly proportional to the viscosity (resistance to 
flow) of the liquid (η) and the length of the tube (ι), but varies inversely with the flow 














The combination of the Darcy’s law with Poiseuille’s Law gives us the following 
mathematical relationship (Equation 2-4): 
 
Equation 2-4 
Q = (Pi - Po).8ηι/π
4 
 
Therefore, for a given fluid (e.g. blood), the larger the diameter of a tube the higher 
the flow rate for a given pressure difference. Moreover, for a given pressure gradient, 
the higher is the viscosity of the blood the smaller the flow rate.  
Some of the limitations for the application of the Poiseuille’s Law in human 
physiology are: its strict relationship to laminar flow, the assumption of constant 
pressure gradient and the presence of cylindrical tubes (vessels) with parallel walls. 
Laminar flow is observed in most of the cardiovascular system (usually in arteries), 
however once turbulence has occurred, more pressure is required to achieve a given 
increase in flow. In addition physiological circulation is maintained by a pulsatile and 











CPP is the difference between cerebral arterial and venous blood pressure (Equation 
2-6). Cerebral arterial blood pressure is usually assumed to be identical to mean 
arterial blood pressure (MABP) in other major arteries in the body. Cerebral venous 




CPP = MABP- ICP  
 
CVR is dependent on blood vessel size, blood viscosity and characteristics of blood 
flow in the vessel. MABP is influenced by cardiac output and total peripheral vascular 
resistance, which differs from CVR.  
Cerebral oxygen supply is tightly coupled to cerebral energy demand under normal 
conditions, however in many pathological states this coupling may be deranged, 
leading to hypoxia. Cerebral oxygen supply is the product of arterial oxygen content 
(CaO2) and cerebral blood flow (CBF) (Equation 2-7):  
Equation 2-7 
 
Cerebral O2 delivery = CBF . CaO2 
 





CaO2 = b ×SaO2 ×cHb+a × PaO2  
Where β (1.39) is the oxygen capacity of haemoglobin (each gram of haemoglobin is 
capable of carrying 1.39 mL of O2), SaO2 is arterial oxygen saturation, cHb is arterial 
haemoglobin concentration, α (0.003) is the solubility coefficient of oxygen in the 
human blood and PaO2 is partial pressure of oxygen in arterial blood. CaO2 is mainly 
dependent on oxygen bound to haemoglobin, as the amount of dissolved O2 is 
minimal.  
Adjustments of cerebral O2 supply due to changes in cerebral O2 demand occur 
mainly due to changes in CBF. However, when there is a reduction in oxygen 
delivery, the metabolic demand is met by increasing the oxygen extraction in the 





Where CaO2 is cerebral arterial oxygen content and CvO2 is cerebral venous oxygen 
content.  
Changes in a cerebral hemodynamic and oxygen supply may affect cerebral 
oxygenation and consequently cerebral energy metabolism (Table 2.2). A reduction in 
oxygen delivery can be caused by a decrease in haemoglobin concentration (anaemic 
hypoxic), a reduced uptake of oxygen (hypoxic hypoxia) or impaired cerebral blood 
flow (ischaemic hypoxia). A disruption in oxygen delivery can cause an energy 
deficit, leading to cessation of neuronal activity and neuronal death
68









Table 2.2 Relationship between cerebral oxygen delivery, consumption and 
extraction 
CDO2 CDO2 CMRO2 CFOE Comments 
CBF cHb SaO2 
      
Hypoxic hypoxia  
no compensatory increase in CBF 
      
Hypoxic hypoxia 
compensatory increase in CBF 
      
Anaemic hypoxia 
no compensatory increase in CBF 
      
Anaemic hypoxia 
compensatory increase in CBF 
      
Ischaemic hypoxia 
CDO2 still adequate to maintain 
CMRO2 
      
Ischaemic hypoxia 
CDO2 no longer adequate to 
maintain CMRO2 
CDO2: cerebral oxygen delivery; CMRO2: cerebral oxygen consumption; CFOE: cerebral fraction 
oxygen extraction; CBF: cerebral blood flow; cHb: arterial haemoglobin concentration; SaO2: arterial 
oxygen saturation (Adapted from Topun Austin, ‘Assessment of cerebral oxygenation in newborn 
infants using optical techniques’ PhD dissertation, University College London, 2008).  
 
In adults and animal studies using PET, an increase in CFOE has been seen in areas of 
the brain surrounding ischaemic lesions, a condition known as ‘misery perfusion’
69
. 
Similarly, the neonatal brain has the ability to adapt to conditions of low perfusion. 
Newborn infants have increased CFOE on the first day of life and higher CFOE has 
been observed in preterm infants compared to term infants
70-72
. It has been suggested 
that this high CFOE in the early postnatal period may be close to maximum levels and 
therefore any further reduction in systemic blood flow or CBF would not result in any 
increased oxygen extraction and potentially increase the risk of hypoxic-ischaemic 
injury. Alderliesten et al. (2013) have shown that infants who developed severe IVH 
with PHI had higher CFOE values on the first day of life when compared to control 
infants
73
. However, the maximum level of CFOE in neonates remains unknown.  
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In preterm infants, CBF is higher in the thalami and brain stem than in the white 
matter according to studies using single photon emission computer tomography 
(SPECT) and MRI perfusion techniques
74, 75
. Borch et al. (1998) studied preterm 
infants born between 25 and 32 weeks and observed that regional CBF to the white 
matter was 0.39 of global CBF while flow to the basal ganglia was 2.33 of global 
CBF
75
. This difference between grey and white matter perfusion may be explained by 
the incomplete development of deep vascular anatomy. Moreover, it is already known 
that CBF in preterm infants is likely to be near the threshold for neuronal viability, 
therefore the relative hypoperfusion of the white matter may explain its vulnerability 
to hypoxic-ischaemic injury.  
Early studies using the Xe
133 
clearance technique have demonstrated that decreased 
levels of CBF, impaired cerebral pressure reactivity and abnormal CBF-CO2 reactivity 
were associated with the development of severe brain injury
76
. Similarly, Meek et al. 
(1999) using NIRS, have described lower CBF within the first 24 hours of age in 




Infants who are born very preterm, with lower gestational age or are clinically very 
sick are at increased risk of presenting with prolonged pressure-passive cerebral 
circulation (Figure 2.8)
40, 78
. Therefore, a sudden increase in CBF may be implicated 
in the development of brain lesions in this population. Milligan et al. (1980) using 
invasive jugular vein occlusion plethysmography, showed the association between a 
sudden rise in MABP and CBF following blood transfusion in preterm infants who 
developed GMH-IVH
79
. More recently, studies using NIRS demonstrated that infants 
who had impaired cerebral autoregulation within the first hours or days of life were 
more likely to develop GMH-IVH
80, 81
. Wong et al. (2012) has shown that in severely 
sick preterm infants, impaired cerebral autoregulation and pressure passive perfusion 





Figure 2.7 Association between cerebral blood flow and GMH-IVH  
 
Median (range) CBF in infants with GMH-IVH was 5.8 (3.2 – 7.5) mL/100g/min in infants who had 
severe IVH and 12.1 (6.1 – 24.5) mL/100g/min in infants who had normal cranial ultrasound (P < 0.01) 




Figure 2.8 Coherence between ultra-low frequency waves of MABP and TOI 
 
Figure A shows the high coherence between MABP and tissue oxygenation index (TOI) (impaired 
autoregulation). Correlating changes between these two waves are observed. Figure B shows low 
coherence between MABP and TOI (intact autoregulation). Despite changes on MABP waves, TOI 





2.2.1. Mechanisms involved in the regulation of CBF   
Neurovascular coupling  
The relationship between neuronal activity and cerebral blood flow was first 
described in 1890. Roy & Sherrington (1890) directly measured the change in 
cerebral blood volume caused by electrical stimulation of exposed sensory nerves in 
dogs
83
. The model used to explain activity-dependent flow is the ‘neurovascular unit’ 
in which an astrocyte anatomically bridges a collection of synapses and penetrating 
arterioles. Neurovascular coupling is spatially specific and characterized by a fast 
response, where vascular diameter changes within one second from neuronal 
activation
84
. However, haemodynamic response to neuronal activation seems to be 
incompletely developed in the infant brain. In preterm infants during the first 48 hours 
of life there is no correlation between CBF and spontaneous changes in CMRO2, but 
instead, changes in cerebral oxygen extraction rather than CBF meet changes in 
oxygen requirement
72, 85
. The mechanisms associated with changes in CBF-
metabolism coupling during brain development may be related with changes in 
astrocytes numbers, size and their connectivity with each other and with blood 
vessels
86, 87
. In addition, the capacity of arterioles to increase local CBF in response to 
neurovascular-coupling is likely to increase with age
88
.  More recently, Kozberg et al. 
(2016) have demonstrated a lack of coupled blood flow responses to neural activity in 
the developing brain during the early postnatal age in mice, suggesting that in the 
newborn brain, neural activity can lead to a relative hypoxia in areas of neural 
activation with consequent deplete of local oxygen consumption to levels below the 
baseline for early developing stages
89, 90
.  
Vasoreactivity to carbon dioxide (CO2) and oxygen (O2)  
Hypercapnia (high PaCO2) may cause GMH-IVH by inducing vasodilation and 
engorgement of the microvasculature
91
. It may also limit vasodilator responses to 
hypotension and hypoxemia, by inducing abnormal cerebral autoregulation
92
. CO2-
induced vasodilation is a strong vasoregulatory mechanism present from 
approximately 26 weeks of gestation, according to animal studies
86
. In healthy term 
infants, CBF changes by 25% per kPa of PaCO2, however in preterm infants changes 
in CBF range from 10%-30% per kPa of PaCO2 
76, 93
. Hypocapnia (low PaCO2) 
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induces vasoconstriction until levels of PaCO2 reach approximately 1.2 kPa. Below 
this level, no further vasoconstriction occurs 
94
.  
The cerebrovascular response to hypoxia is characterized by cerebral vasodilation, 
with an increase in CBF by two to three-fold. O2 vasoreactivity depends on intact 
endothelium and NO production. The ability to increase CBF in response to hypoxia 
is present from approximately 28 weeks of gestation, according to studies in fetal 
sheep
95
. Global hypoxia induces redistribution of blood flow to the brain. In late 
gestational age, the fetal compensatory mechanisms to hypoxia are characterized by a 
decreased in heart rate with consequent fall in the oxygen consumption. The fetal 
blood flow is redistributed from the peripheral vasculature towards vital organs, such 
as the brain
96
. This mechanism is known as ‘brain sparing effect’ and it has been 
demonstrated by using Transonic flowmetry to measure simultaneously carotid and 
femoral blood flow in fetal sheep
97
. Fetal bradycardia and peripheral vasoconstriction 
in response to hypoxia are triggered by carotid chemoreflexes. However, the 
magnitude of the fetal peripheral vasoconstrictor response to acute hypoxia is the 
result of combined carotid chemoreflexes, endocrine response (increase in plasma 
catecholamines, vasopressin, angiotensin II and neuropeptide Y) and vascular oxidant 
tone (presence of reactive oxygen species that regulates blood flow). The circulatory 
response to fetal hypoxia changes as the fetus approaches gestational age at term, in 
association with the increase in plasma cortisol. In preterm infants, the antenatal 
exposure to synthetic glucocorticoids may change the pattern and magnitude of the 
fetal heart rate and promote maturation in the fetal circulatory response to acute 
hypoxia stress in a similar way as advancing gestational age does
96, 98, 99
. In contrast, 
hyperoxia reduces CBF. In preterm infants CBF may be decreased by 15% to 30% per 
kPa of PaO2 and this decrease in CBF may persists beyond the time that blood 
oxygenation was raised.  
Myogenic mechanisms (cerebral autoregulation) 
The myogenic reflex is one of the mechanisms involved in the regulation of cerebral 
blood flow. It depends on the intrinsic ability of vascular smooth muscle cells to 
constrict or dilate in response to changes in transmural pressure
100, 101
. A number of 
endothelial derived vasoactive substances may contribute to cerebral autoregulation. 
Following a decrease in transmural pressure, endothelial-derived NO, carbon 
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monoxide and calcium-activated potassium channels induce vasodilation and, hence, 
an increase in cerebral blood flow
102
. The NO/NO synthase pathway has been related 
to the maintenance of CBF stability
103-106
. Disruption of this mechanism has been 
shown in states of impaired cerebral autoregulation. The contribution of endothelial 
NO in pressure regulation increases with age and therefore it may be less efficient in 
the preterm infant, where other mechanism may possibly dominate
107
.  










2.3. CEREBRAL AUTOREGULATION 
Cerebral autoregulation is the mechanism that maintains cerebral blood flow (CBF) 
relatively constant despite changes in cerebral perfusion pressure. It is a homeostatic 
property of the cerebral arteries and arterioles to constrict or dilate in response to an 
increase or decrease in transmural pressure, respectively ensuring adequate perfusion 
and oxygenation to the brain. It was originally believed that CBF varied passively 
with changes in perfusion pressure (Monro-Kellie doctrine)
108
. However, in 1938 
Mogens Fog was the first to directly observe the changes in the diameter of the pial 
vessels in response to variation in blood pressure through a window in the skull of 
cats
109
. Lassen first used the term cerebral autoregulation in his famous review paper 
published in 1959. Using data from 11 different published studies, Lassen plotted 
mean values of CBF against mean values of MABP (Figure 2.9). The plotted data 





Figure 2.9 Cerebral autoregulation and cerebral pressure passive curves 
 
In blue is the autoregulatory curve of Lassen that represents the intrinsic mechanism of the brain to 
maintain cerebral blood flow relatively constant despite changes in arterial blood pressure (plateau). 
The circles represent the dilatation and constriction of the cerebral blood vessels in response to changes 
in arterial blood pressure. In red is the passive pressure curve that represents absence of the 
autoregulatory mechanism.  
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Disruption of the autoregulatory mechanism will lead to the development of a 
‘pressure-passive circulation’, where fluctuations in systemic arterial blood pressure 
are transmitted directly to the cerebral microvasculature. In adults with intact cerebral 
autoregulation, changes in MABP between 60 and 160mmHg or in CPP between 50 
and 150mmHg, produce little or no change in CBF
110
. Beyond the lower limit of 
autoregulation (LLA) and the upper limit of autoregulation (ULA), hypotension can 
cause brain ischemia and cell death and hypertension can cause hyperaemia and 
cerebral oedema.  
2.3.1. Cerebral autoregulation in preterm infants 
In the preterm brain, the presence and mechanisms of cerebral autoregulation and the 
thresholds of MABP remain poorly understood (Figure 2.10). The first evidence of 
impaired autoregulation in the newborn infant was shown by Lou et al. (1979), in 
Copenhagen, using 
133
Xenon clearance to measure cerebral blood flow a few hours 
after birth in preterm babies with different degrees of respiratory disease syndrome
39
. 
Since then, several studies have suggested that cerebral autoregulation is impaired not 
only in sick infants but also in clinically well preterm infants 
39, 76, 80, 111
.  
 
Figure 2.10 Possible cerebral autoregulation curve in preterm infants 
 
The limits of lower and higher MABP in the plateau area of the curve remain uncertain. Adapted from 






Loss of autoregulation is associated with brain injury and increased risk of mortality 
in newborn infants, children and adults
81, 113, 114
. In adults, following traumatic brain 
injury (TBI), impaired cerebral autoregulation has been considered an independent 
predictor of poor outcome
114
. Data from preterm infants have shown that cerebral 
autoregulation fluctuates in the first week of life, and that the degree of ‘pressure 
passivity’ is associated with the development of significant GMH-IVH
81
.  
NIRS has been extensively used to assess cerebral autoregulation in neonates. The 
most common methods to investigate the relationship between MABP and CBF have 
been frequency and time-domain analysis. The question whether the two methods are 
equivalent or one is superior to the other remains debatable, however, in a recent 
study including 60 preterm infants, time-domain analysis appeared more robust 
compared with coherence function analysis
115
.  
The frequency-domain analysis was first used by Giller (1990) to assess cerebral 
autoregulation as a dynamic process
116
. In the frequency domain, the coherence 
analysis is the correlation that describes the strength of the relationship between input 
signal (i.e. MABP) and output signal (i.e. CBF). Coherence values range from 0 to 1, 
where 0 indicates intact cerebral autoregulation and 1 suggests implies absence of 
cerebral autoregulation. The transfer function analysis is another frequency-domain 
method where gain quantifies the extent to which a waveform is transferred from an 
input signal (i.e. MABP) to an output signal (i.e. CBF). Low gain indicates intact 
cerebral autoregulation and high gain suggests high CBF variability in proportion to 
high variability in MABP.  
The time-domain analysis is a statistical measurement of linearity between MABP 
and CFB where the outcome variables are correlation and regression. In this thesis, 
correlation between systemic pressure and CBF was performed using time domain 
analysis. The characteristics of this method will be discussed in more details in the 
section 2.3.2 and Chapter 4, section 4.4.2 of this dissertation.  
In neonates, Tsuji et al. (2010) were the first to describe the coherence between ΔHbD 
(a NIRS derived signal and surrogate measurement of CBF, ΔHbD = ΔHbO2 – ΔHb), 
and MABP as a measure of cerebral autoregulation. They described a higher rate of 





. O’Leary et al. (2009), using transfer function analysis, studied a cohort 
of preterm infants born < 32 weeks and demonstrated that higher MABP-HbD gain 
was associated with the likelihood to develop early GMH-IVH
81
. However, HbD is 
not an ideal parameter to measure continuous CBF, because it requires offline 
analysis and is more sensitive to changes in cerebral blood volume (CBV). On the 




The development of spatially resolved NIRS allowed the use of continuous 
parameters of cerebral oxygenation (known as the tissue oxygenation index (TOI) or 
regional oxygen saturation (rSO2), depending on the NIRS device) as surrogate 
measure of CBF to assess cerebral autoregulation. TOI and rSO2 have been applied to 
measure cerebral autoregulation instead of HbD
119
. Wong et al. (2009) were the first 
to show that changes in TOI correlate with changes in CBF in both time and 
frequency-domain analysis. TOI strongly reflected changes in CBF during 
fluctuations in MABP over periods longer than 10 seconds (Figure 2.8)
118
. Higher 
coherence between MABP and TOI was observed in more premature and sick infants 
and in those who died or had severe IVH
78
.  
2.3.2. Measurements of cerebral autoregulation: lessons from adult    
 neurocritical care 
The ‘Lassen’s curve of cerebral autoregulation was based on static measurements of 
CBF and MABP. However, cerebral autoregulation is a dynamic process; therefore in 
clinical practice continuous measurement of cerebral autoregulation depends on the 
spontaneous response of CBF to spontaneous fluctuations in CPP or MABP (dynamic 
autoregulation). Haemodynamic oscillations that last between 20 seconds to 3 minutes 
are the best for the assessment of cerebral autoregulation
120
. Oscillations faster than 
20 seconds are too fast to initiate vasodilation or vasoconstriction, which can be 
reliably measured. Oscillations longer than three minutes, in clinical practice can be 
contaminated too much by medication, nursing and changes in cerebral metabolic 
rate. Several invasive and non-invasive methods to assess CBF have been applied for 
research or clinical purpose. Some monitoring modalities, such as Xe
133
 washout 
technique, CT perfusion, MRI and PET, measure direct perfusion but can only offer 
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static measurements; other modalities such as transcranial Doppler, NIRS (both non-
invasive), ICP via intraparenchymal probe or external ventricular drainage and 
invasive brain oxygen monitoring (PbtO2) measure surrogate markers of CBF or CBV 
and usually provide more continuous measurements
121-131
.  
In neonates, invasive methods to assess CBF are currently not ethically accepted for 
either research or clinical use, although some physiological studies have used more 
invasive methods such as Xe
133
 and PET in the past
132, 133
. This section will focus on 
invasive and non-invasive studies that applied similar methodology used in the 
clinical measurements included in this dissertation.  
Cerebrovascular pressure reactivity is one of the key mechanisms responsible for 
cerebral autoregulation. In adult patients with traumatic brain injury a continuous 
computational analytic approach to monitor cerebrovascular pressure reactivity was 
first described by Czosnyka et al. (1997)
130
. By using time-domain analysis to 
calculate continuous moving linear Pearson’s correlation coefficient between slow 
waves of ICP and MABP, they proposed an index of cerebrovascular reactivity, the 
pressure reactivity index (PRx). If pressure reactivity is intact, an increase in MABP 
will lead, within approximately 5-15 seconds, to a vasoconstriction with reduction in 
CBV and thus ICP will decrease. On the other hand, if pressure reactivity is impaired, 
CBV will passively increase with rising MABP and ICP will consequently rise. The 
correlation between spontaneous fluctuations in MABP and ICP waves will result in 
values of PRx between -1 and +1, where negative values reflect normal or intact 
cerebrovascular reactivity and positive values reflect disturbed vasoreactivity (Figure 
2.11). PRx has been shown to be a strong independent predictor of outcome; 






Figure 2.11 Pressure reactivity index (PRx) 
 
The figure shows the correlation between slow waves in intracranial pressure and arterial blood 
pressure. Intact cerebral autoregulation is demonstrated by negative PRx and impaired cerebral 




Based on the methodology used to calculate PRx, other indices of cerebrovascular 
reactivity and cerebral autoregulation using non-invasive techniques have been 
suggested and validated against invasive methods.  
Using the transcutaneous Doppler technique, Czosnyka et al. (1998) have described 
an index of cerebrovascular reactivity between slow waves of MABP and flow 
velocity in the middle cerebral artery, the mean flow index (Mx). This index has been 
extensively used to assess cerebral autoregulation in patients with traumatic brain 
injury. However, some limitations to the use of Mx as a continuous measure of 
cerebral autoregulation include the difficulty to record prolonged monitoring periods 
and operator dependent variability
134, 135
. 
NIRS is a non-invasive technique that provides surrogate measurements of CBF and 
CBV. Brady et al. (2007) using NIRS in a piglet model, described an index of 
cerebrovascular reactivity derived from the linear moving correlation coefficient 
between spontaneous slow waves of CPP and cerebral oxygen saturation, the COx 
(cerebral oximetry index)
129
. COx was sensitive for loss of autoregulation caused by 
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induced hypotension in this animal model and it has been validated against invasive 
methods using laser Doppler and ICP monitoring
129, 136
. Thresholds of COx above 
0.36 had high sensitivity (73% to 99%) and moderate specificity (around 63%) for 
detecting loss of cerebral autoregulation
129
. COx is an attractive method of pressure 
autoregulation monitoring in neonates, because it can be non-invasive measurement 
of cerebral autoregulation. Gilmore et al. (2011) defined COx as the correlation 
coefficient between slow waves of MABP and cerebral oxygenation and studied a 
cohort of preterm infants (born ≤ 30 weeks) during their first four days of life (Figure 
2.12). They observed that lower MABP was associated with more frequently impaired 
cerebral autoregulation (Cox > 0.5); however no difference in COx was observed 




Figure 2.12 Cerebral oximetry index in preterm infants 
Intact cerebral autoregulation is demonstrated by negative COx and impaired cerebral autoregulation 




More recently, Eriksen et al. (2014) used COx to investigate the association between 
dopamine and cerebral autoregulation. In a cohort of 60 preterm infants (born ≤ 32 
weeks), where 13 received dopamine within the first days of life, COx was higher in 






The haemoglobin volume index (HVx) is another NIRS-derived index of 
cerebrovascular reactivity. The HVx is a moving correlation coefficient between slow 
waves of total haemoglobin (rTHb), a surrogate of CBV measured with NIRS, and 
MABP
139
. HVx has a strong correlation with PRx and it has been used to identify 
lower limits of autoregulation in animal models
140
.  
More recently, Mitra et al. (2014) described the tissue oxygenation heart rate 
reactivity index (TOHRx) based on the correlation between slow waves of TOI and 
heart rate (HR) (Figure 2.13). This methodology is based on the fact that changes in 
cardiac output (CO) in preterm infants may rely mainly in changes in heart rate. 
Strong coupling between cardiac output and TOI may be interpreted as a failure of 
regulation of CBF. Higher TOHRx (impaired cerebrovascular reactivity) was 
observed in infants with worse neonatal score of mortality and morbidity (more 
severely sick infants). TOHRx was also higher in infants with lower MABP. 





Figure 2.13 Tissue oxygenation heart rate reactivity index (TOHRx) 
Intact cerebrovascular reactivity is demonstrated by negative TOHRx and impaired cerebrovascular 






2.4. CIRCULATORY ADAPTATION AFTER BIRTH 
2.4.1. Fetal and early postnatal circulation  
The transition from fetal to newborn life is marked by significant changes in the 
circulatory physiology. The fetal circulation is characterised by low systemic vascular 
resistance (SVR), with high systemic blood flow, high pulmonary vascular resistance 
and low pulmonary blood flow (Figure 2.14). The placenta is responsible for oxygen 
and blood supply to the fetus. Both right and left cardiac outputs contribute to the 
systemic blood flow. This combined cardiac output is markedly higher in the fetus (in 
the range of 400-450 mL/kg/min) compared to the systemic blood flow after birth 
(about 200 mL/kg/min). The right ventricle is the main cardiac chamber and pumps 
about 65% of the cardiac output to the systemic circulation bypassing the lungs - that 
only receive 5-10% of the combined cardiac output (CO) - through a channel between 
main pulmonary artery and descending aorta, known as the ductus arteriosus. In 
contrast, the left cardiac output supplies mostly the brain and upper body
142-144
. 




The figure shows the vital three shunts during fetal life: foramen ovale, ductus arteriosus and ductus 





In term infants, the normal transition from fetal to postnatal circulation is 
characterised by an increase in SVR following the removal of the placenta, cord 
clamping and the release of catecholamines and other hormones. The pulmonary 
vascular resistance drops, following the first breath and subsequent lung expansion 
and increase in the partial pressure of oxygen. The antenatal channels usually close 
within the first 24 hours of age, which also contribute to the increase in SVR. On the 
other hand, in preterm infants or in pathological situations the circulatory changes 
following birth may not be complete for days or weeks
142
. This is mainly due to the 
inability of the immature myocardium to adapt to the increased ventricular workload 
and the persistence of the antenatal channels, known clinically as the persistent ductus 
arteriosus (PDA) and persistent foramen ovale (PFO)
145, 146
. Haemodynamic 
instability may occur and the distribution of systemic blood flow may preserve the 
vital organs (brain, heart and adrenals) at the expense of non-vital organs
142, 147
.   
 
Figure 2.15 Transitional circulation in a healthy term infant 
 
1. The opening of airways and pulmonary vasculature induces a fall in pulmonary resistance.  
2. Increased pulmonary venous return leads to functional closure of foramen ovale.  
3. The increase in partial pressure oxygen promotes the closure of ductus arteriosus.  





As previously discussed, following preterm birth, cardiac output and CBF are low and 
both rise over the first days of life
65, 148
. CMRO2 is also low immediately after birth. It 
is unknown whether the low perfusion just reflects low demand or CMRO2 is low as a 
result of the low output state. It may be possible that the infant effectively lowers its 
metabolic rate as a protective mechanism during this transitional phase. The complex 
interaction between systemic blood flow, blood pressure and end organ perfusion 
during the transitional circulation following preterm birth is shown in Figure 2.16.  
Figure 2.16 Interaction between blood flow, vascular resistance, blood pressure 
and cellular metabolic demand 
 
Coupling of oxygen supply and demand plays an important role on the control of microcirculation. 
OBF: organ blood flow, BP: blood pressure, CO: cardiac output, SVR: systemic vascular resistance, 
GA: gestational age, PNA: postnatal age (Adapted from Noori et al, Principles of developmental 
cardiovascular physiology and pathophysiology, 2012)
142
. 
2.4.2. The controversies around “normal” blood pressure in preterm infants 
Strategies for preventing cerebral injury in preterm infants have emphasized the 
importance of maintaining a “normal blood pressure” to ensure adequate perfusion of 
the brain. However, the definition of hypotension or hypertension in this population 
remains uncertain. The current management of hypotension in preterm infants in the 
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first few days of life does not combine quantitative information about blood flow and 
tissue oxygen delivery
149, 150
. The dynamic nature of the cardiovascular system during 
the first hours and days of life with spontaneous increase in blood pressure and the 




Mean arterial blood pressure (MABP) is determined by the interaction between 
cardiac output (CO) and systemic vascular resistance (SVR)  
Equation 2-10 
MABP = CO × SVR
 
Cardiac output (CO) is determined by stroke volume and heart rate.  
CO = SV × HR  
 
Normative data on blood pressure 
Several studies have attempted to define normal ranges of blood pressure in neonates 
during the transitional period; however, there is not yet a consensus on the definition 
of normal thresholds. The majority of studies are of small populations, retrospective 
in design and included both invasive and non-invasive measurements of blood 
pressure
47, 151, 152
. Moreover, the evidence that hypotension in newborn infants is 
associated with poor outcome remains controversial, especially in the preterm 
population, as discussed below.  
The current clinical practice remains based mainly on recommendations from the 
Joint Working Group of the British Association of Perinatal Medicine published in 
1992 where MABP should be maintained at or greater value (in mmHg) than the 
gestational ages in weeks
153
. Another well-adopted concept is to accept the value of 
30 mmHg as the critical lower limit of blood pressure in preterm infants regardless 
the gestational age. The threshold of ≤ 30 mmHg for hypotension has been suggested 
based on a few studies assessing the lower limits of cerebral autoregulation and 
reporting that preterm infants who had mean values of MABP below 30 mmHg were 
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more likely to develop brain injury
151, 154, 155
. In addition, several neonatal guidelines 




 percentile according to age and birth 
weight reference values
156
 (Figure 2.17).  
Figure 2.17 Predicted MABP for infants during the first 72 hours of life 
  
The graph shows the lower limit of 80% confidence interval of MABP for each gestational age group 
for a cohort of 103 infants born between 23 to 43 weeks. The difference of values between term and 
preterm infants and the increase in MABP over the first 72 hours of life can be observed. (Adapted 




Relationship between hypotension and outcome in neonates 
Several studies have associated hypotension with increased mortality and 
development of GMH-IVH and PVL. Most of them had important limitations such as 
small sample sizes, non-consistent blood pressure thresholds and different ways to 




. However, despite 
the differences in methodologies, early studies by Miall-Allen et al. (1987), Bada et 
al. (1990) and Cunningham et al. (1990) all showed an association between “low 
blood pressure” and severe GMH-IVH, supporting the relationship between 
hypotension and brain injury
47, 155, 158
.  
The association between systemic hypotension and low CBF and decreased oxygen 





. Impaired cerebral autoregulation in preterm infants may lead 
to a direct relationship between MABP and CBF, putting these babies at risk of 
hypoxic-ischaemic brain injury
78, 160
. Moreover, the configuration of the cerebral 
vasculature in preterm infants may increase the risk of white matter brain injury. The 
vascular end zone in the white matter not fully developed, making this area more 
sensitive for falls in cerebral perfusion pressure and ischemia
8, 51
 (seen in Chapter 2, 
section 2.2).  
More recent studies have not found an association between hypotension (established 
according to the current definitions) and short or long-term outcomes
161-163
. Some 
studies have shown that efforts to raise and treat hypotension had no improvement on 





Dempsey et al. (2009) observed that preterm infants with MABP below the gestation 
age in weeks but showing signs of good organ perfusion (such as good capillary refill 
time < 3 seconds, normal lactate and good urine output) who did not receive treatment 
had short-term outcome as good as those with “normal” blood pressure
164
. Moreover, 
Alderliesten et al. (2014) have demonstrated that MABP below the gestational age 
alone was not associated with lower cerebral oxygenation or worse 














2.5. DEFINING OPTIMAL CEREBRAL PERFUSION PRESSURE AND 
OPTIMAL ARTERIAL BLOOD PRESSURE BASED ON THE STRENGH OF 
AUTOREULATION 
Optimising CPP or MABP according to the strength of cerebral autoregulation is a 
concept that has been suggested for the management of adult patients with traumatic 
brain injury. More recently, several studies in the context of paediatric traumatic brain 
injury, intra-operative monitoring during cardiac surgery and cardiac arrest have 
applied this same concept of individualised brain monitoring targeting optimal CPP or 
optimal MABP
166-169
. This is an attractive method, as it combines haemodynamic 
measurements of systemic blood flow with end organ perfusion.  
Steiner et al. (2002) were the first to demonstrate that by using PRx it is possible to 
define an optimal value for CPP where cerebral autoregulation is strongest (CPPOPT). 
Data from adult patients with traumatic brain injury, admitted to a neurocritical care 
unit, who had continuous invasive measurements of MABP and ICP recorded and 
analysed using ICM+ software
170
. The determination of CPPOPT for each individual 
patient was possible as CPP values were divided into bins of 5 mmHg and PRx values 
were averaged within these bins. The values were accepted when more than 2.5% of 
the data set was included and when the graph showed a distinct minimum value for 
PRx (Figure 2.18). The difference between CPPOPT and mean CPP for the whole 
monitoring period was calculated. Patients whose mean CPP values were maintained 
close to the values of CPPOPT had better outcome compared to those who had mean 
values away from the optimal. These findings led to a suggestion that the 
management of patients with traumatic brain injury should include individual CPP 
measurements
171
. However, the data published by Steiner et al. (2002) were obtained 
through retrospectively analysis of the recordings of ICP for the whole monitoring 
period, thus they were not necessarily applicable for a more real-time management of 
CPP. Subsequently, Aries et al. (2012) validated an algorithm for automated and 
continuous updating of CPPOPT derived from time windows of 4 hours
172
. Using this 
new method, they were able to define CPPOPT in 83% of patients and confirmed that 
the patients who were treated with values of CPP away from CPPOPT were more likely 
to have bad outcome, defined as death and severe disability
173
. Recently, a 
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prospective pilot study conducted in a single European centre, in which adult patients 
with traumatic brain injury were managed according to continuous monitoring of 
CPPOPT targets, demonstrated that the methodology published by Aries et al. (2012) is 
feasible for real-time bedside monitoring (Figure 2.18)
174
. However, the methodology 
has yet to be refined in order to be applied in randomised control trials. 
Figure 2.18 Optimal cerebral perfusion pressure 
 
The first graph shows the actual CPP and CPPOPT measurements for a 4-hour-window of data. The 
second graph shows the CPPOPT defines by U-shape curve. The CPPOPT is the value of CPP where PRx 
is more negative (strongest cerebral autoregulation). The bottom graph is a frequency histogram of all 





A non-invasive equivalent method of optimising MABP published by Zweifel et al. 
(2010) made an important contribution to cerebral monitoring of patients whose 
invasive measurement of ICP was not indicated or feasible. Using the total 
haemoglobin index (THx) – a NIRS derived index – they were able to define levels of 
MABP where cerebral vascular reactivity was strongest (MABPOPT). They also 
compared values of MABPOPT with CPPOPT assessed with THx and PRx, respectively 
and demonstrated significant agreement between the two indices (Figure 2.19). 
Recently, a feasibility pilot study including twenty adult patients who were admitted 
to an intensive care unit following cardiac arrest defined MABPOPT based on another 
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non-invasive NIRS-derived index of cerebral oximetry (COx)
166
. Although the sample 
size was small, MABPOPT curves were defined for all patients. 
 
Figure 2.19 Invasive and non-invasive measurements of CPPOPT and MABPOPT 
 
The lower the value for PRx and THx the stronger the cerebrovascular reactivity. ABP is equivalent to 




In paediatric traumatic brain injury, Young et al. (2016) published a single centre 
study on continuous monitoring of PRx and CPPOPT. They observed that the time 
spent with CPP values close to CPPOPT was longer in those children who survived 
compared to those who died. In neonates, a non-invasive index of cerebral blood 
volume (HVx) has been to define MABPOPT during therapeutic hypothermia treatment 
and rewarming in infants who had hypoxic-ischaemic injury
176
. Burton et al. (2015), 
in an pilot study, showed that infants who spent more time with MABP below 
MABPOPT during rewarming phase, had greater impaired motor and cognitive 
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3. NON-INVASIVE ASSESSMENT OF CEREBRAL AND 
SYSTEMIC CIRCULATION 
3.1. NEAR-INFRARED SPECTROSCOPY (NIRS) 
NIRS is a technique that can provide real time monitoring of cerebral oxygenation at 
the bedside. NIRS was first described by Jobsis (1977) and first applied in newborn 
infants in 1985 to study cerebral blood flow and oxygenation
178, 179
. Since then this 






NIRS technology is based on two fundamental phenomena: the relative transparency 
of biological tissue to light in the near-infrared spectrum (wavelength between 600 
and 1000nm) and the presence of light-absorbing molecules, or chromophores, in 
biological tissue. The NIRS technique can monitor a variety of chromophores that are 
found in the living tissue. Some of them, such as melanin, bilirubin and water, remain 
relatively constant over a certain period of time. Other chromophores such as 
oxyhaemoglobin (HbO2), deoxyhaemoglobin (Hb) and oxidised cytochrome oxidase 
(CtOx) are more physiologically interesting as their oxygenation status is not constant 
and so will show variation in light absorption over short time periods
183
.  
In the visible part of the spectrum the interaction between the haemoglobin molecule 
and oxygen can be visualised: the arterial or oxygenated blood appears red because all 
colours of visible light except red are strongly absorbed by HbO2 and venous blood 
appears more purple or blue as Hb absorbs red light more strongly. In the near-
infrared region the light absorption by both chromophores decreases but the 
absorption spectra of HbO2 and Hb remain significantly different, allowing the 
spectroscopic separation of the components. Light at 850nm will be absorbed more by 
HbO2 and less by Hb; conversely light at 750nm will be absorbed predominantly by 
Hb. The isobestic point (the wavelength at which HbO2 and Hb molecules have the 
same absorption properties) is seen at 800nm and can be used to calculate the 
haemoglobin concentration independent of oxygen saturation (Figure 3.1)
184
. 
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Figure 3.1 Light absorption spectra of the most common chromophores present 
in the human tissue 
 
A: Light absorption by water is predominantly above 1000 nm wavelength. Below 1000 nm, the 
chromophores that mainly absorb light are Hb, HbO2 and melanin. B: Changes in light absorption by 
Hb and HbO2 in the near-infrared region. At the isobestic point (800 nm) Hb and HbO2 spectra of 
absorption is the same. 
 
Light that has traversed up to 8 cm of a biological tissue can be detected, however this 
propagation of light depends on the combination of reflectance, scattering and 
absorption effects
178
. Conventional NIRS is based on the Beer-Lambert Law, which 
states that attenuation of light passing through a volume containing absorbing 
components (i.e. chromophores) dissolved in a non light-absorbing medium, is 
proportional to the concentration of the components and the distance travelled by the 
light (Figure 3.2). Therefore, the concentration of the chromophores in the medium 
can be calculated by measuring intensity of the emitted light and the detected light 
and the distance travelled by the light through the medium. 
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Figure 3.2 The Beer-Lambert law and the modified Beer-Lambert law used in 
NIRS  
The Beer-Lambert law is valid for a homogeneous and isotropic medium, which 
assumes photons travel in a straight line. However, in a scattering medium, such as 
the biological tissue, which is nonhomogeneous and anisotropic, the Beer-lambert law 
has to be modified to take into account the scattering losses and the subsequent 
increased optical pathlength due to scattering. In a highly scattering medium, photons 
will travel a mean distance that is greater than the geometrical pathlength (d), which is 
the true optical distance and it is defined as the geometrical pathlength (DP). The 
scaling factor is defined as the differential pathlength factor (DPF) (Equation 3-1)
185
.  
Equation 3-1 Modified Beer-Lambert Law 
 
A = lg Io¸ I =a ×c ×d × B+G  
Where A is the attenuation measured in optical density (OD). I0 and I represent the incident and 
transmitted light in the medium, respectively. α is the specific extinction coefficient of the absorbing 




. c is the concentration of the absorbing compound 
in the solution measured in μmolar. d is the distance between the points where the light enters and 
leaves the solution measured in cm (geometrical distance). B is the differential pathway factor. G for 
scattering losses factor.  
 
Conventional NIRS systems using the modified Beer-Lambert law, is able to measure 
changes in the concentration of HbO2 and Hb; absolute quantification of CBF and 
CBV is possible by either the manipulation of inspired oxygen or injection of optical 
 
 
Schematic diagrams representing the (A) Beer- Lambert 
and the (B) modified Beer-Lambert law.  
 
In both cases α is the specific per chromophores extinction 
coefficient [μmol/cm] while c is the concentration of the 
chromophores [μmol/cm].  
 
The α x c is known as the absorption coefficient. When 
multiple chromophores are present the combined 
absorption coefficient is the linear sum of all the 
absorption coefficients.  
 
A – attenuation, I0 – intensity of the light entering the 
medium, I1 – intensity of the light exiting the medium. 
Courtesy of Peter Smielewski 
 




. Real time continuous and quantitative measurements of 
CBF and CBV are not possible due to the inability to resolve the attenuation due to 
scattering of light in the medium and the presence of chromophores in all tissues 
located between the source of light and detector (optode), such as the skin, 
subcutaneous tissue, bones of the skull, meninges, cerebral fluid, cerebral cortex and 
white matter. This problem limited NIRS to clinical research studies because off-line 
processing of the data was required to calculate CBF and CBV
180
. Therefore, a 
method that relies on the photon diffusion theory, rather than the modified Beer-
Lambert law, has been developed, known as spatially resolved spectroscopy (SRS), 
which provides a continuous quantitative measurement of cerebral oxygenation 
(Figure 3.3). By using a single light source that emits three to four wavelengths of 
light within the near-infrared region and multiple closely spaced detectors, the slop of 
light attenuation versus distance is measured. By applying photon diffusion theory, 
the scattering component of light attenuation can be accounted for and an absolute 





Figure 3.3 Spatially resolved spectroscopy (SRS) 
The figure on the right shows the principle of SRS. δA/δρ is the rate of light attenuation over distance 
(Adapted from Valipour, European Respiratory Journal, 2002)
188
. The figure on the left shows an 
example of NIRS probe with a light emittent and two detectors (NIRO 200NX probe, Hamamatsu, 
Japan). 
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The equation below demonstrates the principal of SRS.  
Equation 3-2 
 
Where A is attenuation, ρ the distance from light impulse source and μa means 




The NIRS measurements included in this dissertation were performed using the NIRO 
200NX (Hamamatsu, Photonics Japan). The NIRO 200NX monitor works with a laser 
photodiode emitting three wavelengths of light in the near-infrared spectrum (775, 
810 and 850 nm) coupled with a set of three photodiode detectors (separated by 1 mm 
from each other). The NIRO 200NX measures HbO2 and Hb using the modified Beer-
Lambert law, and the tissue oxygenation index (TOI) and tissue haemoglobin index 
(THI) using SRS. Because in the first order approximation the scatter coefficient (μs’) 
can be treated as a constant (k) with respect to the wavelength, the relative 
concentrations of oxygenated and deoxygenated haemoglobin can be obtained 
(k*HbO2 and k*Hb, respectively) and resolved to the desired depth of the detector, i.e. 




TOI is calculated as the formula below and it is expressed as a percentage (%).  
Equation 3-3 
 
TOI = HbO2 / HbO2 + Hb x 100% 
 
 
Where TOI indicates the Tissue Oxygenation Index, while Hb and HbO2 indicate 
deoxygenated and oxygenated haemoglobin respectively. 
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THI is calculated as the formula below and expressed as a relative value, representing 
a change from the baseline measurement at the start of the study.  
Equation 3-4 
THI = HbO2 + Hb 
 
Where THI indicates the Tissue Haemoglobin Index. Hb and HbO2 indicate 
deoxygenated and oxygenated haemoglobin respectively. 
 
The SRS algorithm has been validated for monitoring of cerebral haemodynamics. 
Al-Rawi et al. (2001) studied a cohort of adult patients undergoing carotid 
endarterectomy and showed that sensitivity of TOI intracranial and extracranial 
changes was 85.7% and 0% respectively and specificity was 100% and 0% 
respectively
190
. Wong et al. (2009) demonstrated that TOI has concordance with CBF 




3.1.1.  Precision, accuracy and limitations of NIRS technology 
Several NIRS monitors have been designed over the last two decades, using the multi-
distance detector approach to provide a continuous quantitative assessment of cerebral 
oxygenation. Different instruments use different terminologies and methods to 
estimate cerebral oxygenation. The two most common NIRS monitors used in the 
neonatal environment are: the NIRO 200NX from Hamamatsu, Photonics K.K, Japan 
(which uses the SRS method described above), and the INVOS 5100c 
(Somanetics/Covidien, Mansfield, USA). The INVOS instrument has a transducer 
containing one LED light emitting source with two different wavelengths (730 and 
810 nm) and two photodiode detectors at a distance of three and four centimetres 
from the emitting source, respectively. The INVOS monitor uses a formula that 
subtracts the light absorbed by the nearest detector (assuming this detector light 
absorbed only by shallow regions as the akin and skull) from the more distal detector; 
it estimates the regional cerebral oxygen saturation (rSO2), diminishing the 
contribution of extra-cerebral tissue. TOI and rSO2 measure the oxygen saturation 
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across veins (70-80%), capillaries (5%) and arteries (20-25%) and both have been 
validated against the jugular saturation as well as against each other
191, 192
. 
The comparison between measurements using different devices remains an important 
limitation to the use of NIRS as a clinical tool. The reproducibility of measurements 
between different NIRS monitors has been assessed in several studies. The validity of 
any monitoring instrument depends in its precision and accuracy. Sorensen & Greisen 
(2006) studied the precision of TOI using the NIRO 300 monitor and observed that 
the variation in measurements within infant was 5.2% and between different infants, 
was 6.9%
193
. Pocivalni et al. (2011) compared the NIRO 300 and INVOS 5100 
instruments and reported a 10% difference between the two monitors with the NIRO 
reading lower values for cerebral oxygen saturation
194
. A similar, but smaller 
discrepancy, was documented by Schneider et al. (2014) comparing the NIRO and 
INVOS (2.9% difference)
195
. The reasons for these discrepancies are complex and 
multifactorial; different manufacturers use different algorithms to calculate the 
saturation values, moreover there is no calibration standard. In addition, several 
studies have used adult sensors to measure cerebral oxygenation in infants. The 
difference between adult and neonatal sensors can reach 15%
196
. 
The proportion of approximately 70% venous saturation and 25% to 30% arterial is 
based on studies comparing positron emission tomography (PET) and NIRS
197
. 
However, significant variation between individual cerebral arterial/venous ratio 
should be considered. Different physiological or pathological status may contribute to 
changes in this proportion, nevertheless the use of NIRS as a trend monitor can 
minimise this limitation
198
. The skull, the presence of high extra-cerebral fluid and 
hair can also contribute to the attenuation of light and reduce the accuracy of NIRS 
measurements
199-201
. However, in preterm infant the thickness of the skull is thinner 
than in adults and the amount of hair is negligible, which may not cause a major 
influence in the continuous trend measurements.  Single channel NIRS provide 
regional cerebral oxygenation (reflectance more) and assumptions of global brain 
perfusion and haemodynamics should be cautiously considered. Using two channels, 
one in each side of the infants’ head or changing the optodes from one side to the 
other every few hours may minimise this limitation.  
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3.1.2. Fractional tissue oxygen extraction  
The balance between oxygen delivery and oxygen consumption can be investigated 




FTOE = SaO2 – rScO2 / SaO2 
Where SaO2 is peripheral arterial oxygen saturation and rScO2 is regional cerebral 
oxygenation. 
Increased FTOE may indicate a reduced oxygen delivery with constant cerebral 
oxygen consumption or a higher consumption than oxygen delivery. On the other 
hand, decreased FTOE may reflect a reduction in oxygen extraction due to decrease in 
oxygen consumption with rise in oxygen delivery
202
. 
3.1.3. Clinical applications of NIRS in neonates 
NIRS has been increasingly applied as a trend monitor of cerebral oxygen delivery 
and perfusion. This technology has been routinely used during cardiac surgery in 
many centres
182
. In infants undergoing cardiac surgery, an association between 
intraoperative low cerebral oxygenation and poor neurodevelopmental outcome at one 
year of age has been described
203
. More recently, some neonatal intensive care units 
in North America and in Europe have adopted the use of NIRS in term infants with 
hypoxic ischaemic encephalopathy (HIE) undergoing hypothermia treatment. The 
rationale to use NIRS in this population is its possible prognostic value on long-term 
neurodevelopmental outcome. Higher cerebral oxygen saturation with lower FTOE at 
24 hours of age has been observed in infants who died or had adverse motor and 
cognitive impairment compared to infants with more favourable outrome
204, 205
. In 
small studies using MRI (magnetic resonance imaging), cerebral oxygenation had 
strong positive correlation with CBF in infants with severe HIE
206
. In addition infants 
who had any degree of brain injury shown on the MRI done on day 10 of life had 
higher cerebral oxygenation on the first day of life compared to infants who had 




. However, larger studies are necessary to define the thresholds of 
cerebral oxygenation in this population and to understand the physiology of brain 
haemodynamics in infants undergoing hypothermia treatment.  
In the preterm population, several studies have used NIRS to assess cerebral 
oxygenation and cerebral autoregulation. A lack of consensus on “normal cerebral 
oxygenation thresholds” and the evidence that monitoring cerebral haemodynamics 
during the first days of life may improve long-term neurological outcome have 
delayed the use of NIRS as a routine cotside monitoring.  
Cerebral oxygenation in preterm infants  
Data from early animal studies and small cohorts originally suggested a “normal 
range” for cerebral oxygenation between 55% and 85%. According to these studies, 
neuronal injury occurs when cerebral oxygenation is below 35%
208
. Over the last 
decade, several groups have used NIRS to monitor cerebral oxygenation in small and 
large cohorts of infants over the first days of life
209-211
. Alderliesten et al. (2016) have 
recently proposed gestational age-specific reference curves for cerebral oxygenation 
(rSO2) and FTOE during the first three days of life in a cohort of 999 preterm infants 
born at less than 32 weeks (Figure 3.4). They suggested that lower thresholds are seen 
in infants with lower gestational age and that postnatal age, haemodynamically 
significant PDA and in-utero growth restriction may have an impact on levels of 
rSO2
210
. Despite being a valid study to elucidate the questions about rSO2 thresholds, 
there were a number of limitations. Infants with different morbidities were included in 
the overall analysis; most infants had rSO2 recorded with a small adult sensor (as 
mentioned, differences between adult sensors and neonatal sensors can reach 15%) 
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Figure 3.4 Reference values of cerebral oxygenation in preterm infants  
 
Each graph shows references and percentiles values for different ranges of gestational age at birth: a 





The importance of defining thresholds of cerebral oxygenation in preterm infants have 
increased since a large multi-centre study demonstrated that NIRS could be used to 
stabilize cerebral oxygenation in extreme preterm infants. The SafeBoosC 
(Safeguarding the Brains of Our Smallest Children) phase II randomized control trial 
has shown that the burden of hypoxia and hyperoxia in preterm infants born at less 
than 28 weeks can be reduced by using continuous monitoring of rSO2 over the first 
72 hours of life. In the 86 infants randomised to the experimental group, where NIRS 
measurements were visible and a dedicated guideline treatment from rSO2 below 55% 
or above 85%, the mean burden (magnitude of deviation from stipulated thresholds) 
of hypoxia was significantly less than in the 86 infants in the control group, where 
rSO2 was blinded (Figure 3.5). Although this trial was not powered to detect 
differences in short or long-term outcomes, its results have emphasized the 
importance of including continuous monitoring of tissue perfusion during the 
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transitional period, when preterm infants are more vulnerable to hypoxic-ischaemic 
brain injury. However, the SafeBoosC trial had several limitations: different monitors 
and sensors were used in different centres, and motion artefacts were not completely 
removed, for example repositioning of the sensors may have induced sudden change 
in cerebral oxygenation
209
. These limitations should be addressed before a larger 
phase III trial having primary outcome of death and/or brain injury and secondary 
outcome of neurodevelopmental outcome is designed.  
 
Figure 3.5 SafeBoosC trial 
 
On the right is a schematic illustration of the estimation of burden of hypoxia (below 55%) and 
hyperoxia (above 85%). On the left is the difference of burden of hypoxia and hyperoxia between 
groups (NIRS = visible measurements together with guideline treatment, Blinded NIRS = control 




Several studies have used NIRS to monitor cerebral oxygenation during the 
immediate transition from birth in term infants
212-214
. However, no definite thresholds 
have yet been defined.  
Cerebral autoregulation 
Cerebral autoregulation using NIRS and the different studies using this technology to 
assess CBF and cerebrovascular reactivity in preterm infants has been described in 
Chapter 2, section 2.3.1.  
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3.1.4. Complexity of biological signals as an alternative method to analyse NIRS 
 signals  
A complex biological system includes a diversity of regulatory mechanisms that 
interact in a non-linear way. Most studies using NIRS or systemic signals apply time 
or frequency-domain analysis. These methods assume linearity or stationarity. 
However, a non-linear method to analyse biological signals may reveal more 
accurately the magnitude of changes over time. A complex biological system has the 
ability to react and adapt to minute changes in its environment. When the complexity 
of a system is reduced or lost, a pathological status is potentially present. Loss of 
complexity has been observed in several diseases and aging
215, 216
. It has also been 
associated with poor outcome in severely sick adults and children
217, 218
.  
Analysis of entropy is a non-linear measurement of system randomness and 
unpredictability, which has been suggested as a method to assess the complexity of 
biological signals in healthy and pathological systems. The entropy of a system 
increases with greater randomness. In 1991, Pincus introduced the approximate 
entropy (ApEn) method to assess the irregularity of biological time series
219
. Several 
studies have shown that ApEn may correlate with subclinical changes that are often 
undetectable by time-series analysis. Moreover, ApEn changes have been associated 
with subsequent clinical changes
219
. ApEn has been extensively used in physiological 
and medical studies. It has been applied to discriminate atypical EEG’s and 
respiratory patterns from normal signals
220, 221
. One decade later, sample entropy 
(SampEn) was proposed as a modified method, which was less dependent on the 
length of the time series and less statistically biased
222, 223
. In neonates, Sample 
Entropy analysis of heart rate variability (HRV) was used to predict the onset of 
neonatal sepsis 24 hours before clinical diagnosis
222
. 
More recently, multiscale Entropy (MSE) has been used to provide a more 
meaningful measure of complexity, exploring calculations of (SampEn) over multiple 
time scales (Figure 3.6). MSE shows that correlated random signals are more complex 
than uncorrelated random signals (white noise). Moreover, MSE describes 
pathological physiology better than simple entropy measures, doing a better 
differentiation between healthy, complex system and deranged or random 




. Since Costa et al., 2002 introduced MSE method; several studies in 
adults and children have been published using this methodology. MSE has been 
applied to assess the complexity of cardiac interbeat from an interval time-series; 
healthy adults had more complex dynamics than adults with congestive heart failure 
or those with atrial fibrillation
225
. Complexity of intracranial pressure (ICP) measured 
using MSE has been correlated with clinical outcome. In adults with traumatic brain 
injury, reduced complexity of mean ICP was associated with poor outcome and 
increased mortality
226
. In neonates, MSE was significantly reduced in infants with 
neonatal seizures and later diagnosis of epilepsy when compared to control infants
227
. 
Figure 3.6 Multi-scale entropy analysis  
 
The illustration (A) shows sequences of time series data and (B) sample entropy. For length m = 2, two 
sequences (dotted circle) match the first two data points and one sequence (circle) matches the first 
three data points (length m + 1). This matching process is repeated for the next two data points and 
then all sequences to determine the total number of matches of length m and m + 1. Sample entropy is 
calculated as the negative natural logarithm of the ratio between the number of length m + 1 matches 
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3.2. NEONATAL FUNCTION ECHOCARDIOGRAPHY  
The lack of reliable continuous measurement of systemic blood flow remains an 
unresolved problem in neonatal intensive care units. Haemodynamic monitoring often 
relies solely on blood pressure and heart rate measurements. Beyond that, the 
assessment of cardiovascular function and organ perfusion is based on poorly 
validated measurements of capillary refill time, skin colour and urine output. Methods 
of continuous cardiac output measurement, such as thermodilution and electrical 
impedance monitoring have not yet been well validated for clinical use in neonates, 
mainly due to the difficulties on assessing the complexity of transitional circulation 
and the persistence of antenatal channels in preterm infants and sick infants.  
Doppler echocardiography is a non-invasive technique that can estimate 
hemodynamic parameters of systemic blood flow and surrogate measurements of 
cerebral blood flow (CBF). Over the last 20 years, neonatologists have developed 
skills to perform targeted functional echocardiography to assess cardiac output, 
myocardium performance, and the presence and patency of the ductus arteriosus and 
foramen ovale. This practice has helped the management of infants with 
hemodynamic compromise and has possibly improved short-term outcome
228, 229
. 
However, the validity and reliability of measurements between observers remains an 
important limitation. Intra-observer variability can range from about 10% and inter-
observer variability from 15% to 20%
230
. Therefore, functional echocardiographic 
measurements should be taken in consideration along with the clinical context.  
Two-dimensional (2D) echocardiography 
2D echocardiography allows the assessment of the structure of the heart and major 
vessels, giving a subjective impression of myocardium contractility, identifying any 
thrombus, pericardium effusion, and allows the positioning the cursor to obtain M-
mode and Doppler measurements
231
. The most common views to perform functional 
echocardiography in neonates are: subcostal, apical, long axis parasternal, short axis 
parasternal (Figure 3.7). These views are used to measure several parameters: left 
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Figure 3.7 Neonatal echocardiography: standard views   
 
The image shows the five most common views for the assessment of cardiac morphology and function 




M-mode modality assesses the insonated structure over time during the cardiac cycle 
by displaying consecutive single lines though part of the heart (Figure 3.19). Each line 
represents the same structure but in a different time. M-mode is useful to get more 





The Doppler principle can be applied to ultrasound because frequency changes when 
sound is reflected from moving objects. Blood flow can be estimated using Doppler 
ultrasound, because the major reflector is the red blood cell. The velocity of the 
moving blood can be calculated if the frequency shift is directly proportional to the 
velocity of the moving object and if the angle of insonation is within 20° of the axis 
of movement. Increasing angle can lead to underestimated values of flow velocity. By 
measuring velocity two parameters can be derived. Firstly, the pressure gradient can 
be determined by using a modified Bernoulli equation (pressure gradient = 4 x 
velocity
2
). Secondly, by measuring the diameter of a vessel as well as the flow 
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In neonatal echocardiography, three types of Doppler are usually used:  
PW (Pulse wave Doppler): it is the most commonly used type of Doppler. It allows 
the operator to focus the velocity assessment on a “range gate” on the 2D image. It 
has the limitation of assessing velocities only up to 2 m/s.  
CW (Continuous wave Doppler): it allows the assessment of velocities above 2 m/s, 
but it assesses the whole path of transmission, being less focused.  
CD (Colour Doppler): it is derived from CW. Flow direction and velocity are 
mapped in colours on a 2D image. Conventionally, flow away from the probe is 
mapped in blue and flow towards the probe is mapped in red.  
3.2.1. Measurements   
The measurements described below are the ones obtained during data collection for 
this thesis and are limited to systemic blood flows and persistent antenatal shunts. 
Several methods to assess myocardium performance and right ventricle function have 
been recently described in the literature; however the discussion about these 
measurements is beyond scope of this thesis.  
Left ventricular output  
LVO is obtained from the measurement of flow velocity from the ascending aorta 
from a modified apical five chamber view and diameter of the ascending aorta from 




. Three different methods to measure aortic diameter 
have been suggested: between the hinges of the aortic arch (AV)
236, 237
, at the aortic 
sinus (AS)
238, 239
 and at the sinotubular junction (STJ)
146
. Mellander et al. (1987) have 
compared ultrasound methods to measure LVO with thermodilution and observed that 
measurements using 2D diameter from AV underestimate LVO
240
. Recent work 
published by Beker et al. (2014) showed that aorta diameter measurement at STJ was 
more precise and accurate to determine LVO than AV and AS. According to this 
study, measurements at AV level underestimate LVO and measurements at AS level 




. Most research studies have used the measurement 
suggested by Evans et al (STJ)
146
. 
Figure 3.8 Aorta diameter measurements  
 
Aortic diameters from 2D (high parasternal long axis view) images for estimation of LVO: 1. between 
the hinges of the aortic valve (AV). 2. at the level of the aortic sinus (AS). 3. at the level of sinotubular 




The methodology suggested by Evans et al. (1996) has been validated against 
invasive methods such as thermodilution and dye dilution
146, 173, 240
. The accuracy of 
LVO measurements is variable. Intra-observer variability has been estimated at about 
10% and inter-observer variability of 20%. However, this variability may be 
decreasing with the use of modern ultrasound machines, which offer better quality 
images and advance software for image reconstruction
232
.  
The main limitation on the use of LVO as a measure of systemic blood flow is the 
presence of a PDA with left-to-right flow, particularly in preterm infants. In infants 
with a closed or restrictive ductus arteriosus, LVO is associated with systemic blood 
flow and RVO reflects pulmonary blood flow. However, in the presence a PDA with 
a left-to-right PDA shunt, RVO would better reflect systemic blood flow and LVO 
pulmonary blood flow, as long as PFO flow is minimal. LVO is usually increased 
with a significant PDA shunt but RVO may be decreased due to reduced systemic 
venous return (‘ductal steal’) (Figure 3.9). 
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Figure 3.9 Systemic and pulmonary blood flows in the presence of PDA 
 
LVO reflects the sum of systemic blood flow and ductal shunt, which is then equal to pulmonary blood 
flow (PBF). RVO provides an estimated measurement of systemic blood flow (SBF), as long as PFO is 






Figure 3.10 LVO measurements 
 
The picture on the left shows the long parasternal axis view at the aorta level for 2D measurement of 
LVO diameter. On the right, the picture shows the LVO flow taken from modified 5 chambers apical 
view.  
 
All functional echocardiography images presented in this section were recorded from infants recruited 
to the studies included in this dissertation. I collected all images and performed all measurements 
(more details in Chapter 4). 
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Right ventricular output  
RVO is usually measured following the methodology published by Evans & Iyer 
(1994) in the main pulmonary artery (MPA) from the true parasternal view. Diameter 
is determined in end systole at the insertion of the pulmonary valve leaflet just before 
the valve closes. Doppler is performed on the same window, placing the range gate 
just beyond the valve leaflets. Flow velocity measurements can be difficult to obtain 
when a large left-to-right ductal shut is present. Moreover, the accuracy of RVO is not 
clear, as studies comparing RVO with other methods of measuring right-sided cardiac 
output have not been published. However, in infants with a closed ductus arteriosus 
and no shunt across the foramen ovale the RVO has been strongly correlated with 
LVO
242
. RVO measurements may not be accurate in infants with a large PFO; 
however, atrial shunts are usually not significant within the first 24 hours of age, and 
therefore RVO is a reasonable measure to assess systemic blood flow in preterm 
infants with significant PDA in this time period. 
Figure 3.11 RVO measurements 
 
The picture on the left shows the upper long parasternal axis view at the main pulmonary artery level 
for 2D measurement of RVO diameter. On the right, the picture shows the RVO flow taken from the 
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Superior vena cava  
SVC flow has been suggested as a surrogate marker of blood flow from the brain and 
upper body
56
. It was initially proposed as a global measure of systemic blood flow 
during transitional period because it is not influenced by atrial and ductal shunts. SVC 
flow velocity is considerably easy to record from low subcostal view but diameter 
measurements (in most studies are performed using M-mode) can show large 
variability and be difficult to obtain. Spontaneous respiration and beat-to-beat 
variability may influence flow velocity since SVC flow is a venous flow. Therefore, 
the diameter should be taken from an average of 10-15 cardiac cycles. In infants with 
a closed ductus arteriosus and LVO similar to RVO, SVC has been estimated an 
average of 37% of LVO
56
. A major limitation in the use of SVC flow in clinical 
practice is the high intra and inter-observer variability. Lee et al. (2010) have reported 
mean intra-observer variability of 17% and 29% in inter-observer analysis
243
.  
SVC flow increases over the first 48 hours of life. Early studies from Evans and 
Klucow’s group have shown an association between low SVC flow (< 40 mL/kg/min) 
within the first 24 hours and later development of GMH-IVH, death, and poor long-
term neurodevelopmental outcome
145, 244
. However, more recent studies have not 
found the same correlation between low SVC flow and poor outcome. Recent data 
have reported higher values of SVC measurements within the first 24 hours of age 
compared to early studies published by Kluckow’s group
245, 246
.  
More recently, Ficial et al. (2017) a modified method to measure SVC flow by 
obtaining flow velocity from a suprasternal window and by deriving the cross-
sectional area from imaging the SVC in short axis and manually tracing the minimal 
and maximal area. This method had better agreement with MRI-derived SVC flow 
and better intra and inter-observer variability when compared to the methodology 
published by Evans and Kluckow in 2000. However, no ranges of normal SVC flow 
measurements have been yet published using this recent method neither data on short 
or long-term outcome
247
. The measurements included in this dissertations were based 
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Figure 3.12 SVC measurements 
 
The picture on the left shows the high long parasternal view at the level where SVC enters the right 
atrium for the measurement of minimal and maximum diameters. On the right, the picture shows the 
SVC flow obtained from the low subcostal view.  
 
 
Table 3.1 Values for LVO, RVO and SVC flow in preterm infants  
 < 12 hrs of life 
Mean (SD) 
24 hrs of life 
Mean (SD) 




 240 (60) 260 (60) 
RVO 
(mL/kg/min) 
 260 (90) 270 (90) 
SVC 
(mL/kg/min) 
60 (25) 80 (20) 90 (25) 




Persistent foramen ovale  
The foramen ovale is situated in the mid-portion of the inter-atrial septum. During 
fetal life, it has the function to divert the blood flow coming from the ductus venosus 
to the left atrium, and the blood flow from the inferior vena cava into the right atrium 
(Figure 3.13). Following birth the changes in pressure between left and right ventricle 
usually induce the closure the foramen ovale over the first few days of life. The PFO 
is usually present in preterm infants and can be measured from the subcostal view 
using low scale colour Doppler. Diameter can be measured using either colour flow 
jet through the atrial septum or by 2D images. PW Doppler can be used to assess the 
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direction and velocity of flow. PFO can increase RVO measurements when diameter 
is bigger than 3 mm and it is less likely to influence CBF compared to PDA
233, 242, 248
.
Figure 3.13 PFO measurements 
 
The picture on the left shows the subcostal view at PFO level. On the right, the picture shows the PFO 
flow obtained also from subcostal view.  
 
Persistent ductus arteriosus  
The clinical significance of a PDA and its association with neonatal morbidities has 
been a controversial subject between neonatologists. Several studies have associated 
haemodynamically significant PDA (hsPDA) with adverse outcome such as GMH-
IVH, necrotizing enterocolitis (NEC), chronic lung disease (CLD) and death 
249-251
. 
However, the definition of what is an hsPDA remains debatable. Different studies 
have applied different classifications. Time of diagnosis and treatment have not been 
consistent across studies either, contributing to the uncertainty on when it should be 




The size of a PDA can be measured directly with 2D ultrasound using modern scans. 
Old studies have reported ductal size using colour Doppler, but measurements done 
using this method usually overestimate the diameter. PDA size and flow characteristic 
are usually obtained from the high left parasternal view. Diameter should be measured 
on the site of maximal constriction in the end of systole. Some studies have reported 
diameters measured from the short axis view, however this view does not show all 
ductal trajectory and the size of the PDA may be overestimated
232, 256
.  
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Clinical signs such as heart murmur, persistent tachycardia, hyperactive precordium, 
bounding pulses, and evidence of cardiomegaly or pulmonary congestion are not 
accurate to predict the magnitude of PDA and they are usually not present within the 




PDA measurements to assess hemodynamic significance:  
Ductal diameter: this has been considered the most important parameter to define the 
degree and severity of PDA shunting. A diameter above 1.5 mm has been associated 
with higher ratio between pulmonary and systemic blood flow
242, 258
.  
Figure 3.14 PDA diameter  
 
On the left: PDA on 2D image from parasternal view. On the right in red is the PDA colour Doppler 
flow. The red colour indicates left-to-right shunt. 
 
Ductal flow pattern: Depending on the difference between pulmonary to systemic 
pressures the ductal flow may have complete right to left flow, bidirectional flow or 
complete right to left flow. A complete right to left flow is always considered 
pathological in neonates. A right to left shunt that accounts for more than 30% of the 
cardiac cycle in a bidirectional shunt is considered a sign of pulmonary hypertension.  
Ductal flow pattern can be recorded from high left parasternal view by placing the 
PW range gate at the pulmonary end the PDA, aiming an angle of insonation below 
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Pulmonary hypertension:  
It is a bidirectional shunt that is usually seen in early postnatal hours in preterm 
infants and in cases of persistent pulmonary hypertension (high pulmonary vascular 
resistance).  
Figure 3.15 PDA flow pattern – Pulmonary hypertension  
 
Growing:  
This is a transitional flow pattern between pulmonary hypertension and pulsatile 
flows. It is a bidirectional shunt with predominant left-to-right flow. It represents the 
falling in pulmonary vascular resistance.  
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Pulsatile: 
It is a complete left-to-right flow with peak velocity of about 1.5 m/sec with 
rhythmically pulsatile change. This pattern has demonstrated high specificity and 
sensitivity to predict PDA with clinical signs. Left-to-right flow across the PDA has 




Figure 3.17 PDA flow pattern - Pulsatile 
 
Closing:  
Differently from the pulsatile flow, the closing pattern has a continuous left-to-right 
flow with peak velocity usually ≥ 2m/sec.  
Figure 3.18 PDA flow pattern - Closing 
 
Closed: absence of flow.  
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Increased LVO:  
High LVO (> 350 mL/kg/min) may indicate increased pulmonary flow in infants with 
a PDA > 1.5 mm. Increased ductal shunting has been associated with low SVC 
(surrogate of systemic blood flow) with an opposite increase in LVO. Additional 
evidence that a moderate to large left-to-right PDA may cause low systemic blood 




Ratio between left atrium diameter and aortic root (LA:Ao): 
The LA:Ao ratio is one of the first suggested markers of PDA significance
256
. This 
ratio relies on the principle that a left-to-right ductal shunt may increase the volume 
load on the left side of the heart, thus the left atrium will dilate in relation to the aortic 
arch that which remains the unaffected. Several studies have suggested values for 
LA:Ao that may predict a significant PDA. The most acceptable value in the literature 
is a LA:Ao ratio above 1.4 – 1.5 . However, it is not an accurate measurement on the 
first day of life
265, 266
.  
Figure 3.19 LA:Ao measurement – M-mode 
 
Descending aorta flow:  
The flow pattern on the post-ductal descending aorta is normally forward, but with 
increasing left-to-right shunt across the PDA this flow pattern can become retrograde. 
This retrograde diastolic flow has also been associated with higher ratio between 
3. NON-INVASIVE ASSESSMENT OF CEREBRAL AND SYSTEMIC CIRCULATION  
72 
pulmonary to systemic blood flow
256
. Goves et al. (2008) measured the blood flow in 
the descending aorta just proximal to the diaphragm and observed that retrograde flow 
in descending aorta is a marker of high volume shunt across the PDA; a possible 
marker of ductal steal and lower body hypoperfusion
267
. 
Figure 3.20 Reversal end-diastolic flow in the post-ductal aorta 
 
 
End-diastolic flow velocity in the left pulmonary artery: 
Increased diastolic and/or mean velocity in LPA has been associated with the severity 
of ductal shunt
266
. The flow velocity can be obtained from the same PDA view by 
placing the PW range gate on the LPA. Normal LPA diastolic velocity has been 
suggested as above 0.2 m/second
268
. Mean LPA velocity of above 0.43 m/sec has 
been suggestive of a large ductal shunt
266
. 
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Figure 3.21 LPA end-diastolic flow velocity  
 
 
3.2.2. Relationship between NIRS and functional echocardiography 
 measurements   
A few studies have attempted to address the correlation between cerebral blood flow 
and oxygenation with echocardiographic measurements. The challenges and 
reliability of correlating continuous NIRS signals with static functional 

















4.1. STUDY DESIGN AND ENROLMENT 
 
The data included in this thesis were collected under two different prospective 
observational study protocols: 
a. ‘RUMBA’1: Study into the control of blood flow and oxygen to the brain 
of preterm infants undergoing intensive care. Data for this cohort were 
collected between September 2010 and March 2013. This study was 




b. ‘SAMBA’ (Study of Autoregulation Monitoring in Babies): Circulatory 
function and cerebrovascular control of blood flow and oxygen delivery to 
the brain in newborn infants undergoing intensive care. Data for this 
cohort were collected between May 2013 and October 2015. This study 
as well as being the main body of work funded by CAPES/COT received 
additional funding from SPARKS (www.sparks.org.uk) for a research 
nurse and computer scientist research associate. 
All data were collected at the Neonatal Intensive Care Unit (NICU) at The Rosie 
Hospital, Cambridge University Hospital Foundation Trust.   
                                                 
1





4.1.1.  Population  
The recruitment criteria were similar for both study protocols: 
 Inclusion criteria:  
 Preterm infants born at ≤ 32 weeks gestational age with birth weight < 1.5 kg, 
who had an indwelling arterial catheter inserted for clinical reasons.  
 Exclusion criteria: 
 Infants born with major malformations (e.g. gastroschisis or major cardiac 
defect), infants who were severely sick or moribund, infants who were more than 72 
hours old (for RUMBA) or more than 12 hours old (for SAMBA).  
4.1.2. Data collection 
RUMBA study:  
This study had two data collection phases:  
 Phase 1: between September 2010 and March 2012 
Dr Mitra recruited and collected data from 31 preterm infants. Most of these infants 
had data collected within the first 72 hours of age, however four infants had data 




 day of life. The median (range) age at the start of the 
study was 44 (7 – 180) hours.  
 Phase 2: between April 2012 and March 2013 
I recruited and collected data from 29 preterm infants. All of them had data collection 
started before 72 hours of life. The median (range) age at the start of the study was 26 
(6 – 74) hours.  
SAMBA study: 
Data for this study were collected from May 2013 to October 2015. I recruited 61 




collected due to problems with the connection between software and cotside monitors 
or clinical indication to remove the arterial catheter before the beginning of data 
collection. The remaining 56 infants were recruited within the first 24 hours of age. 
The median (range) age at the start of the study was 5.3 (3.1 – 12.7) hours. All infants 
had data collected until 48 hours of age, apart from for four infants, whose studies 
were discontinued due to clinical deterioration, maternal request or removal of UAC 
before 48 hours of age. 53 (94.7%) infants were inborn; only three infants included in 
this cohort were transferred from outside neonatal units.  
During the data collection period, a total of 95 preterm infants met inclusion criteria, 
but were not recruited due to the following reasons:  
 NIRS monitors were in use for another study (N = 16) 
 Parents did no consent for the study after being approach and given 
verbal and written information (N = 3) 
 Research team was not informed (N = 4) 
 Research team was not available to recruit (N = 28) 
 It was not ethical to approach parents (N = 4) 
 Cotside monitor was incompatible with ICM+ (N = 4) 
 Arterial line was removed before 12 hours of life (N = 7) 
 Parents were not available to give consent (infants were admitted from 
other neonatal units) (N = 29) 
Table 4.1 shows the distribution of the population recruited for ‘RUMBA’ and 







Table 4.1 Distribution of the population recruited for ‘RUMBA’ and ‘SAMBA’ 
according to the different studies  
 
 ‘RUMBA’ Phase 1 ‘RUMBA’ Phase 2 ‘SAMBA’ 
Chapter 5.1 All infants  
Chapter 5.2   All infants 
Chapter 6.1 All infants  
Chapter 6.2   Infants < 28 weeks 
and data collected 
< 24 hours of age 
Chapter 7  Data collected < 24 hours of age 
Chapter 8   Infants who had 
echocardiography 
The rationale for the infants selected for each study is described in the relevant chapters. 
4.2. ETHICS  
All study protocols included in this thesis were authorized by the Research and 
Development department of Cambridge University Hospitals NHS Foundation Trust 
and approved by The East of England Research Ethics Committee (12/EE/0524 for 
SAMBA and 09/H0306/20 for RUMBA), in accordance with the declaration of 
Helsinki. All infants were studied following signed informed parental consent. 
4.3. MEASUREMENTS  
4.3.1. NIRS and systemic physiological measurements  
Following enrolment, a neonatal NIRS sensor from a NIRO 200NX near-infrared 
spectrophotometer (Hamamatsu Photonics, KK, Japan) was placed on one side of the 
infant’s head in the temporo-parietal area. A sensor holder was used to fix the light 
source at 3 cm away from the receiver diodes and adhesive paper secured the sensor 
to the infant’s skin. A lightproof cover was also used (Figure 4.1). The sensor was 
changed to the opposite temporo-parietal side of the infant’s head every 6 to 8 hours 
(when the study duration was above 6 hours) to avoid skin marks. NIRS signals 




Figure 4.1 NIRS sensor placement 
 
Example of a NIRS sensor placed on an infant’s temporal head and lightproof cover.  
The following systemic physiological signals were recorded simultaneously and 
continuously from the neonatal intensive care monitors (Solar 8000; Carescape B850, 
GE Healthcare, Milwaukee, Wisconsin):  
 Full resolution of arterial blood pressure waveform: sampling 
frequency of 120Hz (Solar) and 100Hz (Carescape). 
 Peripheral oxygen saturation (SaO2): sampling frequency of 1Hz. 
 Heart rate (HR): sampling frequency of 1Hz.  
Transcutaneous carbon dioxide (tCO2) data were collected from TCM400 monitor 
(Radiometer) at a frequency rate of 1Hz.  
Both NIRS and physiological signals were collected, synchronised and stored using 
ICM+ software
®
 (http://www.neurosurg.cam.ac.uk/icmplus), a Cambridge University 
enterprise bedside software designed by Dr Smielewski and Prof Czosnyka and used 
extensively in adult neurocritical care in Cambridge and in nearly 100 neurocritical 
care units worldwide. The ICM+
® 
program records raw signals from intensive care 
monitors, ventilators and different cerebral monitors, and calculates time trends of 
selected brain and systemic parameters. The software allows simple data display in a 
variety of ways, including time trends and more sophisticated statistical analysis 
(examples of raw data, trends and more sophisticated data display using ICM+
® 
are 






Figure 4.2 Cotside monitoring and data collection 
 
Data from all monitors were collected on ICM+ software
®
. The same software was used for 
retrospective analysis.  
 
4.3.2. Clinical data and outcome  
Clinical data within the study period and data on outcome were collected from the 
medical notes. A separate study chart was kept at the cot-side during the study period. 
This chart was used by nurses and the research team to record the date and time of 
events, such as handling/care, examination, procedures, changes on drug infusions or 
any other interventions. Clinical decision-making was at the sole discretion of the 
attending neonatal consultant.  
CRIB II (Clinical Risk Index for Babies II) score of mortality and morbidity was 
calculated for all infants included in this dissertation
270
. The CRIB II score is a 
neonatal risk-adjusted score used worldwide. It takes into account gender, gestational 




within the first 12 hours of life. The range of possible CRIB II scores is from zero to 
27, and lower the score, better is the predicted outcome
270
.   
Cranial ultrasonography scans were performed at the start of the study and repeated 
every 12-24 hours until third day of life and then every 1-3 weeks until corrected 
gestational age at term. GMH-IVH was defined according to Papile et al. (1978) and 




Data on mortality were included for all those infants who died before 40 weeks of 
corrected gestational age. Two infants included in the SAMBA study died after this 
age cut-off (one died at corrected age of 50 weeks due to complications of chronic 
lung disease and pulmonary hypertension and the other died at 6 months of age at 
home due to possible sudden death).  
According to the neonatal unit guideline, all preterm infants were screened for sepsis 
and antibiotics were started within the first hours after birth. Infants were divided in 
two groups: 
 No-sepsis group: included those with no clinical signs of sepsis, normal c-
protein reactive (CRP), negative blood culture or antibiotics given only for the 
first 48 hours of life  
 Sepsis group: included those with presumed sepsis (CRP moderately high, 
negative culture and antibiotics for 5-7 days), clinical sepsis (high CRP, 
clinically unwell, negative culture and antibiotics for 7-14 days) or confirmed 
sepsis (clinical sepsis with positive culture)  
Confirmed necrotizing enterocolitis (NEC) was defined as either clinical or 
radiological signs of NEC and treatment for 7-10 days of antibiotics.  
4.3.3. Functional echocardiography  
Data on cardiac function and ductal patency were collected only from infants 
recruited for the SAMBA study. Anonymised echocardiographic images were 




of age. All measurements were done retrospectively using EchoPAC clinical 
workstation software. In order to avoid inter-observer variability, I was the only 
investigator who collected the images and retrospectively performed the 
measurements. A senior neonatologist with cardiology expertise reviewed the images 
and measurements.  
The following measurements were collected:  
 PFO: 2D diameter (mm), flow pattern (left-to-right, right-to-left or 
bidirectional) and flow velocity were obtained from subcostal view
248
.  
 SVC flow:  SVC diameter was measured from the upper parasternal view 
using M-mode. Measurements were averaged from three to five cycles, as 
diameter can have a mean variability of 22% throughout the cardiac cycle. 
Flow was measured from low subcostal view. Velocity time integral (VTI) 
was calculated and averaged from and 10 cycles. SVC = (VTI x (π x (mean 
SVC diameter
2
/4) x heart rate)/weight
56
.  
 LVO: Aorta diameter was ascending aorta from the long parasternal view 
sinotubular junction (STJ). Flow velocity measurement was obtained from 
modified five chamber view. VTI was calculated and averaged from three to 
five cycles. LVO = stroke volume (π x (aorta diameter)
2






 RVO: diameter of the main pulmonary artery was measured from the 
parasternal view and determined in end systole at the insertion of the 
pulmonary valve leaflet just before the valve closes. Flow velocity was 
performed on the same window, placing the range gate just beyond the valve 
leaflets and averaged from three to five cycles. RVO = stroke volume (π x 
(aorta diameter)
2
/4 x VTI) x heart rate/weight
242
. 
 PDA measurements: diameter was estimated from 2D image and colour 
Doppler flow (mm), flow pattern (left-to-right, right-to-left or bidirectional), 
end diastolic flow velocity in the LPA (LPA EDF vel), presence of reversal 
diastolic flow in the post-ductal aorta at the abdominal level (Ao). Details and 




All measurements were described in more details in Chapter 3, section 3.2.  
4.4. DATA ANALYSIS 
4.4.1. NIRS data pre-processing 
Data collected at the full frequency resolution from the previously described cotside 
monitors were then retrospectively analysed using ICM+
269
.  




The figure shows real-time data before artefact removal. The artefact circled on the arterial blood 
pressure signals are the result of arterial line sampling for either calibration or blood sampling. The two 




Artefacts were identified and manually removed from the raw data (Figure 4.4 and 
Figure 4.5). Most of the artefacts were the result of umbilical arterial line sampling, 
infants being handled or movements. Annotations from the nurses regarding cares and 
handling allowed me to manually exclude periods of data with invalid measurements 
or with transients induced by external interventions. Artefacts were removed with the 
‘global artefact removal’ function in ICM+ software
®
, which means for every artefact 




date and time stamp were removed, and vice-versa. To date there is no universal, 
validated method for automatic robust removal of data artefacts. 
Figure 4.4 Example of a common artefact in the blood pressure raw data  
 
The figure shows the trace for raw arterial blood pressure data. The circled area is an artefact caused by 
arterial central line sampling.  
 
 
Figure 4.5 Example of a common artifact in the NIRS raw data 
 
 
The figure shows the trace for raw TOI data. The circled and shaded area is an artefact potentially 




Subsequently all the recorded physiological variables were treated with a moving 
average filter of 10 seconds length and down-sampled to frequency of 0.1Hz. This 
effectively removed all the components associated with pulse and respiratory 
activities while retaining waves in the low and very low frequency range (<0.02Hz), 
thus focusing further analysis entirely on the cerebrovascular and systemic regulatory 
responses. 
4.4.2. Measurements of cerebrovascular reactivity and cerebral autoregulation 
TOHRx was calculated from moving correlation-coefficient analysis, using 5-minute 
windows between 10-seconds average values of TOI and HR (Figure 4.6). The same 
method was used to calculate TOx (moving correlation-coefficient analysis between 
TOI and MABP), as shown in Figure 4.7. The 5-minute window calculation for 
TOHRx and TOx has its origin in the physiology of “slow brain waves” and inertia of 
the CBF autoregulation. To supress any “high-frequency” waves that are passed 
partially through the autoregulation “filter”, the measured data are first low-pass 
filtered and down-sampled to give 1 sample every 10 seconds. This results in 6 
samples per minute, therefore the subsequent correlation analysis requires at least 
several minutes of data to minimize the variance of the calculated index. In contrast, 
increasing the data buffer size increases the changes of error caused by baseline drifts 
related to the independent physiological fluctuations (e.g. thermal or metabolic).    







Figure 4.7 Correlation between TOI and MABP to calculate TOx 
 
4.4.3. Multiscale entropy analysis (MSE) 
We applied MSE to investigate the complexity of NIRS and systematic physiological 
signals. Details on MSE analysis are described in detail in Chapter 7.  
4.5. STATISTICAL ANALYSIS 
Statistical analysis was done using SPSS software package version 23 and 25 (SPSS, 
Inc., Chicago, IL, USA). Data distribution was assessed for normality using Shapiro-
Wilk test. Depending on the distribution, either parametric or non-parametric tests 
were used. 
The specific statistical methods used in each study included in this thesis are 
described in detail in the respective chapters. 
A statistical test was considered significant if P value was < 0.05 (two-tailed) for all 
studies included in this dissertation.  
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5. MONITORING OF CEREBRAL OXYGENATION AND 
CEREBROVASCULAR REACTIVITY IN PRETERM 
INFANTS UNDERGOING INTENSIVE CARE 
5.1. CONTINUOUS COTSIDE MONITORING OF BRAIN AND SYSTEMIC 
PHYSIOLOGICAL SIGNALS: DEMOGRAPHIC DATA AND CASE 
REVIEWS  
5.1.1. Introduction  
Major changes in cerebral and systemic circulation occur within the first 12 to 24 
hours of life. In preterm infants, the fluctuations in cerebral blood flow and 
oxygenation are associated with ischaemic and haemorrhagic brain injury, as 
discussed in Chapter 2. Therefore, monitoring of brain and systemic physiological 
signals from early hours following birth could provide valuable information on the 
cerebrovascular reactivity and circulatory function during the transitional circulation 
in preterm infants, and indicate those who are at an increased risk to develop a poor 
outcome.  
Data collected from cerebral NIRS and systemic signals are susceptible to noise, 
which are usually due to artefacts. The quality of cerebral and systemic signals should 
be impeccable in order to be meaningful. Therefore, the use of software that combines 
simultaneously data collection, data visualisation and data analysis is important. The 
physiological and NIRS data collected for all studies included in this thesis were 
recorded and analysed using ICM+ software®. This section of this dissertation will 
provide an overview of the physiological data collected and specific cases will 
highlight the value of combining this software to the standard cotside monitoring in 
the care of preterm infants undergoing intensive care.   
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The aim of this section is to describe the general characteristics of the population 
recruited for both ‘RUMBA’ and ‘SAMBA’ cohorts and the incidence of GMH-IVH 
and mortality in these two cohorts. We further aimed to demonstrate the importance 
of cotside monitoring by describing four cases from the ‘SAMBA’ population.   
5.1.3. Methods 
All preterm infants who were recruited for ‘RUMBA’ and ‘SAMBA’ cohorts and had 
demographic and NIRS data collected were included in the data presentation and 
analysis (as described in Chapter 4, section 4.1.1, five infants were recruited for 
‘SAMBA’ but data was not collected). The recruitment details, ethics, population and 
pre-processing data analysis, including the methodology to calculate TOx and 
TOHRx, were described in Chapter 4.  
5.1.4. Results 
Table 5.1 shows the characteristics of the 116 infants recruited in the ‘RUMBA’ and 
‘SAMBA’ cohorts. Table 5.3 shows the frequency of intraventricular haemorrhage 
(IVH) grades of all infants. 
Table 5.1 General characteristics of the all infants recruited for ‘RUMBA’ and 
‘SAMBA’ 
 
Variables Total (N = 116) 
Gestational age 26+0 (23+2 – 32 +1) 
Birth weight 795 (445 – 1440) 
Male/Female 55/61 
CRIB II 11 (4 – 17) 
GMH-IVH 44 (38%) 
Mortality 20 (17.2%) 
Gestational age, birth weight and CRIB II (Clinical Risk Index for Babies II) values are presented as 
median (range). Remaining variables are presented as frequency. 
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More detailed demographic data were collected for the ‘SAMBA’ cohort. Table 5.3 
shows the antenatal and postnatal characteristics and complications for infants 
recruited for ‘SAMBA’.  
Table 5.2 Antenatal and postnatal data from ‘SAMBA’ cohort 
 
Variables Total (N = 56) 
PPROM 23 (41%) 
Antenatal Steroids 55 (98.2%) 
MgSO4 15 (26.8%) 
SVD/C-section  32/24 
 Male/Female 21/35 
Inborn 52 (92.8%) 
Total doses of Surfactant 2 (1-4) 
Apgar 5 min 7 (1-9) 
Caffeine 51 (91%) 
Morphine 24 (42.9%) 
Ventilated at start of study 100% 
Extubated during the study 27 (48.2%) 
PPHN on NO 4 (7.1%) 
Early onset of sepsis 36 (62.2%) 
Confirmed NEC 7 (12.5%) 
 
PPROM is for premature prolonged rupture of membranes. SVD is for spontaneous vaginal delivery. 
C-section is for caesarean section. Inborn is for infants delivered at The Rosie Maternity. PPHN is for 
persistent pulmonary hypertension of the newborn. NO is for nitric oxide. NEC is for necrotizing 
enterocolitis (confirmed NEC was defined as either clinical or radiological signs of NEC and treated 
for 7-10 days of antibiotics). Data on ‘Total doses of Surfactant’ and ‘Apgar at 5 min’ are shown as 
median and range. The remaining data are shown as frequency.  
 
Twelve mothers received an incomplete course of antenatal steroids (one dose) and 43 
received complete course (two doses). Twelve infants had suspected NEC (defined as 
clinical signs of suspected NEC but no abnormalities found on the abdominal x-ray 
and antibiotics given for ≤ 5 days).  
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Table 5.3 Degrees of IVH for infants recruited for ‘RUMBA’ and ‘SAMBA’  
 
IVH Grades Total (N = 116) 
No-IVH 72 (62.1%) 
Grade I (GMH) 9 (7.8%) 
Grade II 20 (17.2%) 
Grade III 8 (6.9%) 
Grade IV 7 (6%) 
GMH is for germinal matrix haemorrhage  
Only one infant developed PVL. This infant was included in the ‘SAMBA’ cohort 
and the case is described in the ‘Case Reviews’ section (Case 2).  
Infants recruited for ‘SAMBA’ cohort had cranial ultrasound performed regularly at 
the start of the study and repeated every 12 to 24 hours. Eighteen infants included in 
the ‘SAMBA’ cohort developed an IVH. In 13 of them, the IVH was diagnosed after 
24 hours of life. In the other five infants the IVH was diagnosed at the ultrasound scan 
done at 12 or 24 hours of life (two of these 5 infants had an IVH diagnosed at the start 
of the study).  
As most infants in the ‘SAMBA’ cohort had an IVH diagnosed at around or after the 
first 24 hours of life, three studies included in this thesis focused on the data collected 
from only in the first 24 hours of life. The rationale was that understanding the 
pathophysiology behind the development of a GMH-IVH before the haemorrhage 
occurred could potentially identify those infants who are at a greater risk of 
developing the brain injury.  
Table 5.4 shows the age and cause of death for all infants included in the ‘RUMBA’ 
and ‘SAMBA’ cohorts. None of the studied infants included in both cohorts died 
within the data collection period. Only 8 infants who died had developed IVH, and 
the presence of IVH was not statistically associated with death (P = 1.0). Infants died 
due to a variety of complications such as necrotising enterocolitis (NEC), sepsis or 
multi-organ failure. Although brain injury visible on cranial ultrasound scan was not 
directly the cause of death for these infants, most of them had a degree of perinatal 
ischaemia or early postnatal cerebral or systemic hypoperfusion.  
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Table 5.4 Age and cause of death for infants recruited for RUMBA and SAMBA 
 




Cause of Death 
01 RUMBA 24+1 26+6 Pulmonary haemorrhage and clinical 
deterioration 
02 RUMBA 24+2 37+1 Fulminant NEC 
03 RUMBA 28+2 30+1 Staphylococcus Aureus sepsis and 
Pulmonary haemorrhage 
04 RUMBA 25+5 26+5 Clinical deterioration, multi-organ 
failure 
05 RUMBA 27+1 30+0 Fulminant NEC 
06 RUMBA 26+2 31+3 Fulminant NEC 
07 RUMBA 26+6 28+2 Pulmonary hypoplasia, PPNH 
08 RUMBA 26+2 29+0 Severe renal failure 
09 RUMBA 24+0 34+6 Fulminant NEC 
10 RUMBA 27+0 30+4 Multi-organ failure 
11 RUMBA 24+1 36+0 CMV infection 
12 RUMBA 25+5 28+4 Severely ill from birth – IVH grade 
IV, pulmonary haemorrhage, NEC 
13 RUMBA 28+0 28+2 Pulmonary hypoplasia, severe 
hypotension 
14 SAMBA 26+2 28+3 Twin-twin transfusion, severe 
antenatal brain and heart hypoxia, 
multi-organ failure 
15 SAMBA 24+4 25+2 Severe antenatal hypoxia, IVH and 
multi-organ failure 
16 SAMBA 30+2 37+2 Fulminant NEC 
17 SAMBA 26+3 31+2 Pseudomonas aeruginosa sepsis and 
meningitis – severely sick from birth, 
IVH grade IV 
18 SAMBA 24+1 25+5 Fulminant NEC 
19 SAMBA 24+2 28+4 PPROM, cord prolapse, fungal 
infection 
20 SAMBA 23+5 24+0 Clinical deterioration, immature 
lungs and grade III IVH 
GA is for gestational age. NEC is for necrotising enterocolitis. CMV is for cytomegalovirus. PPROM 
is for premature prolonged rupture of membranes. The infant numbers are not related with study 
identification.  
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5.1.5. Case Reviews 
The following cases demonstrate the cotside motoring of a stable infant, an infant 
who developed PVL and an infant with severe hypoxic-ischaemic injury. In Chapter 
6, section 6.2, the case of an infant who developed an IVH is discussed.  
1) Stable infant  
The Figures 5.1 and 5.2 show examples of continuous NIRS and physiological signals 
monitoring from a male preterm infant who was born at 25+5 weeks of gestational 
age, weighing 720 grams. He was born by emergency C-section due to cord 
presentation. Apgar score was 1 at 1 minute and 6 at 5 minutes of life. There was an 
antenatal history of maternal vaginal bleeding at 23 weeks, premature prolonged 
rupture of membranes (PPROM) for 40 hours prior to delivery and maternal pyrexia. 
A full course of antenatal steroids (betamethasone) was given 13 days before delivery. 
He was a breech presentation and was intubated and received one dose of surfactant at 
10 minutes of age. CRIB II score was 13. He remained stable during the study period 
and did not require inotropes, saline boluses or blood products. Sepsis was suspected 
due to prematurity but his blood culture and infection markers were unremarkable. He 
was extubated at 13 hours of age and remained on continuous positive airway 
pressure (CPAP).  He did not develop an IVH. He did not develop NEC and was 
discharged home at corrected age of 37 weeks, self-ventilated in air and on full bottle-
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Figure 5.1 NIRS and physiological signals in a stable infant (TOx) 
 
 
The figure shows graphs of continuous monitoring of TOI, MABP, SaO2 and TOx signals for 1-hour-window interval. The infant’s age at this 1-hour-window was between 
39 and 40 hours of life. The bottom chart is a ‘risk chart’: colours changed from green (more negative TOx or more intact cerebral autoregulation) to red (more positive TOx 
or more impaired cerebral autoregulation). TOx is mainly negative for this window interval and remained mainly negative throughout the study. Mean TOI, SaO2, MABP 
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Figure 5.2 NIRS and physiological signals in stable infant (TOHRx) 
 
 
The figure above shows the graphs of continuous monitoring of TOI, HR and TOHRx for the same 1-h-window interval shown in Figure 5.1. TOHRx is also mainly negative 
(more green areas on the bottom ‘risk chart’) for this 1-h-window interval and remained mainly negative throughout the study. Mean HR and TOHRx for this window 
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2) Infant who developed PVL  
The Figures 5.3, 5.4 and 5.5 show NIRS and physiological data from a 3-hour-
window interval from an infant who had normal cranial ultrasound images within the 
first week of life, which only showed some mild degree of periventricular flare, but 
developed PVL, which was diagnosed on day 15 of life (Figure 5.7).  
This female preterm infant was born at 28+2 weeks of gestational age, with a birth 
weight of 1115 grams and delivered by spontaneous vaginal delivery. Her Apgar 
score was 6 at 1 minute and 8 at 5 minutes of life. There was an antenatal history of 
maternal pyrexia and no intra-partum antibiotics were given. Her mother received full 
course of antenatal steroids (betamethasone), but no MgSO4 was given. She was 
intubated at birth and received one dose of surfactant. Her CRIB II score was 8. She 
was extubated at 10 hours of age and remained on CPAP throughout the rest of the 
study period. She did not require boluses of saline, blood products or inotropic 
support during the first 48 hours of life. She was noted to be agitated and had several 
episodes of high-pitched crying and irritability during the study period, which was 
observed by the research and clinical team.  
She was between 25 and 28 hours of age in the 3-hour-window interval shown in 
Figure 5.3 and 5.5. She was on CPAP and her arterial blood gas showed PaCO2 
between 3.9 kPa and 4.6 kPa for this window interval. The fluctuations in the MABP 
signal were only observed because the data was displayed on ICM+
®
 on 1-4 hour-
window intervals. Observations only from the usual neonatal monitors would not 
show this interesting pattern.  
Figure 5.4 shows 45-minute-window interval extracted from the 3-hour-window data 
shown in Figure 5.3, demonstrating the degree of pressure passive circulation. We can 
observe that changes in TOI follow changes in MABP with no influence from SaO2. 
Figure 5.6 shows the raw arterial blood pressure signal (ABP). We can notice the 
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The figure above shows the graphs of continuous data for TOI, MABP and TOx. The bottom figure is a ‘risk chart’: colours changed from green (more negative TOx or more 
intact cerebral autoregulation) to red (more positive TOx or more impaired cerebral autoregulation). Observe the variability in the MABP signal and the amount of time that 
cerebral autoregulation was impaired (predominantly red areas on the ‘risk chart’). Mean TOx for this 3h-window was +0.51, mean MABP was 40 mmHg and mean TOI was 
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Figure 5.4 Pressure passive pattern in an infant who developed PVL 
 
 
The figure above shows a 45-minute-window extracted from the previous 3h-window shown in Figure 5.3. We can observe that changes in TOI follow mainly the changes in 
MABP and not frequently the changes in SaO2. The degree of pressure-passive circulation can be observed from the TOx graph and from the ‘risk chart’ (prolonged period of 
red area or more positive TOx). 
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Figure 5.5 NIRS and physiological signals for an infant who developed PVL (TOHRx) 
 
 
The figure above shows the graphs for continuous data of TOI, HR and TOHRx for the same 3-h-window interval shown in Figure 5.3. The ‘risk chart’ on the bottom shows 
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The figure above shows an interval of 45 minutes of raw arterial blood pressure (ABP) data within the 
same 3-h-window shown in Figure 5.3.  
 
 
Figure 5.7 Cranial Ultrasound images 
 
 
The top two images are the coronal and sagittal views of the normal cranial ultrasound at 24 hours of 
age. The bottom two images are the sagittal and coronal views at day 15 of life, showing bilateral 
cystic PVL. I performed the cranial ultrasound scans and recorded the images above as part of the 
data collection for this thesis.  
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3) Infant with signs of severe hypoxic ischaemic injury from birth  
The examples below show two figures of 1-hour-window each of continuous NIRS 
and physiological data from an infant who had normal cranial ultrasound images 
during the first 48 hours of life, but developed a grade II IVH on day three and died 
on day four of life.  
This female preterm infant was born at 24+4 weeks of gestational age with a birth 
weight of 775 grams and was delivered by spontaneous vaginal delivery. Her Apgar 
score was 1 at 1 minute and 2 at 5 minutes of life. Her mother received only one dose 
of antenatal glucocorticoid (betamethasone) four hours before delivery and no MgSO4 
was given (the infant was recruited before the standard protocol for antenatal MgSO4 
was placed into practice). She was born in poor condition, requiring intubation and 
resuscitation with chest compressions. She received only one dose of surfactant, 
which was given after intubation in the delivery unit. She remained ventilated 
throughout admission. Her CRIB II score was 16. She had persistent metabolic 
acidosis within the first 6 hours of life and received multiple infusions of sodium 
bicarbonate to correct her base deficit. Dopamine and dobutamine were started within 
the first 24 hours of life. An echocardiogram showed poor myocardium contractility. 
The presence of a bulging anterior fontanelle was described during the first 24 to 48 
hours of life.  
She was between 22 and 23 hours of age in the 1-hour-window interval shown in the 
figures 5.8 and 5.9. We can observe that cerebral autoregulation and cerebrovascular 
reactivity were mostly impaired within the period shown in this interval (both ‘risk 
charts’ had mainly orange to red colours). This pattern was persistent over the entire 
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Figure 5.8: NIRS and physiological signals for an infant with signs of hypoxic ischemic encephalopathy (TOx) 
 
 
The figure above shows the graphs of continuous data of TOI, SaO2 MABP and TOx. The bottom ‘risk chart’ shows predominantly severe impaired cerebral autoregulation. 
Values for TOx were positive for this entire period. Mean TOx for this 1h-window was +0.50, mean MABP was 33 mmHg, SaO2 was 92% and mean TOI was 81. High 
values of TOI may reflect the hypoxic ischaemic injury.  
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Figure 5.9: NIRS and physiological signals for an infant with signs of hypoxic ischemic encephalopathy (TOHRx) 
 
 
The figure above shows the graph of continuous data of TOI, HR, TOHRx for the same 1h-window shown in Figure 5.8. The bottom ‘risk chart’ also shows predominantly 
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5.1.6. Discussion  
Recruitment challenges and the impact on outcome data  
The recruitment of preterm infants soon after birth is challenging. Getting consent 
from parents when they are emotionally fragile requires the sensitivity to understand 
when it is not ethical to approach them regarding research studies. In addition, sick 
preterm infants require a huge amount of work and concentration from the clinical 
team. Therefore the addition of extra tools to the standard neonatal care, such as NIRS 
monitors and computers for data collection, may not be well accepted by the medical 
and nursing team. The recruitment criteria and study design for the ‘RUMBA’ study 
allowed our research team to recruit infants and at any time within the first 72 hours 
of life and collect data for short periods of time initially. This allowed me to introduce 
the idea of studying infants from early hours of life and using extra monitors as a 
positive concept. The ‘RUMBA’ study was well accepted in the neonatal unit in 
Cambridge. Nurses and doctors became familiarised with the NIRS monitor and 
ICM+
®
 software, allowing me to expand the duration of data collection for the 
‘SAMBA’ study.  
Most infants recruited for both ‘RUMBA’ and ‘SAMBA’ studies were inborn infants. 
In the ‘SAMBA’ cohort only three infants were born in other smaller neonatal units 
and transferred to the tertiary unit in Cambridge before 12 hours of life. This may 
have had an impact on our results, as inborn infants tend to have less morbidities and 
better outcome. Centralising care in specialist centres and in-utero transfer of preterm 
infants born between 23 to 26 weeks’ gestational age to tertiary hospitals have been 




The use of antenatal medications, such as glucocorticoids and MgSO4 has also 
contributed to reduce the incidence of brain injury and improve neurodevelopmental 
outcome
273-276
. In the fetus, endogenous levels of glucocorticoids increase late in 
gestation to enable organ maturation, fetal growth and survival after birth. Preterm 
infants may not be adequately exposed to endogenous glucocorticoids, predisposing 
them to develop IVH, respiratory distress syndrome (RDS) or necrotizing 
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. Nearly 100% of the infants recruited for ‘SAMBA’ received 
at least one dose of antenatal glucocorticoids. Since 1995 the use of antenatal 
glucocorticoids has been recommended for the prevention of RDS, GMH-IVH and 
neonatal death
279, 280
. A Cochrane review published in 2006, which included 13 
studies with a total of 2872 infants born at less than 36 weeks, showed a significant 
decrease in perinatal mortality, morbidity and incidence of GMH-IVH and PVL. 
Since then, the administration of synthetic glucocorticoids to women who are likely to 




The two most common synthetic glucocorticoids used in pregnancy are 
betamethasone and dexamethasone. They are 25 times more potent than cortisol and 
freely able to cross the placenta and enter the fetal circulation
281
. Because they are 
usually administered before the natural endogenous cortisol surge, they trigger the 
glucocorticoid signalling in the developing brain. This may prevent the negative 
consequences of preterm birth but may potentially increase the risk of metabolic, 
cardiovascular and neuropsychiatric disorders in adult life
277, 278
. Infants included in 
the ‘SAMBA’ cohort most likely received betamethasone as most of them were 
inborn and the protocol of preterm labour at The Rosie hospital has included the use 
of betamethasone for several years. Betamethasone has been associated with 
decreased mortality, reduced risk of periventricular leukomalacia and less side effects 
compared to dexamethasone; therefore betamethasone is currently the preferred 
choice of synthetic glucocorticoids in several maternity hospitals
281-284
. However, it is 
difficult to precise how many infants included in this dissertation have received 
betamethasone or dexamethasone, as protocols were not the same in the different 
hospitals and infants may have received antenatal glucocorticoids in their local units 
before being in-utero or ex-utero transferred to Cambridge.  
The exact mechanism of glucocorticoids in neuroprotection remains elusive, but data 
from animal studies have suggested that antenatal glucocorticoid suppresses the 
vascular endothelial growth factor (VEGF) and angiogenesis, contributing to the 
stabilization of the germinal matrix vasculature and, hence, reducing its propensity to 
haemorrhage
285
. The use of antenatal betamethasone has been associated with an 
increase by 1.5 fold to 2 fold in the fibronectine expression, which may provide 
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vascular stability and a reduction in the risk of GMH-IVH.  In the near term fetal 
sheep, antenatal glucocorticoids have been associated with a decrease in cerebral 




Half way through the data collection for the ‘SAMBA’ study, the antenatal guideline 
on the use of MgSO4 was implemented, and since then a high percentage of the 
infants recruited for the study received the medication. MgSO4 has been widely used 
in Obstetrics for treatment of preeclampsia and tocolysis, but successive studies have 
shown that secondary outcomes of mothers given MgSO4 improved neurological 
outcomes in their infants. In moderate to severe eclampsia, MgSO4 has been effective 
in reducing the risk of maternal seizures
289, 290
 In 2009, a Cochrane review found a 
reduction in cerebral palsy and gross motor dysfunction with no increase in risk of 
paediatric mortality
275, 276
. Although data from meta-analyses and some randomised 
trials are compelling, unlike glucocorticoids, the use of MgSO4 is not universal for a 
number of reasons. Information on therapeutic dose of MgSO4 for neuroprotection 
and data on fetal toxicity remain scarce. Moreover, major randomized control trials 
have used different doses, timing and different gestational ages at randomization. 
Currently, the international consensus is to use of MgSO4 for neuroprotection prior 
delivery at less than 30 weeks
291, 292
.  
The exact mechanism of MgSO4 in neuroprotection in preterm infants is unknown, 
but animal data have suggested that MgSO4 may reverse the effects of 
hypoxic/ischaemic injury by blocking N-methyl-D-aspartic acid (NMDA) receptors in 
oligodendrocytes and acting as a calcium antagonist (reducing the calcium influx into 
the cells)
293, 294
. Extremely preterm infants have an increased risk to develop hypoxic-
ischaemic injury and associated complications, such as neonatal seizures, compared to 
term infants
295
. Bennet et al. (2018) have recently demonstrated that the duration, 
burden and amplitude of seizures was significantly reduced in preterm fetal sheep 
who received MgSO4 after an acute in utero asphyxial insult, with greater impact in 
male compared to female fetuses
296
. MgSO4 may also be implicated in improving 
vascular instability, reducing inflammation, acting against free radical activity, 
stabilizing the neuronal cell membrane and having anti-apoptotic actions
294, 297-299
. 
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Galinsky et al. (2016) have demonstrated that MgSO4 may increase flow in the 
peripheral vasculature in fetal sheep during acute hypoxic-ischaemic insults
300
.   
The use of antenatal glucocorticosteroids and, potentially, the use of MgSO4 may 
improve the clinical condition of infants following preterm delivery. Currently in 
neonatal practice most preterm infants whose mothers received a full course of 
antenatal glucocorticosteroids, are usually born in good condition and do not require 
mechanical ventilation and invasive monitoring of MABP. However, for both 
‘RUMBA’ and ‘SAMBA’ studies, the presence of an indwelling arterial catheter to 
continuously monitor MABP was an inclusion criterion. This may have had an impact 
on the characteristics of the population included in all studies in this dissertation, the 
current guideline in the neonatal unit at The Rosie Maternity recommends the 
insertion of umbilical arterial lines only in preterm infants who either require 
mechanical ventilation at birth or are started on CPAP but are small and fragile. 
Therefore, the population recruited for our studies could have been, potentially, sicker 
compared to other studies published on assessment of cerebrovascular reactivate and 
cerebral oxygenation in infants, although most infants were inborn and had received 
antenatal steroids.  
The percentage of severe IVH (grade III and IV) for both ‘RUMBA’ and ‘SAMBA’ 
cohort was similar to studies using larger database, although the recruitment for our 
studies included mainly inborn infants and those who had indwelling arterial line in 
situ
20
. The age and cause of death for all infants included in the ‘RUMBA’ and 
‘SAMBA’ studies were described in Table 5.4. The discussions about mortality in the 
following chapters will refer back to the results presented in this table.  
 
Monitoring cerebral and systemic signals at the cotside 
‘RUMBA’ and ‘SAMBA’ were prospective observational studies. One of the real 
challenges of observational data on preterm infants is the heterogeneity of the studied 
population and complexity of the physiological data. Interesting information and 
insights about the physiology of these infants can be lost by grouping them together 
for data analysis. Outliers are usually present and may affect the statistical analysis, 
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but at the same time they may contain interesting information (more details about 
outliers are discussed in section 5.2). A wealth of information can be obtained from 
the large amount of data collected from a unique individual and some observations 
described in the case reviews demonstrated the importance and the beauty of 
‘individualised medicine’. ICM+
®
 software allows data collection and real-time 
analysis at the cotside, which could add information on the clinical management of 
the patients, as the current intensive care monitors have limited options to visualize 
data, especially retrospective values and trends. During data collection and 
retrospective analysis, trends could be identified, artefacts were cleaned and events, 
such as increase or decrease of inotropes and vasopressors, handling and procedures, 
were highlighted. This allowed the data analysis to be more meaningful for each 
individual patient and a decrease in bias and confounders caused by artefacts and drug 
administration.  
The cases described in this section demonstrate the value of having cotside software 
that allows clinicians to visualize the changes in the pattern of cerebral and systemic 
signals and the real-time analysis of indices of cerebrovascular reactivity. The pattern 
of changes in the MABP signal shown in ‘Case 2’ could be easily missed with 
standard monitoring. The loss is cerebral autoregulation was clearly observed as 
changes in MABP correlated with changes in TOI. The ‘risk charts’ also provide clear 
information regarding periods of intact and impaired cerebrovascular reactivity.  
‘Case 2’ showed that whilst impaired cerebral autoregulation was predominant, as 
demonstrated by predominant positive correlation between MABP and TOI (positive 
TOx), the correlation between HR and TOI was mainly intact (negative TOHRx). 
Although TOHRx has been suggested as an index of cerebrovascular reactivity based 
on the principle that cardiac output is mainly regulated by changes in HR, the inverse 
correlation between MABP and HR with TOI observed for that infant during that 3-h-
window of data shown in the Figures 5.3 and 5.5 may suggest that TOHRx could 
potentially be influenced by baroreflex sensitive
141
. However, studies on baroreflex 
sensitive in preterm infants are complex and difficult to be designed, as the HR 
component of baroreflex in preterm infant is immature and maturates with gestational 
age and postnatal age
301-304
. Studies on the correlation between autonomic nervous 
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system and cerebrovascular control may require a large cohort of preterm infants; 
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5.2. CEREBRAL AUTOREGULATION, CEREBROVASCULAR REACTIVITY 
AND CEREBRAL OXYGENATION IN PRETERM INFANTS DURING 
EARLY TRANSITIONAL CIRCULATION 
5.2.1. Background 
Decreased cerebral oxygenation and impaired cerebrovascular reactivity within the 
first days of life have been associated with poor outcome in preterm infants, as 
described in Chapter 2. In addition, the degree of pressure passivity increases with 
decreasing gestational age, making extremely preterm infants more susceptible to the 
fluctuations in cerebral blood flow 
40, 305
.  
Measurements of cerebrovascular reactivity and cerebral autoregulation in preterm 
infants using NIRS have been mainly described using the frequency domain method. 
More recently studies have suggested that time-domain analysis could be a more 
robust method to describe cerebral autoregulation
306
. However, indices of cerebral 
autoregulation and cerebrovascular reactivity derived from time-domain analysis have 




The aim of this study was to describe the measurements of cerebral oxygenation 
(TOI), cerebral autoregulation (TOx) and cerebral vascular reactivity (TOHRx) within 
the first 48 hours of life and their relationship with outcome of IVH and mortality. We 
further investigated the correlation between mean values of TOI, TOx and TOHRx 
averaged within the first 24 hours of life with gestational life, MABP, CRIB II and the 
use of inotropes.  
5.2.3. Methods 
This prospective observational study included preterm infants who were recruited for 
‘SAMBA’ cohort, because these infants had more continuous NIRS data within the 
first 48 hours of life. The recruitment details, ethics, population and pre-processing 
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data analysis, including the methodology to calculate TOx and TOHRx, were 
described in Chapter 4.  
NIRS data were averaged within the first 24 hours of life, and between 24 and 48 
hours of life. Infants were included in the ‘inotrope’ group if they had dopamine, 
dobutamine or adrenaline started before 24 hours of life.  
Preliminary analysis showed a difference in the distribution of the data for infants 
who were born < 28 and ≥ 28 weeks of gestational age. Therefore, a further analysis 
including only the subgroups of infants born < 28 weeks was performed.  
Pearson coefficient correlation (r) or Spearman’s correlation (rs) were used to assess 
the relationship between indices of cerebral autoregulation (TOx), cerebrovascular 
reactivity (TOHRx) and cerebral oxygenation (TOI) with gestational age, CRIB II 
score and MABP. Independent samples T-test (φ) or Mann-Whitney test (§) were 
used for comparisons of mean TOx, TOHRx and TOI between outcome groups (IVH 
and mortality) and ‘inotropes’ groups, depending on the data distribution.  
5.2.4. Results 
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Table 5.5 Characteristics of the enrolled infants   













































21/35 16/22 5/13 0.38
Ω
 20/29 1/6 0.24
Ω
 












































Chi-square test. *’Inotropes’ group (total numbers): dopamine only (3), dopamine + dobutamine (16), dopamine + hydrocortisone (1), 
dopamine + dobutamine + hydrocortisone (2) dopamine + dobutamine + adrenaline + hydrocortisone (2), dobutamine only (3). 
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5.2.5. Cerebral Oxygenation 
Mean TOI was predominantly above 70% within the first 48 hours of life. There was 
no difference in mean TOI between 0-24 and 24-48 hours (P = 0.62
§
).  
Figure 5.10 Distribution of TOI within the first 48 hours of life 
 
 
Median (Interquartile Range) TOI for 0-24h interval was 72 (6.4)% and for 24-48h interval was 72 
(5.3)%.  
 
Mean TOI within the first 24 hours had no correlation with gestational age at birth, 
MABP or CRIB II (Table 5.6).  
Table 5.6 Correlation between TOI and GA, MABP and CRIB II 
 
 All infants 
(N = 56) 
Infants < 28 weeks 
(N = 44) 
TOI P TOI P 
GA 0.130 0.34 0.208 0.18 
MABP -0.155 0.25 -0.018 0.91 
CRIB II -0.071 0.60 -0.128 0.41 
GA for gestational age in weeks. CRIB II for Clinical Risk Index in Babies II. All Pearson correlation-
coefficient.  
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Association between TOI and IVH  
Including the whole cohort, no difference between mean TOI averaged between 0-24 
hours and IVH groups was observed, however, mean TOI averaged between 24-48 
hours was significantly lower in the IVH group (Figure 5.11). 
Figure 5.11 Association between TOI and IVH for the whole cohort  
 
Figure shows the difference in mean TOI between IVH groups for 0-24h (P = 0.25
 φ
) and 48h (P = 
0.028
§
) intervals (N = 56). 
 
Including only infants < 28 weeks, mean TOI was significantly lower at 0-24 and 24-
48 hours intervals in the IVH group, as shown in Figure 5.12.  
Figure 5.12 Association between TOI and IVH in infants < 28 weeks 
 
Figure shows the difference in mean TOI between IVH groups for 0-24h (P = 0.040
§
) and 48h (P = 
0.012
§
) intervals. Only infants born at less than 28 weeks were included (N = 44).  
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Association between TOI and Mortality 
Mean TOI averaged between 0-24 and 24-48 hours had not association with mortality 
for the whole cohort (P = 0.38
§ 
and P = 0.90
§
) or only infants < 28 weeks (P = 0.63
§ 
and P = 0.93
§
, respectively).  
 
Measurement of cerebral autoregulation (TOx) 
Mean TOx was predominantly positive within the first 48 hours of life as shown in 
Figure 5.13.  
There was no difference in mean TOx between these two time intervals (P = 0.34
φ
).  
Figure 5.13 Distribution of TOx within the first 48 hours of life  
 
 
Median (Interquartile Range) TOx for 0-24h interval was 0.13 (0.21) and for 24-48h interval was 0.08 
(0.18).  
 
Distribution of mean TOx within the first 24 hours of life and correlation with 
other variables  
 
Mean TOx within the first 24 hours of age for each individual infant was below zero 
for only 13 infants (23.2%). None of the infants had mean TOx ≥ 0.5. Figure 5.14 
shows a frequency histogram for three different thresholds of TOx.  
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Figure 5.14 Distribution of the mean TOx averaged over first 24 hours of life 
 




Mean TOx had no correlation with gestational age at birth (Table 5.7). However, we 
can observe in Figure 5.15 that the pattern of the correlation between TOx and 
gestational is different for infants born < 28 weeks and for those born ≥ 28 weeks. 
When only infants born at less than 28 weeks were included in the analysis, mean 
TOx had a negative correlation with gestational age (Table 5.7).  
Figure 5.15 Correlation between mean TOx and gestational age  
 
 
Mean TOx over the first 24 hours of life and gestational age at birth in weeks  
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The pattern of correlation between TOx and gestational age at birth was the opposite 
from the correlation between MABP and gestational age for infants born < 28 weeks, 
as shown in Figure 5.16. MABP had a significant positive correlation with gestational 
age for infants born < 28 week (r = 0.472, P = 0.001), following the physiological 
norms. However, there was no correlation between MABP and gestational age for 
those born ≥ 28 weeks (r = -0.219, P = 0.50). 




Mean MABP over the first 24 hours of life and gestational age in weeks.  
 
Mean TOx had a negative correlation with MABP as shown in Figure 5.17 and this 
negative correlation was stronger when only infants born < 28 weeks were included 
(Table 5.7).   
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Figure 5.17 Correlation between TOx and MABP 
 
Mean TOx and mean MABP (mmHg) averaged within the first 24 hours of life.  
 
Mean TOx had no correlation with CRIB II, but when only infants born < 28 weeks 
were included, a positive correlation was observed (Table 5.7).  
Table 5.7 Correlation between TOx and gestational age, MABP, CRIB II and 
TOI 
 
 All infants 
(N = 56) 
Infants < 28 weeks 
(N = 44) 
TOx  P TOx   P 
GA -0.108* 0.43 -0.345 0.022 
MABP -0.322 0.015 -0.444 0.003 
CRIB II 0.165 0.22 0.311 0.040 
TOI 0.10 0.94 0.25 0.87 
GA for gestational age in weeks. CRIB II for Clinical Risk Index in Babies II. *Spearman rank 
correlation, the remaining correlations were Pearson correlation-coefficient.  
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Association between TOx and IVH  
Including the whole cohort (N = 56), no difference between the mean TOx and IVH 
groups was observed for 0-24h and 24-48h intervals (P = 0.71
φ 




Including only infants born < 28 weeks, the difference in mean TOx between groups 
remained non-significant (Figure 5.18).  
Figure 5.18 Association between TOx and IVH in infants born < 28 weeks 
 
Figure shows the difference in TOx between infants who did not have and had IVH for 0-24h (P = 
0.094
φ




Independent samples t-test.  
 
Association between TOx and mortality 
Including the whole cohort (N = 56), there was no difference in the mean TOx within 
the first 24 hours of life between mortality groups (P = 0.17
§
). However, the mean 




Including only infants born < 28 weeks, an outlier was observed as shown in Figure 
5.19. When this outlier was removed from the analysis, mean TOx remained non-
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significant between groups at for the 0-24h interval (P = 0.054
§
), but it was 
significantly higher in the group of infants who died for 24-48h interval (P = 0.040
§
) 
(Figure 5.19).  
Figure 5.19 Association between TOx and mortality in infants < 28 weeks 
 
Figure shows the difference in TOx between infants who died and survived. The outlier was the same 
in both intervals: a female infant born at 24+1 week’s gestational age who was stable within the first 24 
hours of age, did not require inotropes, had no early sepsis and did no develop IVH. However, this 
infant developed fulminant NEC with bowel perforation and died on day 11 of life.   
 
Association between TOx and inotropes  
Mean TOx averaged within the first 24 hours of life was significantly higher for 
infants who were started on inotropes compared to the ‘no-inotropes’ group, for the 
whole cohort analysis (P = 0.002
φ
). The difference between groups was significantly 
higher when only infants < 28 weeks were included (P < 0.001
φ
) as shown in Figure 
5.20.  
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Median (Interquartile Range) TOx for ‘no-Inotropes’ group was 0.002 (0.19) and for ‘Inotropes’ group 
was 0.18 (0.16), N = 44.  
 
Measurement of cerebrovascular reactivity 
Mean TOHRx was predominantly negative within the first 24 hours of life and within 
24 to 48 hours as shown in Figure 5.21. There was no difference in mean TOHRx 
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Figure 5.21 Distribution of TOHRx in the first 48 hours of life 
 
 
Median (Interquartile Range) TOHRx for 0-24h interval was -0.025 (0.14) and for 24-48h interval was 
-0.021 (0.13).  
 
 
Distribution of mean TOHRx within the first 24 hours of life and correlation 
with other variables  
 
Thirty-four infants (60.7%) had a mean TOHRx < zero and no infants had mean 
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Figure 5.22 Distribution of the mean TOHRx averaged over first 24 hours of life 
 
 
No thresholds of TOHRx for impaired cerebrovascular reactivity have yet been reported in the 
published literature. The threshold of 0.2 was chosen after observing the data distribution for the first 
24 hours.  
 
Mean TOHRx had negative correlation with gestational age at birth when the whole 
cohort was included in the analysis and remained significant when only infants < 28 
weeks were included (Table 5.8 and Figure 5.23). HR had similar correlation with 
gestational age (Figure 5.24).  
Including the whole cohort, mean TOHRx had a negative correlation with MABP. 
Including only infants below 28 weeks this correlation became insignificant (Table 
5.8). However, three outliers were identified. When they were removed from the 
analysis, the correlation became significant r = - 0.446, P = 0.004 (Figure 5.25).  
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Figure 5.23 Correlation between TOHRx and gestational age 
 
 








Mean HR within the first 24 hours of life and gestational age at birth in weeks (r = -0.339, P = 0.010).  
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Figure 5.25 Correlation between TOHRx and MABP in infants < 28 weeks 
 
All outliers were infants who had severe antenatal hypoxia. Two outliers were infants who were 
severely sick soon after birth and died two weeks of age. The third one was high MABP and very low 
TOI within the first 24 hours of age and developed bilateral grade III IVH after the 1
st




Table 5.8 Correlation between TOHRx and GA, MABP, CRIB II, TOI and TOx 
 
 All infants 
(N = 56) 
Infants < 28 weeks 
(N = 44) 
TOHRx P TOHRx P 
GA -0.367 0.005 -0.304* 0.045 
MABP -0.289* 0.031 -0.202* 0.19 
HR 0.213 0.11 0.218 0.16 
CRIB II 0.404 0.002 -0.370 0.013 
TOI 0.030* 0.82 -0.195 0.20 
TOx 0.146 0.28 0.288* 0.058 
GA for gestational age in weeks. CRIB II for Clinical Risk Index in Babies II. *Spearman rank, the 
remaining correlations are Pearson correlation-coefficient.  
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Association between TOx and IVH  
Including the whole cohort, there was no difference between mean TOHRx between 
IVH groups for the 0-24h interval (P=0.27
φ
). However, mean TOHRx was 
significantly higher in infants who had an IVH for the 24-48h interval (P = 0.045
φ
) as 
shown in Figure 5.26.  
 
Figure 5.26 Association between TOHRx and IVH for the whole cohort 
 
Figure shows the difference in mean TOHRx between IVH groups for 0-24h and 24-48h intervals. All 
infants included (N = 56). 
Including only infants < 28 weeks, there was no difference in mean TOHRx between 
IVH groups for the 0-24h (P=0.58
φ
) and for the 24-48 intervals (P = 0.20
 φ
).  
Association between TOx and mortality 
There was no difference in mean TOHRx averaged within 0-24 hours between those 
infants who died and survived (P = 0.68
φ
). When only infants < 28 weeks were 
included, the difference between groups remained non-significant (P = 0.34
φ
). The 
difference between mortality in the groups remained non-significant when TOHRx 
was averaged between 24-48 hours (P = 0.41
φ
). However, when only infants below 28 
weeks were included, mean TOHRx (24-48h) was significantly higher in those infants 
who died (P = 0.008
φ
) as shown in Figure 5.27. 
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Figure shows the difference in mean TOHRx between IVH groups for 0-24h and 24-48h intervals. 
Only infants born at less than 28 weeks were included (N = 44).  
Association between TOHRx and inotropes  
Mean TOHRx was significantly higher for infants who were started on inotropes 
compared to ‘no-inotropes’ group for the whole cohort analysis (P = 0.040
φ
). Mean 
TOHRx tended to be higher in the ‘inotropes’ group in infants < 28 weeks (Figure 









Median (Interquartile Range) TOHRx for ‘no-Inotropes’ group was -0.05 (0.13) and for ‘Inotropes’ 
group was -0.0009 (0.10), N = 44.  
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5.2.6. Discussion  
Cerebral oxygenation within the first 48 hours of life and its relationship with 
outcome  
In this study, no statistically significant difference in mean TOI averaged between the 
first 24 hours of life and between 24 and 48 hours was observed.  Mean TOI had a 
better correlation with IVH when only infants born < 28 weeks’ gestational age were 
included in the analysis. Cerebral oxygenation was lower for infants who developed 
an IVH but no difference was observed in mean TOI between infants who died or 
survived. Several studies have already reported increased cerebral hypoxia and 
hypoperfusion within days of life in infant who later developed IVH
77, 145, 307
. It is 
well known that hypoperfusion-reperfusion injury is the key mechanism in the 
development of brain injury in preterm infants. The amount of cerebral hypoxia or 
low cerebral blood flow has been suggested as the main factor associated with the 
development of GMH-IVH
36
. However, to date there are no studies on the best 
approach to monitor cerebral oxygenation at the cotside in order to prevent the 
development of brain injury in neonates. The SafeBoosC trial demonstrated that it is 
possible to stabilise cerebral oxygenation, however thresholds of “normal” TOI 
remain uncertain, as discussed in Chapter 3
209
. Mean TOI alone may not be a robust 
method to assess changes in cerebral circulation. The time-domain correlation 
between TOI and other signals may provide more robust information on changes in 
cerebrovascular reactivity at the cotside.  
Pressure passive circulation and cerebrovascular reactivity  
In this study we observed that preterm infants, especially those born at less than 28 
weeks of gestational age, had mainly positive TOx within the first 48 hours of life. 
However, cerebrovascular reactivity, assessed by TOHRx, was possibly more 
preserved (negative TOHRx) in more than 50% of the cohort. Regulation of CBF may 
be determined by other factors than blood pressure alone. Several physiological and 
biochemical mechanisms may have strong influence in the regulation of CBF, 
especially in the preterm population 
308-310
.  
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Thresholds of intact cerebral autoregulation and preserved cerebrovascular reactivity 
in preterm infants have not yet been consistently defined. Brady et al. (2007) 
described the loss of cerebral autoregulation when COx was above 0.3 in a piglet 
model of hypotension
129
. Gilmore et al., 2011 used the percentage of time of COx 
above 0.5 as a threshold of impaired cerebral autoregulation in preterm infants
137
. In 
our study, none of the infants had a mean TOx or mean TOHRx above 0.5, and only 
about 50% of had a mean TOx above 0.3 within the first 24 hours of life. 
Cerebrovascular reactivity in extremely preterm infants  
In our study, nearly 80% of the infants were born at less than 28 weeks gestation. 
According to studies in preterm lambs, the musclaris layers of cerebral arteries and 
arterioles develop approximately after 63% of the gestation, which is equivalent to 
approximately 25 weeks in humans. In lambs, cerebral autoregulation is active from 
the late stage in pregnancy, time equivalent to 36 weeks in humans
311
. Clinical studies 
have shown that cerebral autoregulation improves with increasing gestation age
305
. 
However, some degree of vasoreactivity may be present before cerebral 
autoregulation is established or even in those infants whose cerebral autoregulation is 
absent. In our study, TOHRx had negative correlation with gestational age, which 
may demonstrate that more immature infants had more impaired cerebrovascular 
reactivity. However, HR had very similar correlation with gestational age, showing 
the normal physiological maturation in HR with advance in gestational age and the 
possible limitation in the correlation of TOHRx with gestational age. Mean TOHRx 
over the first 24 hours of age was mainly positive for those infants born at less than 26 
weeks. On the other hand, TOx only had a significant negative correlation with 
gestational age for infants < 28 weeks’ gestation, showing that impaired cerebral 
autoregulation increased with decreasing gestational age. The lack of correlation 
between TOx and gestational age for those infants ≥ 28 weeks’ gestation may be 
related with the underlying pathology affecting those infants, instead of the normal 
transitional adaptation following birth. It is possible that preterm infants born > 28 
weeks actually may present more periods of intact cerebral autoregulation but this 
mechanism may become impaired when they are sick. In addition, TOHRx had no 
correlation with TOx, which may support the suggestion that some infants who are 
5. MONITORING OF CEREBRAL OXYGENATION AND CEREBROVASCULAR REACTIVITY IN 
PRETERM INFANTS UNDERGOING INTENSIVE CARE 
 
137 
passive to arterial blood pressure may have some degree of intact cerebrovascular 
reactivity. 
The small number of infants born above 28 weeks of gestation who were included in 
this study were sick enough to have an umbilical arterial line inserted following birth, 
therefore the negative correlation between MABP and gestation age may represent the 
pathological status of this small proportion of all infants included in the analysis 
instead of normal physiological changes.  On the other hand, the positive correlation 
between MABP and gestational age in extremely preterm infants follows the norms 
for MABP and it may reflect mainly physiological changes in this population. 
However, any assumption considered for the group of infants with more than 28 
weeks of gestational age should be cautiously considered, as only 12 infants were 
included in this sub-group.  
The correlation of indices of cerebral autoregulation and cerebrovascular 
reactivity with outcome 
The correlation between TOHRx and CRIB II was similar to the work previously 
published by our research group
141
. More impaired cerebrovascular reactivity (more 
positive TOHRx) was observed in infants with worse clinical score of mortality and 
morbidity. The correlation between TOx and CRIB II was positive only in preterm 
infants > 28 weeks. In addition, more impaired cerebral autoregulation and 
cerebrovascular reactivity was observed with lower levels of MABP. These findings 
were similar to the work described by Gilmore et al., 2011 which showed that infants 
with a lower MABP had higher percentage of time with levels of COx (equivalent to 




There was no correlation between mean TOx and IVH at any time interval. However, 
mean TOHRx was more positive between 24-48 hours of life in infants who 
developed IVH. This may reflect the loss of cerebrovascular reactivity after the 
bleeding occurred, because, as described in section 5.1.4, most infants developed IVH 
around or after 24 hours of age.  
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Cerebral autoregulation and cerebrovascular reactivity was more impaired in the 
extremely preterm infants who died compared to those who survived. Mean TOHRx 
was higher between 24-48 hours of life in extremely preterm infants who died. Mean 
TOx was higher in extremely preterm infants who died only when an outlier was 
removed from the data analysis. Although the outlier has made the statistical analysis 
non-significant, it has contributed to highlight the complexity of the relationship 
between indices of cerebrovascular reactivity and mortality. The outlier described in 
Figure 5.19 was a preterm infant who died at 11 days of life due to perforated NEC, 
but had a stable first 48 hours of life and did not develop an IVH. The mean TOx for 
the first 0-48 hours of life was negative for that infant, showing that cerebral 
autoregulation was intact and brain perfusion was protected, perhaps at the expense of 
non-vital organs. In this case, gut perfusion may have been compromised with 
redistribution of blood flow to the vital organs (brain, heart and adrenal glands). 
Although all infants in this cohort died after 48 hours of life due to other causes apart 
from brain injury (See Table 5.4) unlike the ‘outlier’, most of them were sick from 
early postnatal age, but any correlation between mortality and cerebrovascular 
reactivity should be considered cautiously, as number of infants who died is small and 
the causes of death are heterogeneous. The association between impaired cerebral 
autoregulation and mortality has been previously described. Wong et al., 2008 using 
coherence analysis, described an association between impaired cerebral 
autoregulation within the first days of life and subsequent mortality in preterm infants 
born ≤ 32 weeks
78
.  
Cerebrovascular reactivity and inotropes 
In our study, mean TOx was higher in infants who were started on inotropes within 
the first 24 hours of life. However, it is difficult to establish whether the relationship 
between inotropes and impaired cerebral autoregulation is purely due to the effects of 
the drugs or due to the fact that infants who received inotropes were sicker and more 
hypotensive. As discussed before, TOx had a negative correlation with MABP. 
Several studies have already reported that hypotension may be associated with 
impaired autoregulation
78, 137, 312
. More recently, Eriksen et al. (2014) have reported 
that mean COx was higher in a group of preterm infants who received dopamine 
within the first 24 hours of life compared to infants who did not received dopamine
138
. 
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In this study, they did not found correlation between COx and gestational age, CRIB 
II or mortality. However, data were collected for short period of time (mean 2.5 hours 
only) and it was not clear if those infants who did not receive dopamine had received 
any other treatment for hypotension such as volume expansion, inotropes or 
vasopressors. TOHRx was slightly more positive in the ‘inotropes’ groups compared 
to the ‘no-inotrope’ group when all infants were included in the analysis. However, no 
difference between these two groups was observed when only preterm infants < 28 
weeks were included.  
Limitations 
In this study we used averaged values of TOI, TOx and TOHRx over approximately 
24-hour time intervals. Data on percentage of time spent above thresholds of 
cerebrovascular reactivity may offer a better correlation with outcome. However, 
definite thresholds of cerebral autoregulation and cerebrovascular reactivity in 
extremely preterm infants have not yet been well defined, which limited our analysis 
to averaged values.  Other factors related to changes in CBF, such as changes in CO2, 
could have had an impact on the final results. In our study, data on continuous 
transcutaneous CO2 were collected for some infants, however values were not always 
reliable and could not be used in the final analysis. Moreover, changes in peripheral 
oxygenation, especially below 85%, can contribute as a confounder. However, major 
episodes of arterial oxygen desaturations were removed from the data during manual 
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6. OPTIMAL MEAN ARTERIAL BLOOD PRESSURE IN   
PRETERM INFANTS  
6.1. MONITORING OF CEREBRAL VASCULAR REACTIVITY FOR   
DETERMINATION OF OPTIMAL BLOOD PRESSURE IN PRETERM 
INFANTS  




6.1.1. Introduction  
Disturbances in cerebral perfusion have been implicated in the pathophysiology of 
hemorrhagic and ischaemic brain lesions in preterm infants, as described in Chapter 2, 
section 2.1.3. Strategies for preventing cerebral injury in preterm infants have 
emphasized the importance of maintaining a “normal blood pressure” to ensure 
adequate perfusion of the brain. However, the definition of hypotension or 
hypertension in this population remains uncertain. The current management of 
hypotension in preterm infants does not combine quantitative information about organ 
perfusion. Nevertheless, regulation of CBF must be a crucial mechanism to ensure 
survival and avoid ischemic or haemorrhagic injury. The concept of optimizing CPP 
or MABP according to the strength of cerebral autoregulation (described in Chapter 2, 
section 2.3.2) could provide an individualized and quantitative approach to the 
management of hypotension in preterm infants.  
 
 




In this study, we hypothesized that using NIRS we could define levels of MABP 
where cerebrovascular reactivity is strongest (MABPOPT). Furthermore, we 
hypothesized that deviations from MABPOPT values would correlate with outcome of 
mortality and IVH.  
6.1.3. Methods 
This prospective observational study included preterm infants born at ≤ 32 weeks 
gestational age who were recruited to the ‘RUMBA’ cohort only. The recruitment 
details, ethics, population and pre-processing data analysis were described in Chapter 
4. In this study we used TOHRx as an index of cerebrovascular reactivity. The 
method to calculate TORHx was described in Chapter 4, section 4.4.1. 
Optimal blood pressure calculation 
The methodology applied to define MABPOPT in this cohort of preterm infants was 
similar to the method previously used by Aries et al to define MABPOPT in adults with 
traumatic brain injury
172
. In adults, different windows have been analyzed, and the 
optimum of 5-minute windows for the autoregulation index and a 4-hour window for 
MABPOPT proved to be the optimal (also showing the strongest association with 
outcome after traumatic brain injury)
172
. The four-hour window for calculation of 
MABPOPT in adults is a trade-off between increasing the range of MABP variation 
(generally increasing with increased window) required to “probe” the MABPOPT and 
making the index available as soon as possible, to be clinically relevant. The 
MABPOPT for individual infants was determined by dividing MABP, recorded within 
a 1-hour period, into 3 mm Hg bins and averaging TOHRx within those bins. An 
automatic U-shape curve-fitting method was applied to determine the MABP value 
with the lowest associated TOHRx value, which corresponds to maximal 
cerebrovascular reactivity, following the method described by Aries at al.  In our 
study MABPOPT was defined as the MABP where TOHRx was lowest. 
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Divergence from optimal blood pressure 
The absolute value of the difference between mean MABP from the total monitoring 
time and mean MABPOPT also from the total monitoring time was defined as ‘ABS’ 
(absolute deviation) and was calculated for each individual patient.  
Statistical analysis 
A non-parametric (Kruskall-Wallis) test was used to investigate the difference 
between ‘ABS’ and mortality. One-sample t test between proportions was used to 
determine whether there was significant difference between deviation from MABP 
and mortality rate and grades of IVH. Pearson correlation coefficient (r) was used to 
correlate the expected MABP thresholds based on gestational age in weeks with 
MABPOPT. 
6.1.4. Results 
The median (range) age of the 60 preterm infants the beginning of the study was 34 
(5-228) hours, and the median time of recorded data was 2 (1-24) hours. Demographic 
data are shown in Table 6.1.  
Table 6.1 Characteristics of the enrolled infants 
 
Variables Total (n=60) 
Gestational age (weeks) 26+2 (23+2 – 32+1) 
Birth Weight (grams) 845g (445g – 1440g) 
Male:Female 1.4:1 
CRIB II 11 (4 – 17) 
IVH  27(45%) 




Gestational age, birth weight and CRIB II (Clinical Risk Index for Babies II) values are presented as 
median (range). Remaining variables are presented as frequency 
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Figure 6.1 Example of TOHRx over MABP plot to determine the MABPOPT in a single infant 
 
A male infant born at 25+2 weeks’ gestational age with a birth weigh of 860 grams who was studied within the first 36 hours of life for 23 hours. This infant was 
ventilated and was not on inotropes during the recording study period. The first graph shows the infants actual MABP. The second graph shows MABPOPT curve. 
The frequency histogram shows the percentage of time spent in each value of MABP. Adapted from da Costa, et al. (2015)
313
.  
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Figure 6.1 shows an example of the MABPOPT graph for a single infant and a 
histogram of MABP, normalized by the total number of data samples. The MABPOPT 
is the minimum value of the U-shape curve fitted to the mean TOHRx versus mean 
MABP data pairs. 
The determination of individual MABPOPT using a sliding 1-hour window was 
possible in 49 (81.6%) infants from a total of 60. In 11 (19.3%) infants, the MABPOPT 
was not identified possibly due to the short period of recording data (< 3hours) or the 
presence of frequent artifacts. The mean MABPOPT averaged from the 1-hour window 
was 35 +/-6.4 mm Hg (mean +/-SD). The MABPOPT increased with increasing 
gestational age (r = 0.390; P < 0.005) as shown in Figure 6.2.  
The measurement of divergence from the MABPOPT, ABS, was greater in those 
infants who did not survive. Infants who survived had a mean ABS of 2.1 (CI 1.64, 
2.56) mmHg, whereas those who did not survive had a mean ABS of 4.2 (CI 3.44, 
4.96) mmHg P = 0.013 (Figure 6.3).  
Infants who had a MABP lower than MABPOPT by at least 4mmHg had greater 
mortality rate (40%) than those with MABP close to or above MABPOPT (13%), P = 
0.049. Infants with MABP greater than MABPOPT by at least 4 mmHg had 
significantly greater IVH score (grades 3 and 4) (P = 0.042).  
Expected MABP threshold (gestation age in weeks) was only moderately correlated 
with MABPOPT (r = 0.42; P < 0.002), with MABPOPT values greater than expected 
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Mean MABPOPT averaged for the entire recording period for each individual infant and gestational age 
at birth in weeks.  
 
Figure 6.3 Difference between ABS and outcome groups 
 
 
Mean ABS was 2.1 (95% CI 1.64 – 2.56) mmHg for those infants who survived and 4.2 (95% CI 2.44 
– 4.96) mmHg for those who died (non-parametric test), P=0.013 
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6.1.5.  Discussion 
In this study, using TOHRx as a marker of cerebrovascular reactivity, we were able to 
define retrospectively MABPOPT in over 80% of the infants studied. In addition, we 
observed a significant correlation between divergence from MABPOPT values and 
adverse outcome. We observed an expected increase in the MABPOPT with increase in 
gestational age, as MABP also increases with gestational age in the human fetus and 




. The value of MABPOPT is a unique measurement 
for each infant, determined by their own physiology rather than population norms.  
Work published by Wong et al. (2012), using coherence spectrum analysis, observed 
that impaired autoregulation and pressure-passive perfusion can be present even with 
only small fluctuations in blood pressure in critically ill preterm infants
82
. In our study 
we observed that, although the values of ABS were small, they significantly 
correlated with mortality, suggesting that small fluctuations in arterial blood pressure 
can have a detrimental impact on outcome, probably by breaching autoregulatory 
limits. An increase in TOHRx with both lowering and increasing MABP below or 
above MABPOPT may be conceptually visualized as a moving ‘working point’ of the 
autoregulatory Lassen curve, similar to the explanation given in the experimental 
study of Brady et al. (2008)
136
.  
Similar to other cerebrovascular indices reported, TOHRx is a dimensionless index, 
which relates the reactivity of the cerebral circulation to changes in the systemic 
circulation. In a previous study, we found that TOHRx was significantly correlated 
with the Clinical Risk Index for Babies II (CRIB II)
141
. As described in a previous 
study from our group, we did not find a high coherence between TOI and MABP 
(previously described as COx or TOx) in this cohort of preterm infants within the 
very low frequency band-with range (0.0002-0.05Hz), selected for its highest 
sensitivity to detect autoregulatory responses. The results of our previous study 
suggested that TOI-HR passivity increased with arterial hypotension
141
. This finding 
is in line with the literature on autoregulation theory. In adults, CBF is not related to 
cardiac output, but in preterm infants a positive correlation between CBF and left 
cardiac output has been suggested
320, 321
.  
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Howlett et al. (2013), using the haemoglobin volume index (HVx) that is based on the 
correlation between the tissue hemoglobin index (THI) and MABP, were able to 
define MABPOPT in over 77% of term infants with hypoxic-ischaemic encephalopathy 
during rewarming phase of therapeutic hypothermia. They showed that infant who 
had moderate to severe MRI abnormalities spent a greater proportion of time with 




In adult patients with traumatic brain injury, a greater divergence from CPPOPT has 
been associated with poor outcome. Mortality increased when the median CPP fell 
below the CPPOPT values and the likelihood of severe disability increased when the 
median CPP was above CPPOPT
170, 172, 175
. In our study, mortality rates were higher in 
preterm infants with a MABP below MABPOPT. In adults, targeting an individualized 
CPP during management of severe traumatic brain injury has been suggested to 
improve outcome and the data from several studies have supported the need for a 
clinical randomized controlled trial. 
Blood pressure monitoring alone is not a reliable predictor of brain injury in preterm 
infants
323, 324
. However, fluctuations in MABP combined with immature vasculature 
and pressure passive cerebral vascular circulation in sick preterm infants has been 
associated with IVH
81
. Several studies have associated low cerebral perfusion with 
the development of IVH, suggesting a ‘reperfusion’ injury as the main 
pathophysiological mechanism
24, 66, 325
. In our study, preterm infants who had MABP 
values higher than MABPOPT had more severe IVH, suggesting that a diminished 
autoregulatory capacity can be found in infants who developed a severe IVH. 
Although we could demonstrate a correlation between deviations from MABPOPT and 
outcome of IVH and mortality, we were not able to predict the development of an 
IVH, as some infants already had established IVHs when the study was performed. In 
order to investigate the haemodynamic and autoregulatory pattern of infants who go 
onto develop an IVH, a studying monitoring preterm infants in the first 24 hours of 
life would be necessary. 
Individualised hemodynamic management of the preterm infant is complex, with 
many variables and output. In this research study we obtained an objective 
‘individualised’ measurement of MABP based on the strength of cerebrovascular 
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regulation. Clearly targeting hemodynamic management to optimize cerebral 
perfusion and oxygenation is critically important given the risk of haemorrhagic and 
ischaemic brain injury in this population group.  
Limitations 
We could not define MABPOPT in all patients because the present methodology 
requires a minimum of 2 to 4-hour windows of continuous data to create a u-shape 
curve. Shorter recordings could not produce any satisfactory information regarding 
optimal values of MABP. In order to calculate MABPOPT using this methodology it is 
necessary to have spontaneous fluctuations in MABP, HR and TOI, which may not 
occur in infants where autoregulation is completely lost or in infants with intact 
autoregulation.  The percentage of time an infant remains at a particular blood 
pressure will determine the confidence interval of the average value of 
cerebrovascular reactivity associated with that pressure level. In most cases, however, 
infants’ MABP followed a Gaussian distribution and may have incomplete coverage 
of the autoregulatory range. Moreover, values of MABPOPT were calculated 
retrospectively and to be clinically useful, these values will need to be calculated and 
displayed in near-real time at the cotside. If an automatic calculation of MABPOPT 
from a running 1-hour period is used, then these values at the cotside may be 
available for making clinical decisions in ‘real time’. This would enable clinical 
prospective trials of MABPOPT versus conventional treatment to be carried out. 
In this cohort of infants we studied the relationship between continuous physiological 
variables but continuous measurements of PaCO2 was not available, although PaCO2 
was monitored through arterial blood gases and kept fairly stable during the study 
period. We cannot exclude an effect of fluctuating PaCO2 our data and therefore we 
acknowledge this limitation.  For future studies we would like to explore different 
models looking at the impact of transcutaneous PaCO2 on cerebrovascular reactivity 
and MABPOPT.  
Another confounding factor is the potential instability of SaO2. Fluctuations of SaO2 
within the frequency range of slow waves (20 sec to 3 min of period) are rarely seen 
and they did not cause coherent changes in TOI. Incidents of deeper desaturations 
(below 90%) often caused changes in TOI. However, the total time of such 
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desaturations was less than 5%, therefore contributing very little to calculated running 
TOHRx index. When we analysed the data excluding these events, it did not change 
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6.2. OPTIMAL MEAN ARTERIAL BLOOD PRESSURE IN EXTREMELY       
PRETERM INFANTS WITHIN THE FIRST 24 HOURS OF LIFE  
6.2.1. Background 
Major changes in systemic and cerebral haemodynamics occur within the first 12 to 
24 hours following birth. As discussed in Chapter 2, section 2.2, a decrease in CBF 
within the first 24 hours of life has been associated with brain injury in preterm 
infants. Most infants included in the SAMBA cohort developed GMH-IVH around or 
just after 24 hours of life, as shown in Chapter 5, section 5.1. Therefore, defining 
MABPOPT and deviations from optimal values before infants develop GMH-IVH may 
help to identify those who are at risk and provide a better understanding of its 
pathophysiology.  
6.2.2. Aims 
In this study, we aimed to define MABPOPT using NIRS in infants born less than 28 
weeks’ gestational age within the first 24 hours of life. We hypothesized that using a 
more refined methodology and with more prolonged periods of continuous NIRS data 
we could define MABPOPT in a higher proportion of infants at the most vulnerable 
time in life in terms of developing IVH. Furthermore, we hypothesized that deviations 
below or above MABPOPT would have associations with outcome of mortality and 
IVH.  
6.2.3. Methods 
This prospective observational study included data from infants born at < 28 weeks 
gestational age recruited for the ‘SAMBA’ cohort. Only NIRS and physiological data 
recorded within the first 24 hours of life were included in the analysis. The 
recruitment details, ethics, population and pre-processing data analysis were described 
in Chapter 4. Similar to our previous study, we used TOHRx as an index of 
cerebrovascular reactivity to calculate MABPOPT. Deviations below or above 
MABPOPT values were included in the configuration profile and were calculated 
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analysis along with MABPOPT values during retrospective data analysis. The mean 
deviations below or above for the entire study period were correlated with outcome.  
Optimal blood pressure calculation 
The methodology applied to define MABPOPT in this cohort of preterm infants was 
similar to the method used in our previous study. However, the configuration was 
adjusted to take into account the different variability in MABP within the first 24 
hours of age in extremely preterm infants. Range of MABP between 15 and 60 mmHg 
were chosen as the analysis of the MABP for each single infant demonstrated that 
20% of the population spent at least 5% of the time with MABP between 15 and 20 
mmHg. The configuration was also adjusted for the calculation of MABPOPT not to be 
re-started after a short period of missing data.  
Statistical Analysis  
Pearson correlation coefficient or Spearman’s rank order correlation were used to 
investigate the correlation between CRIB II and TOHRx, and the correlation between 
MABPOPT and gestational age in weeks. Data distribution was assessed as described 
in Chapter 4. The non-parametric Mann-Whitney test was used to compare mean 
MABPOPT and mean deviations below or above MABPOPT with outcome of mortality 
and IVH. Independent samples t-test was used to compare mean MABP between 
these two groups.  
6.2.4. Case reviews 
Figure 6.3 shows an example of the MABPOPT graph for a single infant and a 
histogram of MABP normalized by the total number of data samples. The MABPOPT 
is the minimum value of the U-shape curve fitted to the mean TOHRx versus mean 
MABP data pairs. The MABPOPT for the infant in Figure 6.3 within that 4-h-window 
was around 32 – 35 mmHg. 
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Figure 6.4 Example of MABPOPT curve for a 4-hour-window data in a single infant 
 
A female infant born at 27+6 weeks’ gestational age with a birth weight of 1120 grams, CRIB II = 8. Her mother was given a complete course of antenatal steroids but no 
antenatal MgSO4. She received one dose of surfactant at birth and was successfully extubated at 15 hours of age. No inotropes or transfusions were given over the first 48 
hours of life. She did not have sepsis and received prophylactic antibiotics for 48 hours only. She was between 12 - 16 hours old at the above 4-h window. The first graph 
shows the infant’s actual MABP. The second graph shows the MABPOPT curve. The frequency histogram shows the percentage of time spent in each value of MABP. This 
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Figure 6.5 shows a 4-h-window of MABP and MABPOPT for a female infant born at 
26+3 weeks’ gestational age with a birth weight of 980 grams, CRIB II = 11. She was 
an IVF pregnancy, and had PPROM from 24+3 weeks; her mother completed a 
course of antenatal steroids, which was given 16 days before delivery when she was 
admitted with vaginal bleeding and threatened labour. She was born by emergency 
caesarean section (inborn), and was a breech presentation. She was intubated at birth 
and a total of two doses of surfactant were given (1
st
 at 12 minutes of age and 2
nd
 
within the first 24 hours of life). She developed PPHN and received NO during her 
first three days of life. She was on dobutamine and dopamine infusions during the 
study period and received boluses of saline and sodium bicarbonate. She received 
antibiotics for presumed sepsis for seven days. Blood and CSF cultures were 
negative. She received three blood transfusions and one transfusion of fresh frozen 
plasma during the first 48 hours of life. She had a possible small GMH at her scan at 
24 hours of life, but developed grade IV IVH between 24 and 48 hours of life. This 
infant died at corrected gestational age of 31+2 week’s gestational age due to 
pseudomonas aeruginosa sepsis and meningitis.  
Figure 6.5 Cranial ultrasound at 24 hours age for the case described above 
 
 
The sagittal images above show the cranial ultrasound performed at 24 hours of life with possible small 
GMH with some periventricular brightness. All images were recorded as part of the data collection for 
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Figure 6.6 MABPOPT graph for a 4-hour-window data for a single infant  
 
 
Infant’s age at this 4-h-window was 20-24 hours of life. The first graph shows the infants actual MABP. The sudden increase in MABP seen at 12:20 (21/07) on the first 
graph followed an increase in dopamine infusion from 15 to 20 mcg/kg/min. The second graph shows MABPOPT curve. The frequency histogram shows the percentage of 
time spent in each value of actual MABP. The MABPOPT for this infant at this 4-h-window was around 35 mmHg. The frequency histogram for this 4-h-window shows that 
the percentage of time that the actual MABP was below MABPOPT  was greater than the percentage of time spent with values ≥ MABPOPT. We can observe that the infant’s 
MABP was around 35 mmHg (which was approximately the value for MABPOPT) for this 4-h-window. A sudden drop on MABP was followed by an increase in dopamine, 
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Figure 6.7 TOI, HR and TOHRx signals for a 4-hour-window data for a single infant 
 
The figure above shows readings of TOI and TOHRx, respectively, for the same infant at same 4-h-window used to calculate MABPOPT shown Figure 6.5. The bottom image 
shows a ‘risk chart’ where colours change from green (TOHRx close to -1) towards red (TOHRx close to +1). The sudden increase in the TOHRx trace seen at 12:20 (21/07) 
followed an increase in dopamine infusion. Comparing Figure 6.5 and Figure 6.6, we observe that the actual MABP was within the MABPOPT values. A sudden fall in MABP 
and the subsequent increase in dopamine infusion may have resulted in an acute increase in MABP along with impaired cerebrovascular reactivity. The high values of TOI 
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Figure 6.7 shows another 4-h-window of MABP and MABPOPT data for this same 
infant at around 30 hours of life.  
 
Figure 6.8 MABPOPT graph at around 30 hours of age  
 
 
The MABPOPT value for this 4-h-window is around 38 mmHg. The frequency histogram with the 
percentage of time spent on actual MABP by this infant during this 4-h-window is slightly shifted to 
values above MABPOPT . 
  
 
The cranial ultrasound performed for at 48 hours of life showed extensive bilateral 
IVH with HPI (grade IV) as shown in Figure 6.8.  
 
Figure 6.9 Cranial ultrasound at 48 hours  
 
 
The coronal views above show bilateral IVH grade IV. All images were recorded as part of the data 
collection for ‘SAMBA’ study.  
 
 




The characteristics of all infants included in this study and differences between 
outcome groups are shown in Table 6.2. The median (range) age of the 44 infants at 
the start of the study was 5.5 (3.1 - 12.6) hours and the median (range) duration was 
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Table 6.2 Characteristics of the infants included in the study 
 












(23+3 – 27+6) 
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15/29 16/22 5/13 0.18
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 15/23 0/6 0.08
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(8 - 16) 
14 






























Gestational age, birth weight and CRIB II values are presented as median (range). Remaining variables are presented as frequency.  
φ 
Independent samples T-test  
§ 
Mann-Whitney test   
Ω
Chi-square test 
6. OPTIMAL MEAN ARTERIAL BLOOD PRESSURE IN PRETERM INFANTS 
 
164 
The determination of MABPOPT was possible in 44 infants (100%). Worse clinical 
status was associated with more impaired cerebrovascular reactivity, demonstrated by 
the positive correlation between TOHRx and CRIB II score: r = 0.370, P = 0.013. 
TOHRx had negative correlation with gestational age (GA) at birth, r = - 0.304, P = 
0.045.  
The mean (standard deviation) MABPOPT was 31.3 (4.7) mmHg. MABPOPT 
increased with increasing gestational age, r = 0.424, P=0.004 (Figure 6.10). 




Mean MABPOPT within the first 24 hours of life for each individual infant and gestational age in weeks.  
 
Association between MABPOPT and outcome 
The deviation below MABPOPT was higher in the group of infants who developed 
IVH as shown in Figure 6.11.  
 
 




Figure 6.11 Association between deviation below MABPOPT and IVH 
 
 
Median (Interquartile Range) deviation below MABPOPT was 1.3 (1.8) for ‘no-IVH’ group and 2.4 (2.4) 
for ‘IVH’ group. P = 0.006 (N = 44). Mann-Whitney test.  
 
The deviation below MABPOPT was significant higher in infants who died compared 
to those who survived (P = 0.015) (Figure 6.12).  
Figure 6.12 Association between deviation below MABPOPT and mortality 
 
 
Median (Interquartile Range) for those who survived was 1.6 (1.7) and for those who died was 3.1 
(3.8), P = 0.015 (N = 44). Mann-Whitney test.  
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The median deviation above MABPOPT was higher in the group of infants who did not 
develop IVH: median (range) 1.8 (0.10 – 3.5) for those infants who did not have IVH 
was 1.08 (1.37) and for those who developed IVH was 1.2 (0.33 – 3.7), P = 0.026
φ
. 




The differences between mean MABP and mean MABPOPT between infants who 
developed IVH and did not develop IVH are shown in Table 6.3. There was no 
difference between mean MABP or mean MABPOPT between infants who died and 
survived (P = 0.27
 φ 
and P = 0.34
§
, respectively).  
 

















30 (24 – 48) 33 (27 –39) 0.016
§ 
φ
 Independent samples T-test. 
§
Mann-Whitney test.   
 
Relationship between MABPOPT and inotropes 
MABP was lower in infants who were started on inotropes within the first 24 hours of 
life (P = 0.001
§
). Similarly, MABPOPT was lower in infants who received inotropes as 
shown in Figure 6.13.   
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Median (Interquartile Range) for MABPOPT in infants who did not receive inotropes was 32 (6.5) 
mmHg and 27 (6.2) mmHg for those who received inotropes (P = 0.006). Mann-Whitney test.  
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There was no statistically significant difference in mean deviation below and above 
MABPOPT between those infants who received inotropes and did not receive inotropes 
(Table 6.4).  





Median (range)  
P 
Mean Deviation Below 
MABPOPT 
1.9 (0.2 – 6.4) 1.4 (0.15 – 5.3) 0.79
§
 
Mean Deviation Above 
MABPOPT 




 Mann-Whitney test 
φ 
Independent samples T-test 
 
6.2.6. Discussion 
In this study, we used TOHRx to define MABPOPT in a different cohort of preterm 
infants from our previous study. More prolonged periods of continuous NIRS and 
physiological data were analysed, which allowed us to refine our methodology and, 
thus, obtain MABPOPT values for 100% of the infants included in this study. 
MABPOPT was defined in 18.4% more infants compared to our previous study using 
‘RUMBA’ cohort (Chapter 6, section 6.1).  
Only data recorded within the first 24 hours of life were included in the data analysis, 
as the main transitional changes in systemic and cerebral blood flow leading to end 
organ hypoperfusion may occur within the first hours of life. Moreover, fluctuations 
in MABP are usually more dynamic within this period
40, 56, 77
. As described in Chapter 
5, section 5.1, most infants included in the ‘SAMBA’ cohort developed IVH just 
before or after 24 hours of life. Some authors speculate that an IVH that occurs before 
12 hours of age could be related to antenatal or perinatal events, such as infection and 
inflammation, and an IVH that occurs after 12 to 24 hours of age are often related to 
haemodynamic changes such as fluctuations in MABP and impaired cerebral 
vascular-reactivity
77, 249, 326
. Therefore, any associations between deviations from 
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MABPOPT values before 24 hours of age found in our analysis may have a more 
meaningful relationship with the underlying pathophysiology and outcome.  
In this study, we observed that MABPOPT increased with gestational age, following 





. Mean MABP averaged over the first 24 hours of life had no 
correlation with IVH or mortality. Several studies have investigated the correlation 
between MABP and outcome of mortality, brain injury and neurodevelopmental 
outcome. The majority of these studies found no association between hypotension, 
which is usually defined as any value of MABP below the gestational age in weeks, 
and outcome
162, 163, 327
. Dempsey et al. (2009) have suggested that permissive 
hypotension in extreme preterm infants is not associated with poor outcome, as long 
as clinical signs of poor tissue perfusion are absent 
164
. Studies from more than a 
decade ago, such as the work published by Bada et al. (1990), observed that infants 
who developed IVH had larger variability in MABP but only a trend to lower MABP 
within the first 48 hours of life
158
. On the other hand, the work published by Miall-
Allen et al. (1987) showed that infants who had severe IVH and died had lower 
MABP compared to infants with no brain injury or survived
157
. However, these both 
studies defined hypotension as any value of MABP below 30 mmHg and none of 
them correlated MABP with CBF or tissue perfusion
157, 158
.  
In our study, MABPOPT was significantly higher in the ‘IVH group’ compared to ‘no-
IVH group’. Steiner et al. (2002) observed similar relationship in adult patients with 
traumatic brain injury (TBI). CPPOPT was higher in patients with unfavourable 
outcome, defined as death or severe disability. They have speculated that higher 
values of CPPOPT in this group of patients could be related with the severity of the 
brain injury, as PRx was also higher in patients with poor outcome
170
. Burton et al. 
(2015) defined MABPOPT in a group of term infants with HIE undergoing therapeutic 
hypothermia and have also reported higher MABPOPT during rewarming phase in 
infants who developed motor and cognitive impairment
177
. In our cohort, there was no 
difference between TOHRx and the outcome of mortality or IVH. However, 
compared to this study, there is an important difference in both the data collection and 
time of injury in the populations from the studies from Steiner et al. (2002) and 
Burton et al. (2015). The assessment of MABPOPT in patients post TBI, in patients 
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following resuscitation for cardiac arrest and in infants with HIE is based on data 
recorded after the brain injury occurred whereas in our population data were collected 
mainly before the IVH occurred. Nevertheless, the difference in MABPOPT between 
IVH groups in our population could indicate that regulatory vascular mechanism in 
the brain tissue and possible vascular resistance may have already been impaired 
before the haemorrhage started.  
In our previous study, using data from ‘RUMBA’ cohort, we observed that mean 
absolute deviation away from MABPOPT values was higher in infants who died 
compared to those who survived. We also observed that 40% of those infants who 
died had MABP below MABPOPT by at least 4 mmHg (average for the entire 
recording period)
328
. In this new cohort of infants recruited for ‘SAMBA’ we were 
able to more consistently define the direction of the deviation away from optimal 
values. Mean deviation below MABPOPT within the first 24 hours of life was higher in 
infants who died. The association between deviation below CPPOPT and mortality has 
been reported in different studies. In adult and paediatric patients with TBI, 
hypoperfusion was associated with death
168, 170, 172
.  Patients who survived and had a 
good outcome maintained MABP or CPP values close to optimal values. Data on 
mortality from our study should be considered with caution as all infants died beyond 
48 hours of life and the presence of an IVH had no statistical association with 
mortality. Most infants died due to multi-organ failure or complication of necrotizing 
enterocolitis (NEC); pathologies that could be related with early hypotension and 
systemic hypoperfusion (as shown in Chapter 5).  
Deviations below MABPOPT have also been associated with brain injury. In infants 
with HIE undergoing therapeutic hypothermia, higher time and degree of deviation 
below values of MABPOPT was associated with worse injury to white matter
176
. In our 
study, mean deviation below MABPOPT was higher in infants who developed IVH and 
mean deviation above MABPOPT was higher in infants who did not have IVH. In 
contrast, data from our previous study showed that infants with MABP greater than 
MABPOPT by at least 4 mmHg had significantly greater IVH scores. However, the 
main difference between these two cohorts was the age at the start of the data 
collection. In this ‘SAMBA’ cohort only data collected before 24 hours of age were 
analysed, whereas in our previous study (‘RUMBA’ cohort) the majority of the 
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infants had data collected after 24 hours of age (median age at the start of the study 
was 34 hours). It is possible that MABP may increase to levels above MABPOPT just 
before, during and after the IVH occurs, as suggested by the data shown in the ‘Case 
Reviews’. The frequency histogram described in Figure 6.6 show that actual MABP 
was below MABPOPT before the haemorrhage started, but around the approximated 
time when the IVH occurred or it is evolving, the percentage of time of actual MABP 
spent above MABPOPT is greater (mainly data after 24 hours), as shown in Figure 6.8. 
Given that hypoperfusion-reperfusion injury is possibly the main mechanism related 
to development of IVH in preterm infants, the degree of deviations below MABPOPT 
may represent the level of hypoperfusion injury and deviation above could potentially 
represent the hyper-perfusion injury. Moreover, mean TOI was lower in extremely 
preterm infants who developed an IVH (data shown in Chapter 5, section 5.2), 
supporting the idea that low cerebral blood flow and higher degree of hypoperfusion 
is present in those infants who subsequently developed brain injury. However, the 
exact time of bleeding differs from each individual infant, hence, it may be complex 
to associate the magnitude of deviation above MABPOPT with IVH.  
Sick preterm infants show more dynamic variability in MABP and shifts between 
autoregulatory curves compared to more stable infants. The MABPOPT curve in Figure 
6.4 (stable infant) is narrower than the MABPOPT curve shown in Figure 6.6 (unstable 
infant).  
Infants who were started on inotropes had lower mean MABP compared to those who 
did not required any inotropic support. Similarly, MABPOPT was lower in the group of 
infants who received inotropes. No difference in deviations above or below from 
MABPOPT was observed between infants who were started on inotropes and those who 
did not.  
Similar to our previous study, we were unable to use TOx as a marker of cerebral 
autoregulation to define MABPOPT in this cohort. Observing the data pattern, we 
noticed that in the cases where a U-shaped curve was created, the TOx values were 
mainly positive. Preterm infants, especially those born < 28 weeks’ gestational age, 
may possibly be pressure passive within the first 24 hours of age, as shown in Chapter 
5, section 5.2. This may have contributed to the failure in obtaining meaningful 
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MABPOPT curves and correlation between mean MABPOPT and deviations from 
MABPOPT with outcome.  
The relationship between cerebral autoregulation and systolic and diastolic phases of 
the cardiac cycle may be distinct in preterm infants. Some authors have suggested that 
in preterm infants, CBF is passive to diastolic blood pressure or could even reach 
near-zero flow during this phase
329
. Cerebral autoregulation would be more robust 
during the systolic phase of the cardiac cycle, although pressure reactivity to systolic 
and MABP may not be observed until 26 to 28 weeks’ gestation, according to animal 
studies. Giving the fact that extremely preterm infants are mainly pressure passive 
within the first 24 to 48 hours of life, TOHRx may reflect the direct changes in 
cardiac output through changes in HR.  
Limitations 
Although the determination of MABPOPT values were obtained for all infants included 
in this study, the presence of MABPOPT curve was variable during the study and for 
some infants it was present only in a small percentage of the recording time. A similar 
problem has been addressed in studies on CPPOPT in patients with TBI
170, 172
. Low 
MABP variability, impaired cerebral autoregulation and interference with sedative or 
vasoactive drugs have been associated with failure in the method to obtain CPPOPT
330
. 
Recent work published by Weersink et al. (2015) investigated the clinical and 
physiological events that may contribute to failure in obtaining CPPOPT values in a 
group of patients with TBI. They observed that persistent high values of PRx (severe 
impaired cerebral autoregulation) were associated with failure in the method to obtain 
values of CPPOPT in patients with TBI
330
. Consistently positive values of PRx, TOx or 
TOHRx may preclude the existence of a Lassen autoregulation curve and, therefore, 
the determination of MABPOPT. Moreover, the use of dopamine and dobutamine in 
nearly half of our population may have contributed to the failure in obtaining 
consistent values of MABPOPT and the association with outcome. Weersink et al. 
(2015) have also suggested that vasoactive drugs may have an impact on the 
calculation of CPPOPT
330
. To improve the percentage of time we can obtain reliable 
MABPOPT values, recent work published by Liu et al. (2017) has suggested the use of 
multi-window and weighting calculation algorithm for calculation of CPPOPT. By 
using this method, more continuous and stable CPPOPT curves were obtained without 
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Carbon dioxide (CO2) is a vasodilator and a potential confounder in studies assessing 
cerebral autoregulation
92
. In our study, continuous monitoring of transcutaneous CO2 
was attempted; however obtaining reliable values was a challenge. Data on 
transcutaneous CO2 was not acquired for all infants due to technical problems or due 
to fragile skin conditions in the very small and immature infants. Regular arterial 
blood gases were performed and PaCO2 was maintained as stable as possible. Similar 
to our previous study, we cannot exclude an effect of CO2 on our data. It is possible 
that if cerebral vascular reactivity is impaired due to CO2 this may have had an impact 
on the calculation of MABPOPT curves and, thus, contributed to the problem on 
obtaining MABPOPT curves. Future studies should improve the methods to obtain 
reliable CO2 measurements and include them to the methodological model of 
MABPOPT calculation.  
Fluctuations on peripheral blood oxygen saturation (SaO2) could be a confounder 
factor as we used TOI as a surrogate measure of CBF. Moreover, hypoxia is a 
powerful vasodilator. However, major episodes of profound desaturations (SaO2 < 
90%) were removed from the data during manual artefact removal and short periods 
of desaturations did not interfere with the final MABPOPT calculation as observed 

















7. COMPLEXITY OF BRAIN AND SYSTEMIC SIGNALS IN 
PRETERM INFANTS UNDERGOING INTENSIVE CARE  
The results presented in this section have been published in Journal of Cerebral 
Blood Flow and Metabolism
332
. 
7.1. COMPLEXITY OF BRAIN SIGNALS IN PRETERM INFANTS IS 
ASSOCIATED WITH OUTCOME  
7.1.1.  Background 
Biological systems are characterised by complex regulatory mechanisms that interact 
in a non-linear way. Therefore, a non-linear method to assess physiological signals 
may reveal more accurately the magnitude of changes over time. As described in 
Chapter 3, section 3.1.4, Analysis of Entropy has been described as method to 
measure the unpredictability and randomness of a biological system. More recently, 
Multiscale Entropy (MSE) analysis has been used to assess the irregularity and 
complexity of biological time series data.  
7.1.2.  Aims 
The aim of this study was to apply MSE to study the complexity of cerebral NIRS 
signals and the complexity of systemic physiological signals in a cohort of preterm 
infants undergoing intensive care. We further hypothesize that the complexity index 
(CoI) of cerebral NIRS signals and systemic signals, measured using MSE, correlate 
with IVH and mortality in this population.  
7.1.3.  Methods 
This prospective observational study included data from infants recruited for both 
‘RUMBA’ and ‘SAMBA’ cohort. Data recorded within the first 24 hours of life was 




included in the analysis. The recruitment details, ethics, population and pre-




MSE analysis was performed using algorithm published originally by Costa et al
224, 
225
. Briefly, the analysis can be divided into three steps: constructing coarse-grained 
time series, computing sample entropy for each of them, and calculating overall 
complexity
333
. Coarse-grained time series for scale τ is derived from original time 
series by averaging its τ samples in a moving (non-overlapping) window. Thus, time 
series for scale τ is τ times shorter than original time series. Particularly, for scale one 
we get simply original time series. For each coarse-grained time series sample entropy 
was computed. Sample entropy estimates the probability that similar sequences of m 
consecutive points in time series will also be similar when sequences of the length 
m+1 are considered. To be precise, two sequences containing the same number of 
points are considered similar if the absolute differences between their corresponding 
points are smaller than a specified tolerance value r. Sample entropy is calculated as 
the negative natural logarithm of the ratio of the total number of (m+1)-point template 
matches to the total number of corresponding m-point template matches 
223
. Higher 
values of sample entropy indicates that time series is more irregular and less 
predictable. We assumed m = 2 and r = 0.15∙SD where SD denotes standard deviation 
of analysed time series, as originally proposed by Costa et al 
225
.  
MSE was calculated up to scale 20 
224, 226
. It can be presented as a function of scale 
factor (Fig. 2). The area under MSE curve, or in other words the sum of sample 




                                                 
2
The multiscale entropy analysis described in this section was performed by Mr 
Michal Placek.  




7.1.4.  Results 
Sixty-one preterm infants were included in this study. The mean (SD) age at the start 
of the study was 8h (± 5h). Fifty-seven (93%) infants had antenatal steroids and all 
infants were intubated and received surfactant within 10-20 minutes of birth. Thirty-
four (55.7%) had a further one to three doses of surfactant after admission. All infants 
were receiving mechanical ventilation at the start of the study. Demographic data and 
differences between groups are shown in Table 7.1.  
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Table 7.1 Demographic data of enrolled infants  
 
Variable Total 
(N = 61) 
no-IVH 
(N = 41) 
IVH 










(weeks + days) 
26+6 
(23+3 – 31) 
26+6 
(23+4 – 31) 
25+5 






(23+3 – 30+1) 
26 








(525 – 1355) 
805 
(525 – 1355) 
802 





(525 – 1355) 
767 
























CRIB II 11  
(5 – 16) 
10  
(5 – 16) 
12  





(5 – 16) 
12  










































Characteristics of enrolled infants and differences between no-IVH (intraventricular haemorrhage) and IVH groups and between infants who survived and died. Gestational 
age, birth weight and CRIBII (clinical risk index for babies II) are presented as median (range). Gender is presented as absolute numbers. Remaining variables are presented 
as frequencies.  
φ










The median (range) gestational age was 26 weeks + 5 days (23+3 -31); 75% were 
extremely preterm infants (born at less than 28 weeks). Twenty infants (32.8%) 
developed an IVH; six of them had an IVH diagnosed within the first 24 hours of life. 
Of those who developed an IVH, 10 infants had a grade II IVH, 4 had IVH a grade III 
IVH and 6 had a grade IV IVH. Only one infant had minimal bleeding in the germinal 
matrix (small grade I IVH) and, therefore, this infant was included in the non-IVH 
group. Eight infants (13.1%) died before term corrected age of 40 weeks. Seven of 
them were born before 28 weeks of gestational age (extremely preterm infants) and 
one was born at 30 weeks + 2 days, who was a severe in-utero growth restricted 
(IUGR) infant and birth weight of 700g. All infants who died had signs of antenatal or 
perinatal hypoxia, resulting from either: severe IUGR, twin-twin transfusion, cord 
prolapse or profound hypotension and hypoplastic lungs. Four of those infants who 
died (50%) also had an IVH diagnosed. There was no statistical correlation between 
mortality and IVH (P=0.42). 
Examples of monitoring of brain and systemic signals are presented in Figure 7.1A 









Figure 7.1 Monitoring of brain and systemic signals  
 
 
Example of brain and systemic signal monitoring for an infant who died (1A) and survived (1B).  
 
Figure 7.2 shows average MSE plots of HbO2 and Hb for the whole cohort of patients. 
Sample Entropy values were averaged individually for each scale and plotted against 
the scale. This was done separately in groups of those infants who had IVH and did 
not have IVH, as well as those infants who died and survived. It can be observed 
through the lower value of sample entropy at each scale factor, resulting in a decrease 
in overall complexity index, that infants who developed IVH or died had consistently 








Figure 7.2 Multiscale entropy between outcome groups  
 
 
Results are mean ± 1.96 standard error of mean. Oxygenated haemoglobin (HbO2) and deoxygenated 
haemoglobin (Hb) 
 
Association between brain and systemic signals with outcome 
Lower mean CoI-HbO2, CoI-Hb and CoI-TOI were observed in those infants who 
developed IVH compared to those who did not (Table 7.2). However, there was no 
difference in mean CoI-THI between the two groups (Table 7.2). Mean TOI was not 
significantly different between infants who had IVH and those who did not have IVH 
(P=0.38).  
Decreased complexity of brain signals was observed in infants who died. Mean CoI-
HbO2 (Table 7.2), CoI-Hb and CoI-THI were lower in those infants who died 
compared to those who survived (Table 7.2). CoI-TOI just failed to reach statistical 
significance (P=0.057). There was no difference in mean TOI between these two 
groups (P=0.52).  
There was no difference between mean CoI of mean arterial blood pressure (MABP), 
mean CoI-HR and mean CoI-SaO2 between those infants who developed IVH and 




those who did not (Table 7.2). Mean MABP, mean SaO2 and mean HR were not 
different between these two groups (P=0.52, P=0.46 and P=0.91, respectively). In 
contrast, mean CoI-MABP was lower in those infants who died compared to those 
who survived. However, there was no difference in mean CoI-SaO2 or mean CoI-HR 
between these two groups (Table 7.2). There was no difference between MABP, SaO2 
and HR between those infants who survived or died (P=0.79, P=0.38 and P=0.20, 
respectively).  
Complexity of brain signals as an independent predictor of IVH  
Out of all the studied parameters and demographic data only CRIB II (P=0.031), 
sepsis (P=0.025) and CoI-HbO2 (P=0.004) were identified by binary logistic 
regression analysis as predictors of IVH when individual analysis was performed for 
each of these variables (Table 7.2).  Subsequently these variables were entered as co-
variants in a binary logistic regression model. The continuous variables in the model 
met the assumption of linearity and there were no studentized residuals. Of the three-
predictor variables only CoI-HbO2 remained statistically significant, showing that 
decreased complexity was independently associated with an increased likelihood of 
having IVH (Table 7.3 and Table 7.4).  
CoI-HbO2 had no correlation with sepsis (P=0.074) or CRIB II (P=0.138). 
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(3.26 – 7.35) 
 
10.60 





































































(10.305 – 19.722) 
 
21.25 








































Mean and 95% confidence interval for complexity index (CoI) of NIRS and systemic physiological signals. 




Table 7.3 Binary logistic regression for CoI-HbO2, Sepsis and CRIB II as 




















95% CI for Odds 
Ratio 
Lower Upper 
CoI-HbO2 -0.236 0.082 8.286 1 0.004 0.790 0.637 0.928 



















95% CI for Odds 
Ratio 
Lower Upper 
Sepsis 1.574 0.704 4.993 1 0.025 0.207 0.052 0.824 



















95% CI for Odds 
Ratio 
Lower Upper 
CRIB II 0.234 0.108 4.663 1 0.031 1.264 1.022 1.563 
Constant 3.371 1.303 6.692 1 0.010 0.034   
Sepsis is for presence of sepsis compared to no sepsis. CoI-HbO2: complexity index of oxygenated 
haemoglobin; CRIB II: clinical risk index for babies.  
 
Table 7.4 Binary logistic regression for CoI-HbO2, Sepsis and CRIB II as 




















95% CI for Odds 
Ratio 
Lower Upper 
CoI-HbO2 -0.216 0.083 6.706 1 0.010 0.806 0.684 0.949 
CRIB II 0.249 0.144 2.979 1 0.081 0.248 0.967 1.701 
Sepsis -1.395 0.799 3.049 1 0.081 0.248 0.052 1.186 
Sepsis is for presence of sepsis compared to no sepsis. CoI-HbO2: complexity index of oxygenated 
haemoglobin; CRIB II: clinical risk index for babies.  
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Table 7.5 Correlation between complexity index of brain and systemic signals 
 
  CoI-HbO2 CoI-Hb CoI-TOI CoI-THI CoI-SaO2 CoI-MABP CoI-HR 
CoI-HbO2 rs 1.000 .696 .442 .411 .301 .428 .330 
P  .000 .000 .001 .018 .001 .009 
        
CoI-Hb rs .696 1.000 .358 .412 .242 .412 .290 
P .000  .005 .001 .060 .001 .024 
        
CoI-TOI rs .442 .358 1.000 .330 .238 .336 .307 
P .000 .005  .012 .065 .008 .016 
        
CoI-THI rs .411 .412 .330 1.000 .262 .279 .223 
P .001 .001 .012  .049 .035 .096 
        
CoI-SaO2 rs .301 .242 .238 .262 1.000 .351 .270 
P .018 .060 .065 .049  .006 .035 
        
CoI-MABP rs .428 .412 .336 .279 .351 1.000 .681 
P .001 .001 .008 .035 .006  .000 
        
CoI-HR rs .330* .290 .307 .223 .270 .681 1.000 
P .009 .024 .016 .096 .035 .000  
        
rs = Spearman’s rank correlation coefficient. P values are not adjusted for multiple comparisons. * P<0.05 
  




Correlation between complexity of brain signals and indexes of cerebrovascular 
reactivity 
TOHRx had negative correlation with CoI-TOI (rs= -0.353, P=0.005), with CoI-
MABP (rs= -0.378, P=0.003) and CoI-HR (rs= -0.324, P=0.011). In contrast, TOx had 
no significant correlation with complexity of brain signals. TOx had negative 
correlation with CoI-HR (rs = -0.330, P=0.009). TOx had no other significant 
correlation with the complexity of systemic signals.  
7.1.5.  Discussion  
This study is the first to assess the complexity of cerebral NIRS signals in critically ill 
preterm infants. We applied MSE to study the complexity of brain and physiological 
systemic signals in a cohort of preterm infants in the first 24 hours of life. The results 
revealed an association between complexity of brain signals and outcome.  
Several studies have suggested that decreased variability in physiological signals is a 
sign of failure in complex regulatory system. In perinatal medicine, the ‘silent pattern’ 
in fetal ECG is a well-known example of loss of ‘natural’ variability of vital signs and 
has been associated with poor neonatal outcome
334
. However, in clinical practice, 
there is no consensus on which method of intrapartum monitoring is the most 
effective
335
. Moreover, the continuous monitoring of neonatal vital signs does not take 
in consideration the non-stationarity characteristic of the biological signals. Entropy 
analysis has been extensively studied to investigate physiological systems. According 
to the ‘decomplexification’ theory of illness, loss of complexity is usually associated 
with pathological states like diseases or ageing. However, despite being an old 
concept, assessment of complexity of physiological signals in the neonatal unit is not 
performed routinely. Moreover, clinicians persist to correlate lack of variability as a 
sign of clinical stability. In our study, decreased complexity of brain signals was 
observed in those infants who developed IVH and who died, supporting the 
‘decomplexification’ theory
219, 336
. MSE of HbO2 and Hb were consistently lower in 
all scale factors for groups of infants with IVH compared to those who did not have 
IVH, and for groups of infants who died compared to those who survived. These 
results are similar to recently published work using MSE to investigate the association 




between complexity of EEG and neurological outcome in a cohort of term infants 
with refractory neonatal seizures
26
. Lower values of MSE were observed in most 
scales in the group of infants who later developed epilepsy, compared to normal 
controls, and to those who did not develop epilepsy. In adults with traumatic brain 
injury, a decrease in entropy of ICP signals across all MSE scales was observed 
during the development of intracranial hypertension and loss of cerebrovascular 
reactivity. In this cohort, the CoI was significantly lower in those patients who had 
moderate and severe disability compared to those who had good outcome 
226
.  
High complexity reflects strong, non-linear interactions between different healthy 
control systems responding to transient stressors or adapting to changes in the 
environment. The impairment of those regulatory mechanisms or the breakdown in 
their interactions is characterized by low complexity of various relevant physiological 
measurements. This may manifest itself in the total breakdown of (auto and cross) 
correlations of the measured signals (e.g. instantaneous change in heart rate in atrial 
fibrillation) or patterns that are overly regular and deterministic in nature (e.g. flat 
heart rate dynamic seen in chronic heart failure)
216, 337
. Assuming that the impairment 
of certain physiological control systems occurs before the onset of clinical symptoms 
of the developing pathology, or even assuming that such impairment could be the 
potential cause of diseases, a decrease in complexity could serve as an alert of 
complications like sepsis or poor outcome 
226, 338
. In our study, complexity of HbO2 
was an independent predictor of IVH and decreased complexity of brain signals 
within the first 24 hours of life was observed in those infants who died later during 
admission, suggesting that the loss of interaction between control systems may be 
present even before the occurrence of brain injury and death. This could potentially, 
from early hours of life, divide those infants who are at more risk of poor outcome to 
those who are more likely to have less morbidity. While the ultimate goal of early 
analysis of physiological signals would be to identify the ‘high risk’ infants and 
develop therapies to prevent IVH and death, identifying those who are ‘healthy’ could 
help clinicians to be less invasive and differentiate between normal physiological to 
pathological adaptation.  
 




The lower complexity of HbO2, Hb and TOI in those infants who developed IVH may 
reflect, at least partially, the underlining loss of cerebrovascular reactivity that 
precedes the occurrence of IVH, as most infants developed IVH after the first 24 
hours of life. Changes in cerebrovascular reactivity and loss of autoregulation within 
the first hours of life have been associated with the incidence of IVH in preterm 
infants
76, 78, 80
. Several studies have shown that cerebral hypo-perfusion is associated 
with the pathophysiology of IVH and death
145, 146
. In our study, most infants who died 
were extremely preterm and all of them had some degree of either antenatal or early 
postnatal hypo-perfusion or hypoxia. Even those infants who died due to NEC or 
sepsis were severely sick within the first days of life. Decreased oxygenation has been 
associated with death as shown in a large cohort of infants included in the BOOST-II 
trial. In this study, infants with lower oxygen saturation target had higher rate of NEC 
requiring surgery or causing death
339
. In our cohort, target SaO2 was kept the same 
(between 91%-95%) in all groups and there was no difference between mean SaO2 
and CoI-SaO2 between those infants who died or survived or between those who 
developed IVH and who did not. However, cerebral hypo-perfusion and loss of 
cerebrovascular reactivity and may be associated with reduced complexity of cerebral 
NIRS signals. This hypothesis should be tested in a larger cohort where other factors 
related with changes in cerebral blood flow, like PaCO2, are also taken into 
consideration.  
In adults, early assessment of complexity of HR and HRV measured by MSE has 
been used to predict outcome in patients with traumatic brain injury and acute stroke 
218, 340
. In neonates, early monitoring of systemic blood flow and cerebral oxygenation 
has been used to understand the pathophysiology of brain injury in preterm infants 
56, 
73, 145, 341
. Although the incidence of severe IVH and mortality in this population has 
decreased in the last 20 years, with improved survival, the prevalence remains high, 
as does the degree of disability and morbidity in survivors 
9
. Preterm infants who 
develop IVH are at risk of higher morbidity during the neonatal period and later in 
childhood, including the development of post-haemorrhagic ventriculomegaly, 
recurrent hospital admissions and mortality. In addition, they may present long-term 
neurodevelopment and cognitive delays, resulting in increased workload for the health 
and educational services 
4, 7
. Studies using cerebral NIRS have attempted to define 




limits of cerebral autoregulation and thresholds of cerebral oxygenation, in order to 
prevent the occurrence of IVH and improve outcome 
137, 141, 210
. However, there is no 
established threshold of cerebral perfusion and the continuous assessment of 
cerebrovascular reactivity and oxygenation has not yet been proved to change the 
outcome of preterm infants. In this context, the analysis of complexity of cerebral 
NIRS signals may offer a new approach - perhaps an alternative if not a 
complementary one to the cerebrovascular reactivity assessment - in order to 
understand the physiological mechanisms involved in the developing brain and to 
identify those infants who are more likely to be severely sick or even die during the 
neonatal period.  
Complexity of brain signals demonstrated stronger association with outcome than 
complexity of systemic signals. In our study the complexity of MABP was the only 
complexity of systemic physiological signals that correlated with outcome. Decreased 
complexity of MABP was associated with mortality but not with IVH. In clinical 
practice, the assessment of organ perfusion in preterm infants still relies on indirect 
measures of systemic blood flow, such as MABP. In adults, the regulation of cerebral 
perfusion is independent of systemic perfusion. The healthy adult brain has 
mechanisms that protect its tissue against ischaemic damage. The complexity of 
cerebral NIRS signals may represent a more direct measure of cerebral perfusion and 
regulation of blood flow than the complexity of systemic signals. On the other hand, 
the positive correlation between complexity of systemic and brain signals may 
suggest that factors associated with loss of cerebral and systemic regulatory 
mechanisms are related to each other. Further studies are needed to explore the 
significance of this relationship. Nevertheless, our findings support the idea that the 
monitoring of brain signals in addition to systemic signals would provide more 
comprehensive grounds for understanding the physiological mechanisms related to 
mortality and brain injury in preterm infants. 
Limitations   
MSE analysis requires a large data set to be able to estimate complexity in a plausible 
way. The minimum number of samples from time series that allows reasonable MSE 
calculation rises with the number of scales. It can be estimated that at least 2000 data 




samples are required to perform analysis up to scale twenty 
342
. In our study, the 
analysed time series had one sample every 10 seconds, so at least a 6-hour long 
monitoring period was required to produce meaningful values. Furthermore, MSE 
analysis is relatively sensitive to outliers and artefacts. Removing a small percentage 
of them is allowed, however, if the structure of time series is grossly altered due to 
artefact removal, the value of entropy may also change 
225
. The amount of data 
containing artefacts from our cohort was small, but the artefacts were manually and 
retrospectively removed. Real-time bedside analysis would require appropriate 
automatic artefacts detection and removal as well as a criterion for automatic rejection 
of data segments with too high artefacts content.  
Our results of the mortality analysis have to be treated with some caution. Although 
the association between complexity and mortality was significant, we acknowledge 
that our sample was small and unbalanced, as only eight infants died. Moreover, most 
infants in our cohort died later during the neonatal period due to factors which were 
not necessarily directly related to changes in cerebral perfusion within the first days of 
life, as sepsis and NEC. However, all infants who died had signs of antenatal or 
perinatal hypoxia and remained very sick throughout the neonatal admission. Further 
studies with a larger sample size should be conducted, in order to understand the 
factors associated with decreased complexity of brain signals in sick preterm infants. 
However, early recruitment should be taken in consideration to better understand the 
pathophysiology of brain injury. We aimed to recruit infants before 12 hours of age, 
but this may have contributed to our limited our sample size, in view of the challenges 
of getting informed consent from parents soon after the delivery of a sick preterm 
infant.  




8. CARDIAC FUNCTION DURING THE EARLY 
TRANSITIONAL CIRCULATION IN PRETERM INFANTS  
8.1. CHANGES IN SYSTEMIC BLOOD FLOW, CEREBRAL OXYGENATION, 
CEREBROVASCULAR REACTIVITY AND DUCTAL PATENCY WITHIN 
THE FIRST 48 HOURS OF LIFE  
8.1.1. Background 
Preterm infants are at an increased risk to develop low systemic blood flow and poor 
cerebral oxygenation within the first hours following birth, as described in Chapter 2. 
Functional echocardiography has been used as a clinical and research tool to assess 
changes systemic blood flow during the transitional circulation in preterm infants. 
Measurements of cardiac output, SVC flow and ductal patency have been used to 
guide clinicians on the management of sick infants, as seen in Chapter 3, section 3.2. 
However, the correlation between measurements of functional echocardiography and 
cerebral blood flow and oxygenation remains controversial.  
8.1.2. Aims 
The aims of this study were:  
1) To describe the measurements of systemic blood flow and cerebral 
oxygenation in a cohort of preterm infants born < 32 weeks within the first 48 
hours of life and the relationship of these measurements with outcome of IVH.  
2)  To investigate the correlation between systemic blood flow and cerebral 
oxygenation measurements.   
3) To investigate the difference in the pattern of changes in systemic blood flow 
and cerebral oxygenation between infants who had and did not have IVH. 




4) To describe PDA measurements during early transitional circulation in sick 
preterm infants and the relationship between these measurements with 
outcome, and to further investigate the relationship between a 
haemodynamically significant PDA and measurements of cerebral 
oxygenation and cerebrovascular reactivity.  
8.1.3. Methods 
This prospective observational study included preterm infants who were recruited to 
the ‘SAMBA’ cohort only, as these were the only infants who had functional 
echocardiography after birth. The recruitment details, ethics, population and pre-
processing data analysis were described in Chapter 4. 
The echocardiographic images and measurements included in this study were 
described in Chapter 4, section 4.3.3. Measurements of LVO, RVO, SVC and PDA 
were included in the data analysis. The following NIRS signals were included: TOI, 
TOEF, TOx and TOHRx. NIRS signals were calculated as described in Chapter 4, 
section 4.3.1 and section 4.4.1. All NIRS signals were averaged over 45-60 minutes 
before or before and around the time when echocardiography studies were performed 
in order to avoid artefacts due to handling or confounders, such as fluid boluses or 
changes in inotrope/vasopressor infusions.  
PDA measurements were considered haemodynamically significant (hsPDA) 
according to two different criteria:  
 PDA 2D size > 1.5 mm  or 
 PDA > 1.5 mm AND LA:Ao ratio > 1.4 or LPA EDF velocity > 2 m/sec or 
presence of reversal EDF in the post-ductal aorta (Ao) 
Data distribution was assessed for normality using Shapiro-Wilk test before each 
statistical test was performed. Independent-samples t-Test (φ) or Mann-Whitney U 
test (§) were used to investigate the association between mean values of cardiac 
output and PDA measurements, and mean values of NIRS signals with outcome. Chi-
square test (Ω) was used to compare groups with dichotomous variables. Pearson 




correlation coefficient (r) or Spearman correlation (r2) was used to assess the 
relationship between functional echocardiographic measurement and NIRS signals. 
ANOVA with Bonferroni correction (δ) and Kruskall-Wallis test (ω) were applied for 
multiple comparisons between mean values of systemic blood flow and cerebral 
oxygenation between time intervals.  
To provide prediction models for the differentiation between patients with and 
without IVH concerning pattern of changes across measurements, the relationships 
between the variables of interest and the different measurement time points were 
expressed as linear mixed effects models (R package lme4). As fixed effects, we 
entered the variable of interest and the patient group (condition status: IVH and no-
IVH) into the model. As random effects, we had intercepts for the repeated 
measurement points for each patient. The chi-square and the P-values for comparison 
of the models were obtained by likelihood ratio tests of the full model with random 
intercepts against the null model without random intercepts.
3
 
8.1.4. Results  
General characteristic of the enrolled infants and outcome data  
Echocardiographic measurements were performed in 50 infants included in the 
‘SAMBA’ cohort. Cardiac data from two infants were excluded from the analysis 
because they were diagnosed with cardiac malformations that could affect flow 
measurements: one infant had a VSD and another had a double SVC. Two infants had 
normal cardiac morphology within the first 48 hours of life, but developed valve 
complications later during their neonatal admission: one infant developed aortic 
stenosis with left ventricle hypertrophy (diagnosed on day 37 of life), and the other 
infant developed severe pulmonary valve stenosis requiring vavuloplasty. One infant 
had hypertrophic heart and developed pericardium effusion after 24 hours of life, 
                                                 
3
The linear mixed model analysis described in this chapter was performed in 
collaboration with Dr Danilo Cardim.  




therefore data from the 48 hours scan were excluded from the analysis. Four infants 
were diagnosed with PPHN requiring nitric oxide (NO). Nineteen infants did not have 
echocardiographic measurements at 6 hours of age because the study started around 
12 hours of age. Nine infants did not have echocardiographic measurements at 12, 24 
or 48 hours either due to clinical deterioration at the time of the scan or because I was 
not available to perform the scans.  
Table 8.1 Demographic data of all infants that had echocardiographic 
measurements and were included in the data analysis 
 
Variable Total = 48 
Gestational age (weeks + days) 25+5 (23+3 – 31) 
Birth weight (grams) 755 (520 – 1350) 
Male/Female 15:33 
Apgar score at 5 min 7 (1 – 9) 
CRIB II 12 (5 – 16) 
Antenatal steroids 100% 
MgSO4 12 (25%) 
Vaginal delivery 26 (54.2%) 
Inotropes 26 (54.2%) 
NO for PPROM/PPHN 4 (8.3%) 
PDA treatment 17 (35.4%) 
Sepsis 29 (60.4%) 
Confirmed NEC 13 (27.1%) 
CLD 24 (50%) 
Laser for ROP 4 (8.3%) 
IVH 16 (33.3%) 
Mortality 7 (14.6%) 
Gestational age, birth weight, Apgar score and CRIB II score are presented as median (range). The 
remaining variables are presented as frequency. NO: nitric oxide. PPROM: premature prolonged 
rupture of membranes. PPHN: persistent pulmonary hypertension of the newborn.  NEC: necrotizing 
enterocolitis. CLD: chronic lung disease. ROP: retinopathy of prematurity.   
 




Seven infants died before 40 weeks corrected gestational age. These infants died due 
multi-organ failure due to complications of extreme prematurity, fulminant NEC and 
sepsis (as described in Chapter 5, section 5.1.4). None of the infants died before 48 
hours of age.  
Sixteen infants developed IVH; eight of them were classified as severe IVH (grade III 
or IV).  
Seventeen (35%) infants received treatment for their PDA with either ibuprofen (N = 
17) or paracetamol (N = 4). Two infants had their PDA surgically ligated: one of them 
had surgery at 63 days of life and had not received treatment with medication prior to 
ligation, the other infant had a PDA ligation at 28 days of life and had previously 
received treatment with paracetamol. The median (range) age at the start of PDA 
treatment was 13 (2 – 63) days old. Only one infant received treatment during the 
study (around 36 hours of life). This infant received an incomplete course of 
ibuprofen in view of clinical deterioration and died just after 48 hours of life.  
 
Measurements of systemic blood flow and cerebral oxygenation within the first 
48 hours of life and their correlation with IVH 
Mean left and right cardiac outputs and SVC flow increased over the first 48 hours as 
shown in Table 8.2.   
Mean LVO, RVO and SVC was not statistically different between infants who 
developed or did not develop IVH as shown in Table 8.3.    
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SVC (ml/Kg/min) 80 (±38) 
 















One-way ANOVA with post-hoc analysis (Bonferroni) showed difference between mean LVO at 6h and 24h (P=0.004), 6h and 48h (P<0.001), 12h and 24h (P=0.002) and 
12h and 48h (P<0.001). There was no difference between mean LVO at 6h and 12h (P=0.99) or between 24h and 48h (P=0.49). Post-hoc analysis (Bonferroni) showed 
difference between mean RVO at 6h and 24h (P<0.001), 6h and 48h (P<0.001), 12h and 24h (P=0.003), 12h and 48h (P<0.001). There was no difference between mean RVO 
at 6h and 12h (P=0.63) and 24h and 48h (P=0.89). Post-hoc analysis (Bonferroni) showed difference between mean SVC at 6h and 48h (P=0.013) only. There was no 
difference between 6h and 12h (P=0.99), 6h and 24h (P=0.060), 12h and 24h (P=0.40) and 24h and 48h (P=0.99).  
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Table 8.3 Systemic blood flow, cerebral oxygenation and indices of cerebral autoregulation, cerebrovascular reactivity and IVH groups 
Measurement 6h (mean and 95% CI)  
P 
12h (mean and 95% CI)  
P 
24h (mean and 95% CI)  
P 












IVH      
(N=15) 























































































































































































(-.14 –  +.05) 
-.11 




(-.10 – +.01) 
-.0.05 




(-.07 – 0.2) 
0.15 
(-.08 – 0.11) 
0.98 -.032 
(-.07 – +.07) 
0.15 
(-.07 –  +.11) 
0.23
§ 
§ Mann-Whitney test    φ Independent samples T-test 




Correlation between cerebral oxygenation and systemic blood flow 
Using all data point measurements (N = 154), there was no correlation between LVO 
and TOI. There was a trend towards a positive correlation between SVC and TOI and 
a weak statistically significant correlation between RVO and TOI as shown in Table 
8.4. Indices of cerebral autoregulation and cerebrovascular reactivity had no 
correlation with LVO, RVO or SVC (Table 8.4).  
Table 8.4 Correlation between systemic blood flow and cerebral oxygenation 
 
  TOI TOEF TOx TOHRx 
LVO 
(mL/kg/min) 
r 0.034 -0.096 -0.078 0.081 
P 0.68 0.25 0.34 0.32 
     
RVO 
(mL/kg/min) 
rs 0.194 -0.227 0.013 0.009 
P 0.019 0.006 0.87 0.91 
     
SVC 
(mL/kg/min) 
rs 0.163 -0.171 0.005 0.121 
P 0.054 0.043 0.96 0.15 
     
All measurements included (N = 156). r for Pearson correlation-coefficient. rs for Spearman’s 
correlation.  
 
A strong positive correlation between LVO and RVO was observed when all 
measurements were included (r = 0.77, P < 0.0001). Using only measurements when a 
non-haemodynamically significant PDA (< 1.5 mm) was present, a stronger positive 
correlation was observed (r = 0.92, P < 0.0001). A positive correlation between LVO 
and SVC was observed when all measurements were included (r = 0.56, P < 0.0001), 
and remained positive when only measurements with a PDA < 1.5 were included (r = 
0.556, P < 0.0001). All these results are in line with the published literature regarding 
left and right cardiac outputs and SVC flow measurements discussed in Chapter 3, 








Pattern of changes in systemic blood flow and cerebral oxygenation in infants 
with and without IVH 
Although no difference in mean LVO, RVO and SVC was observed between infants 
who had and did not have an IVH, we investigated whether the patterns of changes in 
cardiac output and SVC flow over the first 48 hours would be different between these 
two groups. Reviewing the clinical data, we considered that for four infants who 
received NO for PPHN and the only infant with a hypertrophic myocardium do not 
reflect the “normal” transitional physiology for preterm infants, and therefore these 
infants were excluded from the analysis of changes in patterns between groups.  
Following the removal of those five infants, LVO, RVO and SVC increased over time 
with similar mean values and statistical significance as the analysis for the entire 
cohort, as shown in Table 8.5.  The difference in mean LVO, RVO and SVC between 
infants who developed and did not develop an IVH remained non-significant.  
1) Changes in LVO between IVH groups 
The Figure 8.1 shows the mean LVO for each time interval for the IVH and no-IVH 
groups. Infants who did no develop an IVH had a statistically significant increase in 
mean LVO over the first 48 hours of life (P < 0.001
δ
). The pattern of increase in mean 
LVO shows a more steady increase compared to infants who developed an IVH. 
Although the mean LVO appears lower at 12h and higher at 24h in the IVH group 
compared to no-IVH group in Figure 8.1, there was no significant statistical 
difference between groups (P = 0.27
 δ
).  
Using mixed model analysis to compare the pattern of change in LVO between 
infants who had and did not have IVH, no significant difference was observed (P = 
0.66) for full model analysis.   
 
 




Figure 8.1 Changes in mean LVO between IVH groups within first 48 hours of 
life 
 
Data are shown as mean and 95% confidence interval.  There was no difference in mean LVO at 6h (P 
= 0.17
φ
), 12h (P = 0.27
φ
), 24h (P = 0.58
φ
) and 48h (P = 0.28
φ
) between IVH and no-IVH groups. 
φ
Independent samples t-test.  
 
 
Table 8.5 Mean LVO within the first 48 hours of life in the total cohort and in 
the IVH and no-IVH groups 
 
  6h  
mean  (SD) 
(range) 
12h  
mean  (SD) 
(range) 
24h  
mean  (SD) 
(range) 
48h  






(70 – 505) 
256 (±76) 
(113 – 403) 
335 (±85) 
(186 – 560) 
361 (±92) 




no-IVH  LVO 
(mL/Kg/min) 
240 (±83) 
(70 – 379) 
265 (±70) 
(132 – 402) 
330 (±82) 
(186 – 519) 
350 (±96) 









(130 – 505) 
235 (±88) 
(113 – 380) 
346 (±95) 
(187 – 560) 
388 (±81) 





One-way ANOVA with post-hoc analysis (Bonferroni) showed difference in mean LVO 




One-way ANOVA with post-hoc analysis (Bonferroni) showed difference in mean LVO 




One-way ANOVA with post-hoc analysis (Bonferroni) showed difference in mean LVO 
between 12h and 24h (P = 0.048), 12h and 48h (P = 0.006).  
SD is for standard deviation 




2) Changes in RVO between IVH groups 
The Figure 8.2 shows the mean RVO for each time interval for IVH and no-IVH 
groups. The pattern of change in mean RVO was similar in both groups. The mean 
RVO increased over the first 48 hours in the no-IVH group but no statistical 
significant increase was observed in the IVH group (Table 8.6). Using mixed model 
analysis, the patterns of change in RVO between IVH groups showed no statistical 
difference (P = 0.71) for full model analysis.  
 




Data are shown as mean and 95% confidence interval.  There was no difference in mean RVO at 6h (P 
= 0.69
φ
), 12h (P = 0.68
φ
), 24h (P = 0.43
φ
) and 48h (P = 0.39
φ
) between IVH groups.  
φ











Table 8.6 Mean RVO within the first 48 hours of life in the total cohort and in 





mean  (SD) 
(range) 
12h  
mean  (SD) 
(range) 
24h  
mean  (SD) 
(range) 
48h  






(61 – 330) 
213 (±77) 
(93 – 380) 
270 (±73) 
(142 – 409) 
280 (±69) 




no-IVH  RVO 
(mL/Kg/min) 
198 (±72) 
(61 - 330) 
217 (±70) 
(116 – 347) 
277 (±68) 
(173 – 409) 
286 (±59) 









(90 – 253) 
205 (±97) 
(93 – 380) 
257 (±85) 
(142 – 409) 
264 (±91) 





One-way ANOVA with post-hoc analysis (Bonferroni) showed difference in mean RVO 
between 6h and 24h (P = 0.001), 12h and 48h (P<0.001), 12h and 24h (P = 0.005) and 12h and 48h (P 
= 0.001).  
No-IVH: 
δ
One-way ANOVA with post-hoc analysis (Bonferroni) showed difference in mean RVO 




One-way ANOVA with post-hoc analysis (Bonferroni) showed no difference in mean RVO 
between intervals.   
SD is for standard deviation 
 
3) Changes in SVC flow between IVH groups 
Figure 8.3 shows the mean SVC for each time interval for IVH and no-IVH groups. 
The mean SVC in the no-IVH group had a steadily significant increase over the first 
48 hours. Visually the pattern of change in the mean SVC over the first 48 hours was 
different for those who developed IVH, but the mixed model analysis showed no 
statistical difference between the patterns of changed in the mean SVC between these 













Data are shown as mean and 95% confidence interval.  There was no difference in mean SVC at 6h (P 
= 0.58
φ
), 12h (P = 0.94
§
), 24h (P = 0.69
φ
) and 48h (P = 0.17
φ
) between IVH groups.  
φ




Table 8.7 Mean SVC within the first 48 hours of life in the total cohort and in the 





mean  (SD) 
(range) 
12h  
mean  (SD) 
(range) 
24h  
mean  (SD) 
(range) 
48h  






(18 – 163) 
94 (±45) 
(22 – 189) 
107 (±34) 
(44 – 183) 
112 (±40) 









(18 - 162) 
93 (±35) 













(55 – 152) 
97 (±63) 
(22 – 175) 
110 (±33) 
(71 – 183) 
98 (±32) 






One-way ANOVA with post-hoc analysis (Bonferroni) showed no difference in mean RVO 
between time intervals.  
No-IVH: 
δ
One-way ANOVA with post-hoc analysis (Bonferroni) showed difference in mean LVO 
between 6h and 48h (P = 0.038) only.  
IVH: 
δ
One-way ANOVA with post-hoc analysis (Bonferroni) showed no difference in mean LVO 
between intervals. 
 




4) Changes in TOI and TOEF between IVH groups 
Mean TOI was significantly lower at 12, 24 and 48 hours in the IVH group compared 
to the no-IVH group, and mean TOEF was significantly higher between these two 
groups in those same time intervals (Figure 8.4 and Figure 8.5). The mean TOI and 
mean TOEF did not have a statistically significant increase or decrease over the first 
hours of life in either the IVH or no-IVH groups (Table 8.8 and Table 8.9). However, 
the mixed model analysis showed that patterns of change in TOI between these two 
groups were statistically different (P < 0.001) for full model analysis, but the 
difference in the pattern of changes in TOEF between groups did not reach statistical 
significance (P = 0.066), for full model analysis.  
 




Data are shown as mean and 95% confidence interval.  Mean TOI at 12h, 24h and 48h was 
significantly lower in the IVH group (P = 0.011
φ
, P = 0.002
φ
, P = 0.001
φ
, respectively). There was no 













Table 8.8 Mean TOI within the first 48 hours of life in the total cohort and in the 





mean  (SD) 
(range) 
12h  
mean  (SD) 
(range) 
24h  
mean  (SD) 
(range) 
48h  






(58 – 92) 
71 (±7.7) 
(56 – 88) 
71 (±5.8) 
(61 – 84) 
72 (±6) 




no-IVH  TOI 
(mL/Kg/min) 
70 (±7.8) 
(62 – 92) 
73 (±7) 
(61 – 88) 
73 (±5) 
(64 – 84) 
73 (±5.8) 









(58 – 78) 
66 (±7.6) 
(56 – 80) 
67 (±5.4) 
(61 – 78) 
67 (±3.8) 






One-way ANOVA with post-hoc analysis (Bonferroni) showed no difference in mean TOI 
between time intervals.  
No-IVH: 
δ
One-way ANOVA with post-hoc analysis (Bonferroni) showed no difference in mean TOI 
between time intervals.  
IVH: 
δ
One-way ANOVA with post-hoc analysis (Bonferroni) showed no difference in mean TOI 
between time intervals. 
 
 




Data are shown as mean and 95% confidence interval.  Mean TOEF was significantly lower at 12h, 
24h and 48h in the IVH group (P = 0.015
φ
, P = 0.07
φ
 and P = 0.009
 φ
, respectively). There was no 




Independent samples t-test. 
§
Mann-Whitney test  




Table 8.9 Mean TOEF within the first 48 hours of life in the total cohort and in 





mean  (SD) 
(range) 
12h  
mean  (SD) 
(range) 
24h  
mean  (SD) 
(range) 
48h  






(0.1 – 0.38) 
0.24 (±0.08) 
(0.05 – 0.42) 
0.24 (±0.06) 
(0.08 – 0.34) 
0.24 (±0.07) 




no-IVH  TOEF 
(mL/Kg/min) 
0.27 (±0.07) 
(0.1 – 0.34) 
0.22 (±0.07) 
(0.05 – 0.34) 
0.22 (±0.06) 
(0.08 – 0.33) 
0.22 (±0.07) 









(0.18 – 0.39) 
0.30 (±0.08) 
(0.15 – 0.42) 
0.28 (±0.06) 
(0.17 – 0.35) 
0.29 (±0.03) 






One-way ANOVA with post-hoc analysis (Bonferroni) showed no difference in mean TOEF 
between time intervals.  
No-IVH: 
δ
One-way ANOVA with post-hoc analysis (Bonferroni) showed no difference in mean TOEF 
between time intervals.  
IVH: 
δ
One-way ANOVA with post-hoc analysis (Bonferroni) showed no difference in mean TOEF 
between time intervals 
 
Mean TOx and mean TOHRx had no significant change within the first 48 hours of 
life (P = 0.94
δ
 and P = 0.62
δ
, respectively) for the full cohort. Mean TOx and mean 
TOHRx had no difference within the first 48 hours in the no-IVH group (P = 0.65
δ
 
and P = 0.87
δ
, respectively) or in the IVH group (P = 0.54
δ
 and P = 0.61
ω
). Mixed 
model analysis showed no difference between patterns of changes in TOx (P = 0.57) 











Correlation between systemic and cerebral blood for each time interval  
In order to understand the relationship between systemic blood flow and cerebral 
oxygenation during the transitional circulation we analysed the correlation between 
LVO, RVO and SVC with TOI, TOx and TOHRx for each time interval for the total 
group and for each individual IVH groups independently. A strong positive 
correlation between systemic and cerebral oxygenation was observed at 24 hours of 
age in the IVH group only. A negative significant correlation between TOx and LVO 
was observed, showing that the lower the systemic blood flow, the more impaired was 
cerebral autoregulation (Table 8.10). No other correlations between systemic blood 
flow and cerebral oxygenation or cerebrovascular reactivity were observed in any 
other time intervals in infants in either IVH groups.  
Table 8.10 Correlation between systemic and cerebral blood flow at 24 hours of 
age for infants who developed IVH 
 
  TOI TOx TOHRx TOEF 
LVO 
(mL/kg/min) 
r 0.750 -0.570 -0.022 -0.802 
P 0.003 0.042 0.94 0.001 
     
RVO 
(mL/kg/min) 
rs 0.703 -0.358 -0.110 -0.746 
P 0.007 0.23 0.72 0.003 
     
SVC 
(mL/kg/min) 
rs 0.217 -0.498 0.107 -0.258 
P 0.48 0.084 0.73 0.40 
     
Pearson coefficient-correlation (r), Spearman rank (rs).   
 
PDA measurements within the first 48 hours of life and the relationship between 
a haemodynamically significant PDA and cerebral oxygenation 
Table 8.11 shows the characteristics of the PDA measurements at 6, 12, 24 and 48 
hours. Overall, 105 (68.2%) of all PDA measurements were above 1.5 mm. PDA size 
did not significantly increase over the first 48 hours of life, but other measurements of 
haemodynamic significance, such as presence of reversed end diastolic flow (EDF) on 
the post ductal aorta (Ao), LA:Ao ratio and end diastolic flow velocity on LPA (LPA 
EDF vel), increased over time. By 48h of life, the flow pattern changed to 
bidirectional with mainly left-to-right flow or pulsatile. In our cohort, only a small 




number of infants had a constricting or closing PDA.  
The mean LVO was significantly higher when the PDA was above 1.5 mm. 
Measurements of haemodynamic significance, such as ‘Ao’, increased ‘LA:Ao ratio’ 
and ‘LPA EDF vel’ were higher when the PDA > 1.5 mm. There was no difference in 
the mean TOI, TOEF, TOx or TOHRx between a PDA greater or less than 1.5 mm 
using all measurement (N = 156) (Table 8.12).  
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Table 8.11 PDA measurements for each time interval  









PDA 2D diameter 1.75 (0.95-3.8) 1.7 (1 – 3.3) 1.75 (1.1-3) 1.8 (1 – 3.23) 0.19
ω
 
PDA Doppler diameter 2.03 (1.3-1.8) 1.88 (1.05-3.6) 1.8 (1.1-3.9) 2.3 (1.12 -4.4) 0.21
ω
 
PDA > 1.5 mm 22 (81%) 23 (56%) 31 (69%) 29 (71%) 0.16
 Ω
 
Constricting Flow/ No flow 1 (3.7%) 7 (17.1%) 6 (13.3%) 8 (19.5%) 0.34
 Ω
 
Pulmonary Hypertension type 12 (44.4%) 4 (9.8%) 3 (6.7%) 0 (0%) <0.001
Ω
 
Growing 6 (22.2%) 15 (36.6%) 11 (24.4%) 13 (31.7%) 0.51
Ω
 
Pulsatile 8 (29.6%) 15 (36.6%) 25 (55.6%) 20 (48.8%) 0.11
Ω
 
Ao 2 (7.4%) 4 (9.8%) 9 (20%) 19 (47.5%) <0.001
Ω
 
LA:Ao ratio 1.33 (0.83-1.75) 1.3 (0.81-1.86) 1.48 (0.82-1.94) 1.42 (0.83-2.26) 0.023
 ω
 
LPA EDF vel (m/sec) 0.12 (0.03-0.05) 0.08 (0.03-0.25) 0.14 (0.04-0.41) 0.17 (0.01-0.56) 0.001
 ω
 







Kruskall-Wallis test. Ao is for ‘presence of reversal flow in the post-ductal aorta. LA:Ao ratio is for left atrium: Aorta ratio. LPA EDF 
vel is for left pulmonary artery end diastolic flow velocity.  




Haemodynamically significant PDA 
Table 8.12 shows the differences in systemic blood flow and cerebral oxygenation, 
cerebrovascular reactivity and markers of haemodynamically significant PDA 
between an hsPDA defined by size. 
Table 8.12 Difference in systemic blood flow, cerebral oxygenation and 
cerebrovascular reactivity between hsPDA and non-hsPDA according to size 
 
 PDA ≤ 1.5 mm 
(N=49) 
PDA > 1.5 mm 
(N=105) 
P 
LVO (ml/kg/min) 264 (240 – 287) 306 (284 – 328) 0.010 φ 
RVO (ml/kg/min) 247 (222 – 271) 228 (211 – 245) 0.21 φ
 
SVC (ml/kg/min) 99 (86 – 111) 99 (90 – 107) 0.70
§ 
LA:Ao 1.3 (1.22 – 1.38) 1.4 (1.4 – 1.5) 0.003 φ
 
Ao 2% 32% 0.024
 Ω
 
LPA 0.10 (0.08 – 0.12) 0.17 (0.15 – 0.19) <0.0001
§ 
Pulsatile 51% 41% 0.30
 Ω
 
TOI 73 (71-75) 71 (69-72) 0.18
§ 
TOEF 0.23 (021-0.26) 0.25 (0.23-0.26) 0.85
§ 
TOx 0.16 (0.11-0.21) 0.11 (0.08-0.14) 0.08 φ 
TOHRx -.04 (-.08 - +.005) -.02 (-.05 - +0.01) 0.82
§ 
LVO: left ventricle output, RVO: right ventricle output, SVC: superior vena cava, LA:Ao: Left atrium 











Including only measurements of a PDA > 1.5 mm, a significant positive correlation 
between TOI and RVO was observed (r = 0.308, P = 0.003) and between TOI and 
SVC (r = 0.226, P = 0.033), but there was no correlation between TOI and LVO (r = 
0.15, P = 0.16). No correlation was observed between TOx and RVO (r = 0.188, P = 
0.074), LVO (r = 0.095, P = 0.37) and SVC (r = 0.188, P = 0.078). No correlation was 




observed between TOHRx and RVO (r = -0.054, P = 0.59), LVO (r = 0.024, P = 0.81) 
and SVC (r = 0.051, P = 0.61).  
The ‘Ao’ was associated with a higher PDA 2D diameter and a higher LVO, 
suggesting higher ductal steal and haemodynamic significance (Figure 8.6).  
Figure 8.6 Differences in mean PDA 2D diameter and mean LVO according to 
the presence of absence of reversal EDF in the post-ductal aorta 
 
Ao for presence of reverse EDF in the post ductal aorta. Mean (95% CI) for PDA 2D diameter when 
Ao was present was 2.16 (1.97-2.31) compared to 1.75 (1.65-1.84) in no-Ao measurements, P<0.001
§
. 





Mann-Whitney test.  
  
‘LPA EDF vel’ had a significant positive correlation with LVO (rs = 0.372, P<0.001), 
suggesting that higher velocity was associated with increased ductal steal.  
No significant difference was observed in mean TOI, TOEF, TOx or TOHRx when 
measurements were divided between no-hsPDA and hsPDA according to size and 









Table 8.13 Differences between systemic blood flow and cerebral oxygenation 







LVO (ml/kg/min) 262 (240 – 284) 328 (304 – 352) <0.001φ 
RVO (ml/kg/min) 224 (204 – 244) 245 (227 – 264) 0.13 φ
 
SVC (ml/kg/min) 93 (83 – 103) 103 (94 – 112) 0.06
§ 
TOI 72 (70 – 73) 71 (69 – 72) 0.53 φ
 
TOEF 0.25 (023 – 0.27) 0.24 (0.22 – 0.25) 0.40
§ 
TOx 0.14 (0.10 – 0.18) 0.11 (0.07 – 0.14) 0.18 φ 
TOHRx -.04 (-.08  – -.01) -.02 (-.05  – +0.01) 0.32
§ 
hsPDA in this table stands for PDA > 1.5 mm AND LA:Ao ratio > 1.4 or LPA EDF velocity > 2 m/sec 
or presence of reversal EDF in the post-ductal aorta (Ao) as described in the Methods section of this 
chapter.  
φ 




Table 8.14 shows the differences in measurements of haemodynamically significant 
PDA between IVH groups. Mean LPA EDF vel was higher in the ‘no-IVH’ group at 
12 and 24 hours of life. Reversed EDF in the post ductal aorta (Ao) was higher in the 
‘no-IVH’ group at 24 hours of life.  
Table 8.15 shows the difference in cerebral oxygenation, cerebrovascular reactivity 
and systemic blood flow between PDA groups (according to 2D diameter size only).  
Table 8.16 shows the difference in mean pH, PaCO2, lactate, Haemoglobin (Hb), 
SaO2, MABP and left ventricle stroke volume (LVSV) between IVH groups. Hb was 
significantly lower at 12 hours of life in infants who developed an IVH but 
significantly higher at 48 hours of life in this same group.  
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6h   
 
P 
12h   
 
P 
24h   
 
P 












































































































































































































































LPA EDF vel for end-diastolic flow velocity in the left pulmonary artery. Ao for presence of reversed flow in the post-ductal abdominal aorta. hsPDA for haemodynamically 
significant persistent ductus arteriosus. PDA 2D Diameter, LPA EDF vel are shown as mean and 95% confidence interval, the remaining variables as shown as absolute 
numbers. 
φ 
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Table 8.15 Difference in mean cerebral oxygenation, cerebrovascular reactivity, systemic blood flow and outcome groups between 





6h   
 
P 
12h   
 
P 
24h   
 
P 
48h   
 
P 
PDA ≤ 1.5 
(N = 5) 
PDA > 1.5  
(N = 18) 
PDA ≤ 1.5 
(N = 16) 
PDA > 1.5  
(N = 20) 
PDA ≤ 1.5 
(N = 11) 
PDA > 1.5  
(N = 27) 
PDA ≤ 1.5 
(N = 11) 
PDA > 1.5  




(58 – 86) 
70 




(69 – 78) 
70 




(68 – 76) 
71 




(69 – 78) 
71 






(0.24 – 0.35) 
0.26 
(0.23 – 0.29) 
 
0.34§ 
  0.23 
(0.17 – 0.28) 
0.26 




(0.18 – 0.29) 
0.24 




(0.17 – 0.28) 
0.23 






(-0.46 - +0.58) 
+0.10 




(+0.04 - +0.24) 
+0.10 




(+0.07 - +0.27) 
+0.12 




(+0.05 - +0.22) 
+0.12 






(-0.31 - +0.16) 
-0.06 




(-0.12 - +0.05) 
-0.03 




(-0.12 - +0.08) 
-0.01 




(-0.14 - +0.02) 
-0.002 






(119 – 356) 
238 




(200 – 281) 
251 




(244 – 327) 
342 




(250 – 368) 
380 




(116 – 299) 
168 




(173 – 258) 
195 




(225 – 319) 
261 




(250 – 356) 
267 




(60 – 105) 
79 




(69 – 121) 
87 




(84 – 130) 
104 




(73 – 129) 
113 




(29 – 37) 
32 




(27 – 32) 
31 




(29 – 36) 
32 




(32 – 39) 
31 
(30 – 32) 
 
0.005§ 
Results are shown as mean (95% confidence interval). φ Independent samples t-test. § Mann-Whitney test 
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Table 8.16 Differences in mean pH, arterial carbon dioxide (PaCO2), lactate, haemoglobin (Hb), MABP, peripheral arterial oxygenation 




6h   
 
P 
12h   
 
P 
24h   
 
P 






















(7.30 – 7.36) 
7.32 




(7.29 – 7.32) 
7.31 




(7.24 – 7.29) 
7.28 




(7.23 – 7.27) 
7.26 







(4.84 – 6.15) 
5.79 




(5.23 – 5.95) 
5.58 




(5.78 – 6.68) 
6.29 




(5.74 – 6.61) 
5.78 







(2.0 – 4.0) 
4.2 




(2.3 – 3.0) 
4.0 




(2.2 – 2.9) 
2.4 




(2.01 – 3.07) 
2.6 






(134 – 160) 
137 




(147 – 165) 
137 




(136 – 149) 
132 




(124 – 135) 
141 






(91 – 96) 
95 




(93 – 95) 
97 




(94 – 95) 
94 




(94 – 95) 
94 






(30 – 34)  
32 




(28 – 32) 
31 




(30 – 33) 
32 




(30 – 34) 
32 




(108 – 149) 
135 




(118 – 148) 
114 




(145 – 174) 
167 




(153 – 192) 
169 




Results are shown as mean (95% confidence interval). PaCO2 is for partial tension carbon dioxide. Hb is for haemoglobin. SaO2 is for peripheral arterial oxygen saturation. 
LVSV is for left ventricle stroke volume.  
φ Independent samples t-test. § Mann-Whitney test 
 





This study described the relationship between systemic blood flow, cerebral 
oxygenation and cerebrovascular reactivity in relation to the patency of the ductus 
arteriosus and their relationship with the presence of IVH, in a cohort of preterm 
infants undergoing intensive care within the first 48 hours of life.  
Changes in systemic blood flow within the first 48 hours of life and its correlation 
with IVH 
The significant increase in left and right cardiac outputs and SVC flow values over the 
first 48 hours of life as well as the mean (range) values of LVO and RVO were 
similar to data previously published by several authors
146, 235, 343
. However, the values 
for SVC were higher than values initially suggested by Evans et al. (2000), although 
the values for SVC range values were similar
56
. Most studies reporting ‘normal’ 
thresholds for LVO, RVO and SVC had data collected from stable term and preterm 
infants. Our cohort, in contrast consisted mainly of extremely preterm infants, many 
of whom were ventilated for the majority of time data was collected and half of whom 
were started on inotropes or vasopressors were commenced within the first 48 hours 
of life.  
Several other authors, in more recent work, have described higher SVC values within 
the two days of life
245, 344
. Even more recent work published by Kluckow et al. (2009) 
has shown fewer infants with an SVC flow of ≤ 41 mL/kg/min (described as low 
flow)
345
. The improvement in neonatal care over the last decade, with more consistent 
use of volume guarantee ventilation and antenatal steroids may have contributed to 
this increase in SVC values observed in more recent studies. Low SVC values were 
associated with IVH in a cohort of preterm infants born at less than 30 weeks’ 
gestational age
145
. Kluckow et al. (2000) observed that infants who developed severe 
IVH after 24 hours of life had low SVC initially but values improved to normal range 
just before IVH occurred
145
. This finding may support the hypoperfusion-reperfusion 
theory and the possible combining effects of systemic and brain haemodynamic 
changes in this cycle. However, in our study we did not observe a difference in mean 
SVC values between infants who had or did not have an IVH in any of the four time 




intervals within the first 48 hours of life (Table 8.3). Using a threshold of less than 40 
or 50 ml/kg/min as ‘low SVC’, the differences between groups remained unchanged. 
The patterns of changes in SVC were not significantly different between these two 
groups. The lack of association between SVC flow and IVH has been described by 
other research groups in more recent published work
245
.  SVC remains a very complex 
measurement, with high inter-observer variability and questionable reliability. These 
may be the main reasons why SVC has not been widely applied in clinical practice.   
In our population, mean LVO and mean RVO over the first 48 hours of life were not 
different between the IVH groups. Soon after we started collecting data for our 
‘SAMBA’ cohort in 2013, Noori et al. (2014) published data from a similar cohort of 
preterm infants, using a similar study design
341
. In their study, they did not find any 
difference between mean LVO in infants with or without IVH in the first 72 hours of 
life, but they showed that the pattern of changes in LVO tended to be different 
between these two groups. In our cohort, we did not find a statistical difference in the 
pattern of changes in LVO within the first 48 hours of life. However, similarly to 
those results described by Noori et al. (2014), we observed a trend towards a lower 
LVO around 12 hours of age in infants who later developed an IVH followed by a 
significant increase at 24 hours of age to levels above the mean LVO in the group of 
infants who did not develop an IVH (Figure 8.1). Noori et al. (2014) described this 
pattern of change in LVO as consistent with hemodynamic changes associated with a 
hypoperfusion-reperfusion cycle and, as similar to our data, the increase in LVO was 
observed just before the IVH occurred (around or soon after 24 hours of age for our 
cohort). They have also observed lower stroke volume and a trend towards a lower 
MABP at the start of the study in infants who later developed an IVH. Moreover, 
myocardial performance was better in the IVH group at the time the LVO increased, 
just before the IVH occurred. In our study, we did not observe differences in mean 
MABP between the IVH groups and nor was left ventricle stroke volume significantly 
different (Table 8.16). In the study from Noori et al. (2014), mean PaCO2 was higher 
in the IVH group at the possible reperfusion phase. In contrast, we did not observe 
significant difference in mean PaCO2 between these two groups at any time interval. 
However, the mean Hb was lower at 12 hours of age in the IVH group. This could 
reflect the initial bleeding in those who had IVH diagnosed at the scan performed 




around 24 hours of age and may have had an influence in the lower TOI and LVO 
observed at 12 hours of age. Interestingly, Hb was significantly higher at 48 hours of 
age in those who developed an IVH, although this could be related to blood 
transfusions received between these two time intervals.  
Changes in cerebral oxygenation within the first 48 hours its correlation with 
IVH 
In our cohort, cerebral oxygenation was significantly lower and the TOEF was 
significantly higher from 12 hours of life in infants who developed an IVH (Figure 
8.4 and Figure 8.5). Several studies have already reported lower cerebral oxygenation 
with higher oxygen consumption in infants who had brain injury
73, 341, 346
. In addition 
to these findings, our study demonstrated that the pattern of changes in the TOI was 
statistically different between infants who had and did not have IVH. Infants who did 
not develop an IVH seemed to follow a steady increase in the TOI from 6 hours of 
age, while infants who had an IVH showed a decrease in the TOI from 6 to 12 hours 
of age and levels remained lower in this group compared to the no-IVH group 
throughout the 48 hours. Noori et al. (2014) described an increase in the TOI in the 
IVH group to levels close to that in the no-IVH group at around 12 to 18 hours of age; 
we did not observe this in our cohort
341
. In our study, TOI appears to increase from 12 
to 24 hours, but this increase was not statistically significant.  
Correlation between cerebral oxygenation, cerebrovascular reactivity and 
measurements of systemic blood flow  
In order to explore further the changes in systemic and cerebral haemodynamics and 
the complex relationship between these two systems in the mechanisms involved in 
the possible hypoperfusion-reperfusion injury, we investigated the correlation 
between cardiac output and cerebral oxygenation for each time interval and for each 
IVH group independently. We observed a strong positive correlation between the TOI 
and left and right cardiac outputs, and in infants who developed an IVH, a negative 
correlation between TOx and LVO, at the 24-h interval. Because most infants in our 
cohort developed an IVH just before or after 24 hours of age, we could speculate that 
around the same time when reperfusion occurred, cerebral autoregulation and 




cerebrovascular reactivity were both impaired. Hence, cerebral oxygenation in those 
infants who developed IVH became passive to systemic blood flow (cardiac output). 
In addition, the lower the systemic blood flow (LVO), the more impaired was cerebral 
autoregulation (more positive TOx) (Table 8.10). As described in Chapter 5, 
extremely preterm infants are mainly pressure passive within the first 24 hours of age, 
as observed by the predominantly mean positive TOx. However, some degree of 
cerebrovascular reactivity seems to be intact as mean TOHRx over the first 24 hours 
of life was negative for nearly half of the cohort (results shown in Chapter 5, section 
5.2). Complete loss of mechanisms involved in vascular reactivity may have occurred 
either during the reperfusion period or during active haemorrhage.  
The correlation between continuous measurements of cerebral oxygenation, using 
NIRS, with static measurements of systemic blood flow, performed by functional 
echocardiography, has been applied in several studies but results remain 
controversial
347-349
. Takami et al. (2010) published a study in a small cohort of 16 
very stable preterm infants born at less than 29 weeks’ gestational age and small for 
gestational age and showed a positive correlation between TOI and SVC flow. In 
addition, they have described a significant decrease in LVO, SVC and TOI from 
around 6 to 12 hours of age. However there was no discrimination between infants 
who had or did not have IVH
350
. Dempsey et al. (2009, 2013) have reported different 
results regarding the correlation between TOI and SVC
349, 351
. In 2009, they reported a 
positive correlation between TOI and SVC flow in a cohort of infants with a birth 
weight below 1500 grams. In this same study they described no correlation between 
TOI and RVO or LVO (all echocardiographic measurements were performed at a 
mean age of 18 hours of life)
351
. Conversely, in 2013, the same group reported a 
negative correlation between TOI and SVC at 6 hours of life but no significant 
correlation between these two measurements at 12, 24 and 48 hours of life
349
. In our 
study, when measurements from all time intervals were included in the analysis 
(similar to the analysis done by Takami et al. (2010), RVO had a weak positive 
correlation with TOI and a weak negative correlation with the TOEF. In addition, 
SVC had shown a positive trend with the TOI and a weak negative correlation with 
TOEF. These weak correlations were probably reflecting, at least in part, the strong 




correlation between systemic and cerebral oxygenation at 24 hours of life in infants 
who developed an IVH.  
The controversial correlation between cardiac output and cerebral blood flow 
The evidence that changes in CO affect CBF is controversial. It has been suggested 
that CBF is controlled based on integrating mechanisms that would take into account 
changes in CO. It is already known from basic physiology that optimal organ 
perfusion is dependent on the relationship between blood pressure and specific organ 
vascular resistance and that distribution of cardiac output is dependent on the organ’s 
metabolic requirement
352
. There is evidence that dynamic cerebral autoregulation is 
not affected by acute changes in CO; however, it remains unknown if the plateau or 
upper and lower limits of autoregulation are changed when CO is altered. Studies in 
adults have shown that CBF may either be independent or passive of changes in 
CO
353-356
. In adult patients with stroke, an association between CO and CBF velocity 
(estimated using Transcranial Doppler) was present in areas affected with ischaemia 
but not in the unaffected areas
308
. Moreover, there is evidence that CO contributes to 
the regulation of CBF via sympathetic nervous system
357
. In neonates, there is not 
much evidence that changes in CO will result in changes in CBF. A short report from 
Kusaka et al (2005) has shown a positive correlation between CO and CBF in a small 
cohort of infants undergoing intensive care
320
. It has been suggested that CO would be 
regulated by changes in heart rate in preterm infants as a compensation for the 
immature myocardium
142
. In our study we only observed a positive correlation 
between CBF and CO in infants who had IVH and this correlation was only present 
around the possible time that reperfusion injury occurred. It is possible that regulatory 
mechanism may have been disrupted at that same moment, and that cerebral 
circulation in those infants with susceptibility to develop an IVH may be passive to 
changes in systemic haemodynamics. However, it will always be difficult to be 
precise as to the exact time of the start of the injury; therefore it is also possible that 
CBF became passive to CO during the actual process of bleeding.   
 




The controversial correlation between hsPDA and cerebral blood flow and 
oxygenation 
In studies assessing the relationship between CO and CBF, the presence of a PDA 
could be a confounding factor. In the presence of a haemodynamically significant 
PDA (> 1.5 mm and presence of left to right flow), LVO would reflect the pulmonary 
blood flow and RVO the systemic blood flow. Noori et al. (2014) argued that the 
differences in LVO patterns in infants with or without an IVH could be related to 
changes in the PDA rather than systemic blood flow
341
. In our cohort, more than 50% 
of the infants had a PDA above 1.5 mm before 48 hours of age, however other 
markers of hemodynamic significance and “ductal steal” such as an increased LA:Ao, 
presence of reversal flow on the post-ductal aorta, high LPA end diastolic flow 
velocity and high LVO, increased over the time intervals (Table 8.11), becoming 
more haemodynamically significant from 24 hours of age. Therefore, it is possible 
that, within the first 24 hours of life, LVO may still be a reliable trend measure of 
systemic blood flow and consequently ductal steal may not affect CBF.  
The relationship between a PDA and IVH is complex and possibly multifactorial. In 
our study, no correlation was observed between a haemodynamically significant PDA 
and the presence of IVH. Several other authors have reported this similar lack of 
association. The concept that a haemodynamically significant PDA is more frequently 
observed in infants who develop IVH has been based on findings from relatively old 
studies. Kluckow & Evans, 1996 were one of the first authors to observe that infants 
who developed an IVH had a larger PDA than preterm infants with who did not 
developed IVH. They have also observed that a severe IVH (grades III and IV) was 
associated with lower RVO, but no association with LVO was found. However, there 
are some important limitations in these studies. Firstly, in some infants, the PDA 
measurements were collected after the development of the IVH. Echocardiography 
was performed between 7 and 31 hours of age and they acknowledged this as a 
possible confounder factor. Secondly, antenatal steroids were not given to all infants, 
and the lack of antenatal steroids is an independent risk factor for the development of 
IVH
249
. Jim et al. (2005) have also observed that the incidence of IVH in preterm 
infants with haemodynamically significant PDA was higher compared to those with 
non-haemodynamically significant PDA
358
. However, in this study the IVH may have 




also occurred before the echocardiogram was performed. Measurements were 
collected at any time within the first week of life. In addition, possible confounders 
for fluctuations on cerebrovascular reactivity, such as mean airway pressure and 
PaCO2 were significantly higher in the group of infants who had a haemodynamically 
significant PDA
358
.  In our study, 100% of the infants who had echocardiography and 
were included in the data analysis received antenatal steroids. Moreover, most PDA 
measurements were performed before the IVH was detected on cranial ultrasound. In 
our study, when reviewing the cases of severe IVH, all infants who developed a 
severe IVH (grade III or IV) had a non-significant PDA within the first 24 hours of 
age and the PDA became more significant after the haemorrhage occurred.  
The impact of a haemodynamically significant PDA on CBF has been assessed in 
several studies using NIRS
252, 253, 255, 359
. In our cohort, there was no correlation 
between TOI, TOEF and the presence of a haemodynamically significant PDA. 
However, the definition of a haemodynamically significant PDA is not the same 
between different studies. Lemmers et al. (2008) defined a haemodynamically 
significant PDA (hsPDA) as having 2D diameter above 1.4 mm, LA:Ao ration above 
1.4 and LPA > 0.2, and investigated cerebral oxygenation (rScO2, equivalent to TOI) 
and TOEF before, during and after treatment of infants with a hsPDA with 
indomethacin. In this study, mean values of rScO2 and MABP were lower and TOEF 
were higher in infants with a hsPDA compared to infants with no PDA before and 
during the treatment. After the course of indomethacin was completed, mean values of 
rScO2 and MABP increased and TOEF decreased to levels similar to the control 
group. Furthermore, no difference in frequency of IVH in the hsPDA and control 
groups were observed Interestingly, in this cohort none of the infants had a severe 
IVH (grade III or IV). Lemmers et al. (2008) attributed the “ductal steal” as the 
possible cause of low rScO2 in infants with a hsPDA
253
. However, indomethacin may 
have had a direct influence on the increase in rScO2, as this drug has been shown to 
enhance cerebrovascular reactivity. Besides that, prophylactic indomethacin has been 
associated with decrease in severe IVH, which could explain the absence of IVH 
grade III and IV and reinforce the association between the effects of this drug on 
cerebral circulation.  




In a more recent study, Lemmers’ group used a different cohort to investigate the 
association between the PDA and cerebral oxygenation over the first days of life. The 
definition of an hsPDA was similar to their previous study from 2008, but in this more 
recent cohort not all infants received PDA treatment. Using mixed model analysis, 
they observed that ductal diameter was the only variable related to cerebral 
oxygenation when gestational age and small for gestational age were included in the 
model. Again, by applying mixed model analysis, they attempted to use rScO2 as a 
screening tool to detect an hsPDA, which would not be ideal as rScO2 may be affected 
by several other parameters than the ones they included in the model. Moreover, 
NIRS and echocardiographic measurements were performed after the first 12 hours of 




The association between cerebral oxygenation and a hsPDA described in those studies 
published by Lemmers’ group had been cited by several authors; however other 
research groups, using more simple statistical tests and different methodology have 
found similar results to our study. Petrova et al. (2011) assessed the difference in 
rScO2 between infants with a ‘moderate’ PDA (defined as diameter between 1.5 mm 
to 3 mm) and a ‘severe’ PDA (diameter above 3 mm) and found no difference in 
rScO2 and FTOE between the two groups
254
. More recently, van der Laan et al. 
(2016), using predominant left-to-right flow across the PDA, LA:Ao ratio >1.4, LPA 
EDF velocity > 0.3 and Ao as markers of hsPDA, and performing measurements at 
mean (range) 77 (70-107) hours of life found no difference in TOI or TOEF between 
hsPDA or no-hsPDA. However, they observed that LPA had a positive correlation 
with TOI and a negative correlation with FTOE. Similar to our results, they found a 
higher mean ductal diameter in the Ao and higher LPA in Ao. There was no statistical 
significant difference in the TOI between non-Ao and presence of Ao but the mean 
TOI was higher in Ao group, which was similar to our findings. No correlation 
between ductal diameter and TOI or FTOE was observed in that study and no 










The most important limitation of this study is the comparison between continuous 
NIRS measurements with static functional echocardiographic measurements. There is 
no consensus on how to average NIRS data for correlations with cardiac data. We 
averaged the NIRS around 1-hour interval just before or around the echocardiography 
measurements, always trying to avoid periods in which drugs or transfusions were 
given or inotropes and vasopressors were increased or decreased as they may affect 
CO measurements. Other studies have applied NIRS data averaged only before or 
only during echocardiographic measurements
341, 349, 350
. Ideally, continuous cardiac 
output should be applied for studies assessing correlation between systemic and 
cerebral blood flow. However, the presence of a PDA remains as a major confounder, 
as all existing methods to measure continuous CO measure surrogate values of LVO.  
Our cohort was small and our study was not powered to include multivariate analysis, 
including several other factors related to development of low systemic blood flow and 
changes in cerebral oxygenation related to IVH.  The immature myocardium has been 
claimed as one of the major aetiological factors related to the decreased CO and low 
CBF in preterm infants following birth
360
. However, changes in systemic and cerebral 
haemodynamics may be influenced by a combination of different factors, such as 
peripheral vascular resistance, end-organ metabolism regulation, autonomic response 
and genetic predisposition to IVH. The puppy model of hypoperfusion-reperfusion 
injury was based on induced hypovolaemia, as well as several other animal studies on 
cerebral autoregulation
36, 37
. However, in preterm infants other factors such as 
chorioamnionitis and early onset of sepsis may play an important role in the 
development of cerebral ischaemia during hypoperfusion phase with not necessarily 
important decrease in systemic and cerebral blood volume. 
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9. SUMMARY AND CONCLUSIONS 
Early monitoring of cerebral oxygenation, cerebrovascular reactivity and systemic 
blood flow can provide valuable information on the transitional circulatory function 
and on the pathophysiology of brain injury in preterm infants. Combining systemic 
with cerebral NIRS signals to optimise the management of blood pressure by using 
the strength of cerebrovascular control and information on end-organ perfusion is a 
feasible way to provide individualised care to preterm infants. Moreover, the 
complexity of cerebral NIRS signals during early hours of life, measured by using 
multiscale entropy analysis, can predict those infants who are at increased risk to 
develop GMH-IVH or die. Finally, the use of functional echocardiography may be a 
valuable tool to identify those infants with low systemic blood flow and with 
haemodynamically significant PDA within the first 48 hours of life. However 
combining static echocardiographic measurements with continuous cerebral NIRS 
signals was of limited value in predicting those infants at risk of developing brain 
injury.  
9.1. MONITORING OF CEREBRAL OXYGENATION AND 
CEREBROVASCULAR REACTIVITY IN PRETERM INFANTS 
UNDERGOING INTENSIVE CARE  
In Chapter 5, monitoring brain and systemic signals at the cotside was demonstrated 
to be feasible and easy to be incorporated to the routine clinical care. Recruiting sick 
preterm infants within the first hours after birth is challenging. However, the data 
from cerebral NIRS and systemic signals collected from the very early hours of life 
offer valuable information on the transitional circulation and could be used to predict 
which infants are at increased risk to develop IVH or die.  
Real time data collection, visualisation and analysis was possible with the use of 
ICM+®software. Data trends, artefacts and patterns were easily visualised. This made 
the retrospective analysis of the data more meaningful and individualised before batch 
and group analysis were performed to differentiate patterns of cerebral oxygenation 
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and cerebrovascular reactivity between outcome groups. The case reviews 
demonstrated the different patterns of cerebral NIRS and systemic data and the degree 
of intact or impaired cerebrovascular reactivity between infants with different 
pathologies.  
Data from all infants recruited for the ‘SAMBA’ cohort were included in the study 
shown in section 5.2. The correlation between cerebral autoregulation and 
cerebrovascular reactivity with the outcome of mortality and IVH, as well as with 
MABP and with gestational age was stronger in extremely preterm infants. More 
immature and sicker infants had more impaired cerebral autoregulation and 
cerebrovascular reactivity. Although most infants were pressure passive within the 
first 24 hours of life, which was demonstrated by a large number of infants with 
positive mean TOx, more than half of them had a negative mean TOHRx, showing 
that some degree of cerebrovascular reactivity may be present when the cerebral 
pressure regulation is lost. The association of mean values of TOx and TOHRx with 
outcome of IVH and mortality was affected by the heterogeneity of the data and the 
presence of outliers. Although none of the infants died before 48 hours of life and the 
relationship between IVH and death was not statistically significant, most of them had 
a degree of poor end-organ perfusion within the perinatal and immediate neonatal 
period.  
9.2. OPTIMAL BLOOD PRESSURE IN PRETERM INFANTS  
The results from Chapter 6 demonstrated that individual targeting of MABP based on 
the strength of cerebrovascular reactivity index (TOHRx) was feasible and safe. The 
combined analysis of cerebral NIRS signals with continuous monitoring of MABP is 
potentially a more reliable method to estimate end-organ perfusion than the individual 
analysis of these two signals.  
In preterm infants born ≤ 32 weeks, the analysis of the NIRS data collected at any 
time within the first 72 hours of life showed that lower MABP than MABPOPT was 
associated with a higher mortality rate, while infants with MABP greater than 
MABPOPT by at least 4 mmHg had significantly severe IVH, as shown in Chapter 6, 
section 6.1.   
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In Chapter 6, section 6.2, the methodology was refined and MABPOPT was calculated 
from prolonged periods of continuous NIRS and MABP data from extremely preterm 
infants at less than 24 hours of life. Mean deviation below MABPOPT was 
significantly higher in infants who developed IVH and infants who died later during 
neonatal period. MABPOPT was significantly higher in infants who developed an IVH 
and lower in infants who had inotropes or vasopressors started within the first 24 
hours of life. Because the majority of these extremely preterm infants developed an 
IVH around or after 24 hours of age, the deviations below MABPOPT in the ‘IVH 
group’ may represent the degree of cerebral hypoperfusion before the haemorrhage 
occurred.  
The MABPOPT approach would help on individual care based on the strength of 
cerebral vascular reactivity. Further development of these monitoring techniques and 
refinement of the methodology should enable the implementation of a bedside tool 
that could determine MABPOPT in near real time.  
9.3. THE ASSOCIATION BETWEEN THE COMPLEXITY OF BRAIN SIGNALS 
AND OUTCOME IN PRETERM INFANTS  
In Chapter 7, multi-scale entropy analysis was applied to assess the complexity of 
brain and systemic signals in preterm infants undergoing intensive care. NIRS and 
systemic data collected within the first 24 hours of life were used, and the calculation 
of complexity index of brain and systemic signals was feasible when at least six hours 
of continuous data were available.  
Decreased complexity of cerebral signals was more strongly associated with outcome 
of IVH and mortality than the complexity of systemic signals. Infants who died or 
developed an IVH had lower mean complexity index of HbO2 and Hb compared to 
those who did not have an IVH or survived. Furthermore, the complexity index of 
HbO2 was independently associated with an increased likelihood of having IVH when 
binary logistic regression analysis was performed and included CRIB II and presence 
of sepsis in the model.  
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Decreased variability in physiological signals is a sign of failure in complex 
regulatory system. The use of entropy analysis has been extensively studied to 
investigate physiological systems. However, the continuous monitoring of neonatal 
vital signs does not take in consideration the non-stationarity characteristic of the 
biological signals. Therefore, real-time cotside complexity signal analysis could offer 
more information on infants who are at increased risk to develop brain injury or die 
and represent a significant advance in the brain oriented care of critically ill newborn 
infants.  
9.4. CARDIAC FUNCTION IN PRETERM INFANTS DURING TRANSITIONAL 
CIRCULATION  
In Chapter 8, functional echocardiography measurements were used to assess the 
relationship between changes in cerebral and systemic haemodynamics in preterm 
infants during the transitional circulation. Left and right cardiac output and SVC flow 
increased significantly over the first 48 hours of life in preterm infants, but there was 
no significant difference in these measurements between the IVH groups.  
The pattern of changes in LVO, RVO and SVC were not different between the IVH 
groups, however mean LVO tended to be lower in infants who developed an IVH at 
12 hours of life with a significant increase from 12 to 24 hours. On the other hand, the 
pattern of change cerebral oxygenation between IVH groups was significantly 
different and mean TOI was significantly lower in infant who developed IVH from 12 
hours onwards.  
The correlation between systemic blood flow and cerebral oxygenation and 
cerebrovascular reactivity was weak for the group analysis. However, a strong 
positive correlation was observed between cardiac output and TOI at 24 hours of life 
in the IVH group. There was also a negative correlation between TOx and LVO at this 
same time in the IVH group, suggesting that more impaired cerebral autoregulation 
was present with lower cardiac output. Moreover, this finding may suggest that 
cerebral blood flow may have become passive to changes in cardiac output around the 
same time that the haemorrhage occurred, as most infants in the study developed 
GMH-IVH around or soon after 24 hours of life.  
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PDA measurements had a significant change within the first 48 hours of life. 
Measurements of ductal steal such as Ao, LPA EDF velocity and LA:Ao ratio 
increased between 6 to 48 hours of life. However, the presence of hsPDA had no 
association with IVH or with cerebral oxygenation. Although our sample size was 
small, most infants had PDA measurements performed before the haemorrhage 
occurred, which may suggest the reliability of our results on the lack of significance 
between ‘ductal steal’ and IVH. 
In conclusion, neonatal functional echocardiography may be a useful tool to assess 
changes in systemic blood flow and ductal patency in preterm infants during the 
transitional circulation. However, the lack of correlation between LVO, RVO and 
PDA with NIRS signals of cerebral oxygenation and cerebrovascular reactivity 
demonstrates the difficulties in assessing changings between systemic and cerebral 
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10. FUTURE WORK 
Future research on early monitoring of brain and systemic signals in preterm infants 
should ally non-invasive methods to assess cerebral and systemic haemodynamics 
with advance methods to combine and analyse data.  
10.1. EARLY RECRUITMENT AND DATA COLLECTION FROM EXTREMELY 
PRETERM INFANTS 
The work presented in this dissertation showed the importance of monitoring the 
changes in cerebral and systemic haemodynamics within the first 24 hours of life. 
Future studies should focus on collecting cerebral and systemic data as soon as 
preterm infants are admitted to the neonatal intensive care units. However, this will 
always demand dedicated and motivated research and clinical teams.  
Ideally, future studies should stratify the population according the gestational age. 
Sick preterm infants born ≥ 28 weeks may have a different adaptation from preterm 
infants born < 28 weeks and the regulation of cerebral blood flow to the brain is 
possibly different between these two groups. The results showed in Chapter 5, section 
5.2 and in Chapter 6, section 6.2 had stronger association with outcome when infants 
born at less than 28 weeks were included in the analysis.   
10.2. THE FUTURE OF NEUROCRITICAL CARE MONITORING 
The addition of extra sensors and monitors to the standard care of small and fragile 
infants are usually seen as a burden from parents and medical and nursing staffing. 
Ideally, future neonatal intensive care monitors should combine a minimally invasive 
approach with high technological data analysis. Wireless sensors to monitor heart rate 
and SaO2 are under development, but the technology remains unreliable and 
expensive. Future cotside monitors should offer more information than data averaged 
every seconds or minutes. In the era of artificial intelligence and big data analysis, our 
cotside monitors still offer limited information. Ideally, every infant admitted to an 
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intensive care cot should have a combined software like ICM+
®
, which collects raw 
data and allows real-time data analysis and display with easy visualisation for the 
clinician.  
10.3. THE IMPORTANCE OF OPTIMISING BLOOD PRESSURE CONTROL IN 
PRETERM INFANTS 
Feasibility trials on the management of adult patients with traumatic brain injury 
according to optimal CPP values are currently being undertaken. In neonates, 
managing preterm infants according to MABPOPT remains a new concept. The 
methodology used to define MABPOPT is promising however more studies on refining 
this method and applying the MABPOPT approach on the clinical management of 
preterm infants should be considered.  
10.4. NIRS DATA MAY PROVIDE MORE INFORMATION THAN 
THRESHOLDS AND TRENDS 
Several studies have been published on cerebral NIRS since we started the data 
collection for the work included in this dissertation. Most of them focused on defining 
thresholds of cerebral oxygenation and advocated the use of NIRS as cotside tool. 
However, a few studies applied the combination of NIRS with systemic signals or 
used more refined methodology to analyse the data. The use of multiscale entropy 
analysis to define complexity of brain signals and predict outcome is promising. 
However, future studies using similar methodology should focus on using short period 
of data and improving artefact detection. 
10.5. NON-INVASIVE CARDIAC OUTPUT MONITORING  
The relationship between systemic blood flow and cerebrovascular reactivity may be 
better understood by using measurements of continuous CO. Thoracic electrical 
impedance (TEI) technology is a continuous non-invasive method of CO monitoring, 
which is based on the principle that electrical conductivity of blood is higher than that 
of muscle, fat and air cells
361
.This technology has been validated in term and preterm 
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infants and the accuracy and precision was comparable to echocardiography to 
estimate CO in term infants 
362, 363
. However, further work is required to validate this 
technique in the preterm population, taking into account the challenges posed by the 
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